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The presence of bacteria in patient tumours of various types has been reported by 
numerous groups since 2014, but the findings of these and many similar studies 
remain contentious. Tumour samples provide many obstacles to carrying out robust 
and reliable microbial surveys, primarily the anticipated low biomass of these 
samples, which leaves them vulnerable to environmental contamination. While the 
debate over the presence or absence of bacterial communities in these tumours 
continues, it impedes any research into how such bacteria might be utilised in 
medicine. Larger sample numbers are required, from diverse tumour tissues within 
the human body, and these must be analysed in a reproducible and accurate manner 
to allow for the drawing of definitive conclusions in this debate. To accommodate 
this requirement, the primary methodological aspects of this thesis were: i) The 
assembly and validation of a contamination control pipeline using recent advances is 
bioinformatic contamination control detection. ii) The development and validation of 
a bacterial DNA extraction protocol for formalin fixed, paraffin embedded (FFPE) 
samples, with accompanying FFPE biological standards for use as controls. A key 
aim of this thesis was to increase the accuracy and reproducibility of research into 
clinical tissue biopsies by eliminating the role of contamination, and to expand the 
applicability of FFPE tissues which represent an invaluable resource of samples for 
analysis.  
 
In this thesis, ecological surveys of a variety of related environments were conducted 
with the common goal of characterising a detectable bacterial community and 
identify potential bacterial biomarkers unique to these host environments. Regardless 
of whether or not a consistently present and detectable tumour microbiome exists, 
tumours possess several phenotypes making them hospitable environments for 
bacteria to colonise. Where the unique physiology of tumours is seen as an obstacle 
for traditional cancer treatments, they represent an opportunity for bacterial-mediated 
solutions. Therefore, findings from sequencing-based research of host environments 
have potential to be translated into the use of administered bacteria as delivery 





There are two considerations in this context, requiring two very different 
applications of bioinformatics. i) The first is to identify which bacteria colonize the 
desired niche in body; this can be a ‘foreign’ body such as a tumour (Chapter 3 and 
4), or parasite (Chapter 5), or a distal niche such as the gut. ii) The second, often 
under-considered parameter, relates to what these bacteria produce. Synthetic 
biology presents enormous scope for sophisticated medical therapy mediated by 
novel synthetic proteins. However, the task of getting a bacterial cell to successfully 
express and secrete a stable protein that it does not produce naturally is far from 
trivial, and is becoming a key aspect of the synthetic biology field. To facilitate this 
synthetic protein aspect, a novel strategy for the performance prediction of designed 
protein constructs was developed. This tool was able to predict the overall 
performance of a protein construct in vitro using only in silico derived data.  
 
Thesis aim: 
This thesis aimed to develop novel strategies for the analysis of bacterial 
communities within tumours by i) increasing the sample sizes available to future 
projects by enabling the use of FFPE samples and ii) improving the accuracy of 
analysis by designing bioinformatics analysis pipelines appropriate for these 
samples. This enabled further research concerned with finding differentially present 
taxa between the tumour and surrounding environment, which have the potential for 
use as therapeutic vectors. As the key aim is to establish the presence of potential 
bacterial therapeutic vectors rather than to establish the role these bacteria play in 
tumorigenesis, this approach is easily translatable to other foreign bodies, and could 







16S ribosomal RNA gene: Transcribed form of the small subunit gene located in 
the 30S subunit of a prokaryotic ribosome. Contains 9 variable regions that can be 
targeted for amplification and used for profiling of microbial communities.  
ASV: Amplicon Sequence Variant. Refers to individual DNA sequences recovered 
from high throughput marker gene sequencing following the removal of spurious 
sequences.  
BER: Base Excision Repair 
DADA2: Divisive amplicon denoising algorithm 
FFPE: Formalin-Fixed, Paraffin-Embedded 
LASSO: Least absolute shrinkage and selection operator 
MICROBIOME: The genetic material of all microorganisms that live on or in an 
ecological niche, such as the human body. 
MICROBIOTA: The ecological community of commensal, symbiotic and 
pathogenic microorganisms found in and on all multicellular organisms.  
NGS: Next Generation Sequencing 
NMR: Nuclear magnetic resonance 
OTU: Operational Toxonomic Unit. Cluster of sequences with similarity above a 
specified threshold, eg. 97%.  
PCR: Polymerase Chain Reaction 
qPCR: Quantitative Polymerase Chain Reaction 
QIIME: Quantitative insights into microbial ecology 
READS: DNA segments obtained from a sequencing experiment.  
SNP: Single Nucleotide Polymorphism.  
VARIANT CALLING: Process of identifying variants between closely related sets 
of sequence data, typically taking the form of SNPs. 










SECTION 1: SEQUENCING AND THE MICROBIOME 
A portion of this section has been submitted as “Bioinformatics Platforms for 
Metagenomics”, currently under review with the Elsevier editorial team as part of 
the book “Comprehensive Foodomics” 
Julia Eckenberger* 1,2 , Sidney Walker* 1,2,3 , Marcus J Claesson 1,2 






Introduction to the Microbiome 
The term Microbiome refers to the cumulative genetic material found within a 
microbiota. The Microbiota is a term used to define a community of micro-
organisms living within an ecological niche. These niches range from well 
researched environments such as the human gastro-intestinal tract (1) or vaginal 
tract(2) to some of the most extreme locations where life has been found. These 
include the Door to Hell gas crater in the Karakum Desert of Turkmenistan, Deep-
sea brine lakes in the Gulf of Mexico, and the Permafrost of Siberia(3).  
The Human Microbiome 
Current estimates place the size of the human microbiota at between 10 and 100 
trillion microbial cells, spanning the kingdoms Bacteria, Archaea, Fungi and 
Viruses(4). The study of these microbial communities within the human host owes 
its origins to Antonie van Leewenhoek. As early as the 1680’s this Dutch scientist 
was comparing his faecal bacteria with his oral bacteria, although calling them 
“animalcules” at the time(5).  
Research into the human microbiome has focused predominantly on the niches 
outlined in below; 
• Oral Microbiome(6) 
• Skin Microbiome(7) 
• Gastro-Intestinal tract microbiome(1) 
• Urogenital tract microbiome(8) 
• Nasopharyngeal tract microbiome(9) 
The number of human body sites found, or suspected to harbour endogenous 
microbial communities is constantly increasing and now potentially includes sites 
such as the brain, breast tissue(10), the lungs(10) and a variety of tumour sites(11). 
Sites such as these typically harbour considerably lower levels of micro-organisms 
than the more thoroughly researched tract-based microbiomes, as such there is a risk 
of environmental contamination mistakenly being recognised as biological 




Human Microbiome in Cancer 
The human microbiome is known or suspected to play a role in a diverse spectrum of 
host indications. Due to the incredible potential for therapeutic use or intervention, a 
plethora of studies can be found investigating possible links between specific micro-
organisms, or fluctuations in the overall microbial community at a given niche and 
cancer. This relates in particular to the gut microbiome (13). To date, the only 
definitively proven causative link between a bacteria and cancers is that of H. pylori 
and gastric adenocarcinoma as proven by Barry Marshall in 1983 (14) and mucosa 
associated lymphoid tissue lymphoma. This has led to H. pylori being the only 
bacteria identified as a class 1 carcinogen by the World Health Organisation (13). 
Research is ongoing into the role played by other bacteria in cancers, and there are 
several interesting prospects that encourage further research. Fusobacterium has 
been consistently found enriched in patients with colorectal cancer(15) suggesting 
the strong possibility of a causative link. This is supported by a potential mechanism 
as Fusobacterium nucleatum in particular has been shown to recruit tumour-
infiltrating immune cells, contributing to the generation of a pro-inflammatory 
environment conducive to the progression of colorectal neoplasia (16).  Recently 
published work highlights how infection with Salmonella enterica serovar Typhi 
through a cascade of events can leave individuals with a considerably elevated risk 
of developing gallbladder cancer. This involves both the secretion of a typhoid toxin 
with carcinogenic potential, in conjunction with biofilm production promoting a 
persistent infection(17).  
In addition to the numerous studies hypothesising causal relationships between 
bacteria known to commonly colonise human hosts and cancer, certain protective 
interactions may also exist. The most interesting of these is that despite being 
classified as a class 1 carcinogen, H. pylori infection is associated with a reduced 
risk of Barrett’s Aesophagus, but considerable follow up work is required before any 
medically significant conclusions can be drawn from this inverse association(18).   
 
Intratumoural bacteria? 
There have been several conflicting studies in relation to the presence of a 
consistently detectable tumour microbiome since the concept was first postulated 




communities in new tumour sites (11,20,21) has been matched evenly number of 
studies urging caution when seeking to characterise novel environments of low 
biomass, due to their susceptibility to contamination (22,23). More high-quality 
research, accounting for the numerous sources of error when analysing samples of 
this type is required before this question can be definitively answered.  
 
Sequencing 
Three generations of sequencing strategies 
Moore’s Law states that the number of transistors on a microchip doubles every two 
years, along with a halving in the overall cost (24).  As sequencing technology 
improves in accuracy and price in accordance with this law, it is an extremely 
dynamic field that is difficult to precisely define. To assist in this, different 
sequencing strategies are grouped together in different generations of the technology, 
a current snapshot of the state of the art is as follows.   
Sanger sequencing, developed in 1977, is referred to as the first generation of 
sequencing. While still widely used for some projects due to its relatively long read 
length, on average 650 base pairs, and high accuracy, it is not an appropriate tool for 
metagenomics studies due to its low throughput and relatively high cost (25).  
Next generation sequencing methods are massively parallel and can often produce 
millions of reads during a typical run, where genomes present are sequenced 
repeatedly in small random fragments. The two predominant NGS methods are Ion 
Torrent and Illumina but differences between them in terms of cost, underlying 
chemistry, output and accuracy mean they are not always suited to the same tasks. 
The Illumina sequencing platforms provide the most popular sequencing solutions 
owing to their low cost, high accuracy, and high output (26). They function by 
synthesising the complementary strand of DNA present in a sample followed by 
fluorescence based detection of DNA bases. The Illumina MiSeq platform offers low 
sample output of up to 15Gb but relatively long reads at an affordable price. The 
paired end functionality offers overlapping reads of up to 300bp each, making this 
the technology of choice for amplification based sequencing experiments such as 
16S rRNA gene sequencing. Other Illumina platforms such as the HiSeq, NextSeq 




but with shorter read lengths of up to 150bp (27).  Ion Torrent sequencing platforms 
also sequence by synthesis of the complementary strand, but detection of the base 
composition relies on pH meters measuring the release of hydrogen ions when the 
DNA is polymerised. The sequencing run is shorter, taking only hours compared to 
days for Illumina technology, and the read length yielded is up to 400bp, however 
only single end reads are available and the low total output of up to 15Gb makes this 
technology impractical for anything other than amplicon sequencing, this method 
also has a higher error rate when long repeat regions are present in the sample (28). 
In the context of WGS, the short reads generated by second generation technologies 
often yield incomplete genome assemblies. In more complex cases such as genomes 
with long repeat regions, paralogs or bacteriophages, longer reads are often required 
to close the genomes (29). Third generation sequencing platforms targeting 
individual DNA molecules, have been developed to meet this demand. The two 
platforms currently available are the Oxford Nanopore sequencing methods, and the 
Pacific Biosciences PacBio platform. Nanopore sequencers identify DNA bases 
based on the changes in electrical conductivity due to a DNA strand passing through 
a biological pore. There are a variety of Nanopore solutions available based on the 
number of flow cells they contain, ranging from the portable minION, designed for 
use in the field to the scaled up promethION with on board data processing. These 
Nanopore methods produce reads of up to 100kb in length (30). The PacBio platform 
uses single molecule real-time sequencing technology (SMRT). Similarly to the 
Illumina short read technologies the sequencing is synthesis based and uses 
fluorescent dyes, but in this instance single stranded DNA molecules are sequenced 
individually by being deposited in wells with immobilised DNA polymerase (31). 
The PacBio Sequel2 is the current state of the art technology in this respect and can 
sequence reads up to 60kb in length. As these third generation strategies begin to 
reliably upscale their output, their use in metagenomics studies will become more 








Table 1.1: Summary of major sequencing solutions and their associated 
performances 
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Sequencing an ecological niche 
Strategies for characterising a microbial environment are split into two distinct 
categories, amplification based sequencing and whole genome shotgun sequencing. 
These two approaches differ considerably in terms of cost, information content and 
sample requirements. Unfortunately there is no one size fits all solution, and the 
decision on which strategy to pursue should be performed on a study by study basis.  
Amplification based methods 
Amplicon sequencing refers to the sequencing of PCR products, obtained by a 
targeted amplification of a variable region of interest. In human genomics this is 
often carried out to test for somatic mutations in specific exons, in metagenomics 
marker genes are targeted to characterise complex environments that may not be 
fully described with a whole genome sequencing approach. Common marker genes 




discriminate bacteria and some archaea(32), and the internal transcribed spacer (ITS) 
region for fungi(33).  
The 16S rRNA gene sequence is sequence within the 30S small subunit of the 
ribosome, a small subunit has an integral function in mRNA translation(34). The 16S 
rRNA gene sequence is almost ubiquitous in bacteria, and present in many archaea, 
it consists of highly conserved regions that can be targeted by primers, interspersed 
with hypervariable regions making it an ideal genetic marker(35) for bacterial 
characterisation. The sequence is ~1500bp in length, and contains nine hypervariable 
regions varying in length and conservation(36). As most microbial surveys are 
carried out using Illumina technology, which have a maximum read length of 
2x300bp, a subset of these hypervariable regions are usually selected for 
amplification and eventual sequencing. No one hypervariable region reliably 
outperforms all others although considerable research has gone into comparing and 
contrasting the effectiveness with which different regions can resolve complex 
bacterial communities (36,37).  The level of variability in each of these 9 regions is 
shown in the figure below, adapted from research by Bodilis, J et al(38). The higher 
this variability, the better the discriminatory power between bacterial taxa.  
 
Figure 1.1: Variability over the length of the 16s rRNA gene sequence. Window 
size = 50 bases. (Adapted from (38).) 
 
The two most commonly used regions at present are V1-V2 and V3-V4 regions(37), 
although an eventual shift to sequencing the entire gene sequence with 3rd generation 




when combining primers to cover a region spanning 80% of the 16S rRNA gene 
sequence(39).  
WGS Sequencing 
Whole genome shotgun metagenomics entails non targeted sequencing of all genetic 
material in a microbiome, resulting in the key difference that while marker gene 
studies can tell us what organisms are present, the presence of entire genomes 
yielded by WGS gives detailed information about metabolic potential, evolutionary 
relationships, and the structure and organisation of microbial genomes. Since the 
seminal work by Craig Venter in 2004(40) sequencing microbial populations present 
in the Sargasso Sea, this sequencing strategy has contributed to breakthroughs in a 
range of research areas. These range from bacterial associations in Inflammatory 
Bowel Disease(41) to tracking the outbreak of human and foodborne pathogens(42). 
WGS sequencing vs 16S sequencing for characterising a bacterial community 
Before deciding on which approach to take, there are advantages and disadvantages 
to both approaches that must be considered, which are outlined in the table below. 
Table 1.2: Comparison of 16S rRNA gene sequencing and Whole Genome 
Shotgun sequencing, for exploration of bacterial communities. 
 16S rRNA WGS 
Cost • Minimum 10x cheaper per 
sample than WGS 
metagenomics sequencing 
• Analysis more accessible as 
less computational power 
needed 
 
• Prohibitively expensive for 
smaller labs 
• Requires considerable 




• Provides data specific to 
amplicon used, ie. 
Bacteria/archaea with 16S 
rRNA 
• Genus level resolution with 
some species level resolution 
possible 
• Taxonomy only, with some 
• Provides data on all micro-
organisms present in a 
sample 
• Species and strain level 
resolution possible 
• Detailed taxonomic and 
functional information 





information using tools such as 
PICRUST2 
generated with sufficient 
sequencing coverage 
Suitability • Amplification step can 
introduce bias in samples of 
low biomass due to presence of 
contaminant DNA or large 
quantities of host DNA in 
biopsies. 
• Databases more comprehensive 
when characterising novel 
environments, as they are 
easier to populate  
• Less susceptible to bias as 
no amplification is 
required.  
• No amplification means 
that in biopsies where host 
DNA can make up ~99% 
of all DNA, WGS is 
unsuitable without 
microbial enrichment.  
 
These methods are not mutually exclusive, and often an effective trade-off is to carry 
out a broad analysis with an amplicon sequencing method, before proceeding to 
WGS metagenomics with a subset of interest. Figure 1.2 below outlines the two 







Figure 1.2: The divergence and convergence of WGS vs Amplicon sequencing 
strategies 
 
Analysis of Bacterial Sequence Data 
Quality Filtering of sequence Data 
As mentioned, the quality of sequencing data returned can be variable, so quality 
filtering of this data is always a crucial first step in any analysis. This is particularly 
important when working with 2nd generation sequence data. Although the error rate 
in 3rd generation technologies is higher, it remains stable across the length of the 
sequence, whereas 2nd generation sequencing technologies, Illumina in particular, 
have a quality profile that depreciates with sequence length, particularly in the 
reverse read of a pair(43). This makes quality filtering prior to downstream analysis 
a critical step in any analysis pipeline.  
The typical output of a sequencing experiment is paired or unpaired reads, in the 
fastq format (Illumina and Ion Torrent). This format contains sequence information 
and a corresponding per base quality score called a Phred score. This ranges from 1-
40 and is translated as -10 x log10(P), with P being the probability of a base being 




the base being called incorrectly, whereas the maximum score of 40 means a 
1:10,000 probability of error.   
The fastq file format, contains sequence data with machine readable error 
annotations for each sequenced base and serves as input for most programmes which 
are utilized to trim away lower quality reads, either based on manual visual analysis 
and trimming to a certain length, setting a minimum quality cut off, or both. Freely 
accessible technologies for quality filtering sequence data include Trimmomatic(44) 
and Fastx toolkit(45). 
 
Figure 1.3: The FastQ format 
 
16S Sequence Analysis 
The operational taxonomic unit, as coined in 1965(46) is generally accepted to refer 
to closely related groups of organisms, that are clustered into one “OTU” based on a 
threshold of identity, typically 97%. 16S sequence data can be collapsed into these 
units either by clustering sequences against a 16S reference database, in what is 
called “closed reference” OTU picking, or clustered based on pairwise similarity, 
which is called de novo OTU picking. While opinion is divided on which method 
returns the more biologically relevant taxonomic unit, the increased computational 
demands of “closed reference” picking means that “open reference” is the only 
option available to those without access to a computing cluster(47). A shortcoming 
that applies to OTUs regardless of which picking method is used is that a certain 
amount of diversity is obscured during the clustering process. The original purpose 
of clustering was to shield against spurious false speciation events that are a function 




that OTUs can be considered obsolete and a new method able to explore the full 
diversity of bacteria in an environment is more suitable.  
New methods have been developed resolving sequence data into Amplicon Sequence 
Variants (ASVs). Each ASV directly relates to a bacterial or archaeal sequence 
found in the original sample, prior to amplification. These methods function on the 
assumption that biological sequences are more likely to be repeated than sequences 
containing erroneous bases. These require the constructon of an error model, built on 
the reads present in the sequencing run that correct errors by a process termed 
“denoising” (48).  
The two premier facilities for generation of Amplicon Sequence Variants are The 
Divisive Amplicon Denoising Algorithm (DADA) 2 and DeBLUR. DADA2DADA2 
first constructs an error model trained on a user defined subset of the dataset, before 
collapsing the reads found into ASVs. The key advantage of training the error model 
on the entire dataset is that it allows for the merging of different sequencing runs 
prior to analysis by accounting for any run bias(49). Deblur also employs a 
“denoising” approach facilitated by an error model. In this instance the model is 
constructed on a per sample basis, which significantly reduces computational 
memory requirements, but means the algorithm is unable to compensate for batch 
effects when merging samples(50).  
Regardless of which unit is used to represent the genetic material present in a 
sample, the process of taxonomic classification remains constant. Several databases 
of 16S rRNA gene sequences exist, the most popular of which are SILVA(51), the 
Ribosomal Database Project (RDP) (52), and Greengenes(53). Of these, SILVA is 
the most regularly updated. Aligning sequence data to these databases would cause 
considerable computational bottlenecks, and to alleviate this a variety of tools exist 
to merge sequence data with the information provided by these databases as 





Table 1.3: Databases available for analysis of meta-barcoding sequencing data. 




Dec 2017 85% Bacteria, some 
Archaea and Eukaryota 
RDP 3,356,809 Total Sep 2016 Comprehensive 
Bacteria and Fungi, 









Sep 2019 Eukaryota 
The classify.seqs tool within Mothur is a versatile taxonomic classifier. It allows the 
user to dictate which database is used, and also whether to employ a k-mer or k-
nearest neighbour approach. The k-mer approach examines each query sequence as a 
collection of 8 base k-mers and assigns taxonomy based on their cumulative 
probabilistic classification. The k-nearest neighbour approach first finds the 10 most 
similar sequences to the query sequence in the selected database, and then uses thee 
to generate a consensus classification(56).  
As mentioned, classification of 16S rRNA gene sequence reads beyond genus level 
is unreliable and some cases impossible. For example, E.coli have seven different 
copies of this sequence(57). SPINGO is a stand-alone tool dedicated to this 
challenge. It uses a customised modification of the RDP database containing 95210 
sequences which represent 12394 species. This is queried using k-mer fragments of 




More detailed analysis of different steps and considerations involved in 16S rRNA 
gene sequence analysis more pertinent to the scope of this thesis is provided in 
section 4 of this Literature Review, entitled “Characterising intratumoural bacteria.” 
WGS Sequence Analysis 
The expansion in applicability of whole genome shotgun sequencing has been 
mirrored only by the rapid advances in the number of bioinformatics platforms 
available for analysis of the ensuing data. Be it for aligning reads to reference 
genomes, assembling reads into contiguous segments of overlapping DNA (contigs), 
or functionally annotating a metagenome, there is a myriad of potential tools, none 
of which outperform all others in every circumstance. A comprehensive review of 
the relevant literature is recommended before undertaking any analysis of shotgun 
sequence data.  
Whole genome sequencing (WGS) strategies fall under two umbrella terms, based on 
whether the target DNA is well characterised, or if novel DNA is expected. Simply 
put, if the sample is expected to contain previously characterised bacteria, taxonomic 
and functional annotation can be performed by referring to available databases. If 
these are not available, sequencing reads must be manually assembled into contigs 
using a variety of methods. There are advantages and disadvantages to both 
approaches that must be considered before proceeding beyond this point.  
The depth of read coverage of genomes present can dictate which method to use, as 
20x coverage is generally recommended as a minimum for genome assembly(28). 
This limits the effectiveness of assembly-based methods in analysing complex 
microbial communities given the current sequencing technologies available.    
Genome assembly, and the associated downstream tasks are computationally 
intensive which can often limit the size of the study, whereas most reference based 
methods emphasise efficiency allowing for large scale metagenomics analyses(59). 
As is indicated by the name, reference-based methods require a database which 
contains at a minimum closely related microbes to those found in the samples, 
whereas assembly-based strategies are able to resolve genomes of novel 
organisms(60).  While some degree of manual supervision is required for reference-
based assembly, the tools involved require minimal intervention when compared to 




binning(28). The theory of metagenomics assembly is the same in principle as 
genomic assembly, and the same underlying principles are observed.  
 
Assembly of metagenomics samples 
Most metagenomics assemblers use a modification of the De Bruijn Graph 
approach, however as sequencing errors dramatically increase the size of the graph, 
and therefore the processing power required, overlap-layout-consensus methods 
have returned to the fore when assembling data from single molecule technologies 
such as PACBIO and Nanopore (61). 
Metagenome assembly is still undoubtedly an imperfect science, and no one 
assembler can be relied upon to outperform all others in every situation. As such, a 
variety of assemblers have been designed to supplement the existing established 
assemblers which have added metagenome specific extensions. These include the 
Iterative De Bruijn Graph De Novo Assembler (IDBA) and the Saint Petersburg 
genome assembler, (SPAdes). IDBA-UD(62) is built as an extension on to IDBA, 
and was specifically designed to take into account the Uneven read Depth of typical 
metagenomics sequence data. A drawback in terms of implementing this tool is that 
it was originally designed for read lengths up to 100bp, and a k-mer size of 120bp. 
Modification of this to suit a longer fragment length requires the modification of 
some accessory scripts when compiling the tool, which may be beyond the casual 
user. MetaSPAdes(28,63) first constructs a De Bruijn graph of all reads available, 
using SPAdes. This is followed by a variety of graph simplification strategies to 
transform this into an assembly graph. This step constructs the paths corresponding 
with fragments within the genomes sequenced. Variations between highly similar 
contigs, potentially due to strain level variation are not considered by MetaSPAdes. 
The tool instead aims to assemble reliable consensus sequences giving the most 
accurate representation of species present, without accounting for strain level 
variation. Unlike the two previously mentioned tools, BBAP(64) is an overlap-
consensus based genome assembler, making it more suited to sequence data with 





Considering no tool consistently outperforms all others, multiple assembly methods 
should be attempted and compared before proceeding in the analysis. 
Assembly free taxonomic profiling 
Many tools combine both assembly and classification/function analysis, particularly 
in the case of reference-based methods. Profiling of microbial species present, and 
their abundance, in an environmental sample can also be carried out without prior 
genome assembly. Assembly-free profiling is similar in principle to the tools used 
for single genome alignments to a reference, but adapted for metagenomics use. This 
approach has a number of advantages, it is less computationally demanding and can 
provide information on low abundance organisms that would not be sequenced to 
sufficient depths for assembly(28). Also, reference based approaches generally 
require less manual intervention than assembly-based methods. The principal 
limitation is that even with improvements to the algorithms used, if the biological 
material present in the sample has not at the minimum had a close ancestor 
sequenced, they are impossible to identify (28). Despite this, the complex 
community structure of common sample sites such as the human gut, make assembly 
free profiling the more suitable method.  
At a fundamental level, assembly free profiling means comparing sequence data 
yielded from a sequencing experiments to existing databases of micro-organism 
genomes in a way that is accurate and computationally efficient. In practise, this is 
carried out in four different ways. Sequences can be classified by sequence similarity 
to a reference genome, similarities in composition such as codon usage, hybrid 
methods that combine elements of the first two approaches, or finally, marker-based 
methods. These classify sequences based on presence of specific marker sequences 
such as the 16S rRNA gene fragment in bacteria, or the internal transcribed spacer 
(ITS) region in fungi (65). These tools all rely on models derived from reference 
sequences of existing sequenced genomes. 
Simple “brute force” mapping of reads to sequenced genomes in a database leads to 
spurious false positives in terms of taxonomic classification. A selection of more 
reliable approaches are outlined below;  Kraken (66)  which uses as default the 
REFseq database hosted by NCBI extracts k-mers of default length 31 from 




database. It is therefore still a similarity-based method, but considerably faster than 
BLAST based methods. Relative synonymous codon usage (RCSU), based on the 
established fact that codons are differentially favoured in different organisms, is a 
computationally efficient way to discriminate between microbes, particularly at 
higher levels of taxonomic resolution (67).  
MetaPhilan (68), and the recently released extension MetaPhilan2 (69) use clade 
specific marker genes to characterise microbial communities. As of the most recent 
release, this classification programme contains over oneone million clade specific 
markers, which equates to approximately 145 markers per bacterial species for over 
7,000 commonly identified species. Additional functionality for classification of 
viral and eukaryotic components of metagenomics samples has also been added. 
When classifying microbial reads a balance must be found between accuracy and 
speed. Similarity based classification methods based on BLAST are often the 
slowest methods, but modifications of similarity-based classification using short 
regions, considerably improves on this speed without sacrificing accuracy.  
 
Functional Profiling 
As with taxonomic classification, functional annotation is at its most fundamental, 
the process of identifying coding regions within sequenced genomes, and aligning 
these to a translated protein database. There are several databases containing 
functional information relating to genes and genomes. The Kyoto Encyclopaedia of 
Genes and Genomes (KEGG) (70) is an online database of genomes and genes with 
the primary aim of assigning functional meaning to both. The information is stored 
in a hierarchy of different levels as Kegg Orthology (KO) containing molecular level 
functional annotations, with each annotated KO being homologous to a gene or 
protein. Higher level functional information for a gene or protein is kept in BRITE 
hierarchies and KEGG pathway maps (70). The Clusters of Orthologous Groups 
(COGs) of proteins database is curated by clustering together orthologues from 
different genomes, with the hypothesis that orthologous genes can be expected to 
have a conserved function. Functional prediction of proteins is performed by 
querying which cluster the protein falls into, using the COGNITOR program (71). 




of protein sequences and functional information in UniProtKB/Swiss-Prot, and a 
much larger database of automatically annotated records in UniProtKB/TrEMBL. 
This database is provided by the UniProt Consortium, which is comprised of the 
subsidiaries Swiss Institute of Bioinformatics, the Protein Information Resource, and 
the European Bioinformatics Institute (73).   
Without refinement, analysis of this kind leads to considerable computational 
bottlenecks, particularly in a large scale metagenomics dataset. It is impossible to 
manually cross-reference all available data with databases of this type, intermediary 
programmes such as HuManN2 (74) and MEGAN (75) are therefore required to 
bridge the gap.  MEGAN, currently in its 6th iteration has an advantage over many 
other metagenomics platforms in that it is compatible with all Windows, Mac and 
Linux operating systems. MEGAN first uses the DIAMOND alignment tool to align 
all reads to a database, typically the NCBI-nr database. MEGAN then takes this 
alignment file as a reference for binning the reads, functionally and taxonomically. 
The lowest common ancestor (LCA) algorithm assigns each sequenced read to the 
lowest taxonomic rank of common ancestor of all organisms the read in question 
aligns to. This is repeated for all reads in the dataset. Functional annotation is carried 
out by searching for the best alignment between a sequenced read, and a functionally 
annotated DNA sequence from one of the following databases;; SEED (76), KEGG 
(77), InterPro2Go (78) or eggnog (75). 
HuManN2 (74) performs species level functional annotation of metagenomes and 
metatranscriptomes. Unlike taxonomic profiling, functional profiling quantifies the 
metabolic potential of a microbial community. HuManN2 uses a “tiered search” 
strategy to rapidly profile the functional composition of a metagenome.  Initially, 
MetaPhIAn2 is used to identify previously characterised microbes in the sample, and 
constructs a database per sample, merging existing data with pan genomes of 
identified species. Following this, reads in a given sample are mapped against the 
samples pan genome database at the nucleotide level. The reads that do not align are 
then translated and used to query a protein database which as by default either 
UniRef90 or UniRef50. The alignments created by this tiered search strategy, once 
weighted by sequence length and quality of alignment, are used to generate per-




As with any other aspect of metagenomics research, a thorough understanding of the 
tools available and their strengths and weaknesses is recommended.   
 
Variant Calling 
Reference based sequence assembly also allows for variant calling analysis. This is 
the process of identifying variants between closely related sets of sequence data, 
which typically take the form of single-nucleotide polymorphisms (SNPs). Variant 
calling analysis based on WGS data has superseded more traditional methods such as 
PFGE or MLST, as the level of sensitivity to small, localised changes is much higher 
(79). 
A typical workflow for variant calling involves aligning WGS sequence data to a 
reference genome, creating BAM files. This is done using a genome aligner such as 
Bowtie(80), or Burrows-Wheeler aligner (81). Following this, differences between 
the aligned reads and the reference genomes are identified and written to a variant 
call file (VCF),,using tools within the SAMtools package (82). Lastly, this VCF file 
must be filtered to ensure results are significant, and not resulting from artefacts of 
the sequencing process also performedperformed within the SAMtools 
package. Lastly, this VCF file must be filtered to ensure results are significant, and 
not resulting from artefacts of the sequencing process. This can also be done within 
the SAMtools package.  
Variant calling allows for the differentiation of micro-organisms at the strain level 
(83), which can be of crucial significance in metagenomics. For example, the fact 
that some members of the E.coli genus are harmless commensals and others are 
major pathogens such as the Shiga toxin-producing E.coli O157:H7(84) makes 
analysis of this nature to differentiate between them invaluable. Variant calling can 
be scaled upwards to process entire metagenomic datasets, and tools such as 
StrainPhilan(85) work off the same principle, but are tuned for the complexities of 
large mixed samples.  
 
This facility of variant calling to detect minor differences or mutations between 
closely related sequences is also used to detect DNA damage. This is a challenging 
task as although most organisms expose their DNA to potential sources of DNA 




damaged. As such it can be difficult to differentiate these from the general noise of 
sequencing miscalls(86). When reliably performed, variant calling can be a valuable 
tool for assessing DNA damage due to formalin fixation in WGS sequencing 
samples, and thus can be used to compare different strategies of DNA repair.  
 
Statistical analysis of microbiome data 
Metagenomics data is usually summarized as a table of read counts per OTU /ASV 
or gene/genome per sample. Those tables tend to be very sparse, where counts of 
zeroes may mean the true absence of an OTU/ASV or gene/genome or that its 
presence is below the detection limit. This detection limit can vary between samples 
due to differences between sequencing runs and an unequal representation of 
samples in pooled sequencing libraries. One way of bioinformatically dealing with 
this problem is to discard instances which are observed in less than a certain percent 
of samples, proportion of reads or given number of independent samples (87). 
Once a metagenomics dataset has been characterised taxonomically and functionally, 
statistical comparisons between groups, experimental conditions or time series 
experiments among others can be carried out using regular parametric and non-
parametric methods within traditional multivariate statistical approaches. Beyond 
this, several traditional ecological methods can also be applied to microbial ecology, 
and packages such as vegan(88) and phyloseq (89) exist within the R environment to 
facilitate their use. These can be complemented by multidimensional scaling tools 
which are extremely important for the visual representation of high dimensional data 
and are facilitated by the ape (90) package within the R environment.  
These measurements are typically broken down into alpha and beta diversity.  Alpha 
diversity describes the diversity within a sample of environment. At its most simple, 
this means the number unique species observed at a given site and is therefore scaled 
from 0 to infinity. Beta diversity allows for the comparison of diversity between 
samples, again at its most simple this strategy counts the number of species unique to 
one environment being compared, and adds this to the number of unique species in a 
second environment, giving an eventual score of beta diversity, or dissimilarity 
between the two samples or environments (91). 
In practice, there are a variety of strategies for measuring both alpha and beta 




comparison, such as phylogeny. Some of the more common measures for alpha 
diversity used in microbial ecology are as follows. The Shannon diversity index 
takes into account both the evenness and the abundance of species in an environment 
(92). If a sample is dominated by a small number of species, it is not considered 
diverse, and both the number of species obvserved and an evenness in their 
abundance is required for an increase in diversity using this metric. Simpson’s 
diversity index uses a similar principle. Chao1 species richness belongs to a class of 
methods called nonparametric estimators, which are adapted from mark-release-
recapture ratio approaches in macro-ecology(93). This means that the number of 
observed species is added to the ratio of species only seen once versus species seen 
twice. This index is noted for its accuracy with sparse datasets, such as microbiome 
data. 
Despite the concept of beta or between sample diversity being quite simple, there is 
no gold standard methodolgy for its measurement. The most common metric used in 
microbial ecology is the Bray-Curtis dissimilarity(94).  Always a number between 
zero and one, this measure of dissimilarity between two samples is measured by 
subtracting two times the sum of lesser counts of species shared between both sites, 
divided by the total number of counts of species in both sites, from one. Therefore, a 
score of one indicates that the samples are identical and zero that they have no 
species in common.  The Jaccard index is similar to Bray-Curtis, with the exception 
that it does not account for the quantities of species observed, instead working off a 
binary view of presence or absence(95). The number of shared species between two 
samples, are divided by the cumulative number of species found in both samples, 
this number is then subtracted from one to give a measure of dissimilarity. 
While the previous examples are common ecological techniques that have stood the 
test of time and have now been adapted for use in microbiology, Unifrac is a more 
modern method, designed specifically with microbial communities in mind. A 
common complaint of metrics such as the previously described Bray-Curtis 
dissimilarity when analysing microbial data is that they treat sequences with 99% 
and 20% sequence similarity as equally different, resulting in a loss of information 
potentially useful for descrimination. UniFrac or the unique fraction(96), measures 




different implementations of this measure based on whether (weighted) or not 
(unweighted) the abundances of these species are taken into account. 
Specific tools tailored to metagenomics data also exist, which have been modified to 
be more sensitive to the specific nature of the data. For instance, the problem of 
calculating differential abundance across experimental conditions, be it of taxa or 
gene expression, is one that has been significantly improved on with the 
development of bespoke bioinformatics tools.The DeSeq algorithm was developed 
for RNAseq data, with the aim of finding genes that are differentially expressed 
across treatment groups, samples or time points based on the negative binomial 
distribution. In the second iteration (DeSeq2) this has been extended to other types of 
HTS data(97). MetagenomeSeq was specifically designed for marker gene surveys 
such as 16S rRNA gene sequencing but can equally be used for count tables 
generated by whole genome shotgun sequencing experiments. It addresses the effects 
of both normalization and under-sampling of microbial communities and also 
incorporates the testing of feature correlations (98). The Anova-Like differential 
expression tool for high through put sequencing data (ALDEX2) uses underlying 
assumptions of compositionality (99).  
 
Reproducibility and Benchmarking 
There are a multitude of bioinformatics platforms available for metagenomics 
analysis, and not only the tools of choice but also how a specific pipeline is used can 
have an effect on the conclusions drawn by the resulting data. As every step of a 
metagenomics study can bias the result and change our perception of the underlying 
microbial community, it is vital to keep all variables consistent throughout a study 
and include them in the method section. Apart from the DNA extraction method and 
choice of sequencing technologies, and in case of amplicon sequencing studies 
which 16S rRNA region was targeted with which exact primers, this also must 
include a description of how DNA contamination was controlled for, how the 
sequencing error rate was assessed and importantly an in depth description of the in 
silico  analysis. It is not sufficient to only report the used tools but also the versions 
and specific parameters (if divergent from the defaults) have to be indicated. To 




the generated data of study available but also the implemented code used to analyse 
the data (100,101) 
When developing a suite of tools or pipeline for analysis, the benchmarking of 
different potential platforms is an effective way to ensure the pipeline developed 
suits the experimental needs. Tools such as MetaSim (102) provide the raw materials 
for such a benchmarking project. This allows the user to define and simulate a 
sequencing dataset of known microbial composition, and consequently to assess the 
accuracy and speed of potential metagenomics platforms(102). In terms of 
reproducibility, an important initial step in promoting this is to deposit the results of 
any sequencing experiment into one of the online sequence data repositories 
available. Two of these are the Sequence Read Archive (SRA) (103) and 
Metagenomic Rapid Annotations using Subsystems Technology (MG-RAST) (104).   
The sequence read archive, or SRA, is one of the most important platforms involved 
in metagenomics research. It is the primary repository of high throughput sequencing 
data hosted by the National Institute of Health in the United States, and part of the 
International Nucleotide Sequence Database Collaboration. A wide range of 
sequencing data is accepted, such as Roche454, Illumina and Pacific Biosystems 
data. All data submitted to this portal is publically available, and serves the purpose 
of aiding new discoveries by increasing access to data, and promoting the 
reproducibility of the field of metagenomics, which is at present one of the key 
weaknesses of the field(103). MG-RAST is another repository for sequence data. It 
currently stores over 150,000 datasets with over 23,000 of them in the public 
domain. As the name suggests, it also provides some limited functionality in 
metagenomics analysis. Raw reads can be uploaded in fastq format, which are then 
taxonomically and functionally annotated with minimal user input. Further analysis 




SECTION 2: CHARACTERISING INTRATUMOURAL BACTERIA 
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Tumours environments are amenable to bacterial growth and several recent studies 
on cancer patient samples have introduced the concept of an endogenous tumour 
microbiome. For a variety of reasons, this putative tumour microbiome is 
particularly challenging to investigate, and a failure to account for the various 
potential pitfalls will result in erroneous results and thus false claims. Before this 
potentially significant habitat can be accurately characterised, a clear understanding 
of all potential confounding factors is required, and a best-practice approach should 
be developed and adopted. 
This review summarises all of the potential issues confounding accurate bacterial 
DNA sequence analysis of the putative tumour microbiome, and offers solutions 






The tumour microbiome: Current status and future challenges 
The existence of a tumour bacterial microbiome is still a contentious concept, but an 
increasing number of articles are being published exploring this novel habitat, and 
simultaneously exploring the possible effects these bacteria could have. To inform 
the direction such research will take in the future, it is important to take stock of the 
research carried out to this point to learn from past mistakes, and similar analyses in 
relevant fields. Research to date has focused on two key questions; what is there, and 
what does it do? This has involved comparing the microbiota of malignant and non-
malignant breast tissue (including non-cancer patient) in the original studies 
(19,106,107). Subsequent studies examined potential causative links between 
bacteria and their host tumours, or assessing their metabolic activity, for example 
their effect on chemotherapeutics (108,109). These concepts have important 
potential in cancer care, in terms of treatment regime, diagnosis or prevention, but 
rely on the field developing a thorough understanding of the microbial-related 
tumour microenvironment.  
The key hurdles in accurately characterising these environments are outlined as 
follows.  
• Tumour samples are regions of known low microbial biomass, a feature 
which complicates any metagenomic analysis. This review will include suggested 
methodologies for bioinformatic analysis of tumours, and also of low biomass 
samples in general. Linked to the issue of low biomass, tumour samples present an 
extremely high ratio of host to bacterial DNA, which can lead to bias in amplicon 
based sequencing strategies such as 16S rRNA sequencing, and can make whole 
genome sequencing impossible without a microbial enrichment strategy (110). 
• A further problem relates to the quality and quantity of patient tumour-related 
samples. Sourcing high numbers of aseptically-collected samples to enable statistical 
power is challenging, due to potential impact on standard of care, the workload of 
healthcare professionals, and competing requirements of the hospital diagnostic and 
other research teams for a limited amount of sample. A resource with potential for 
higher sample throughput for tumour metagenomics analysis is formalin-fixed 
paraffin-embedded (FFPE) tissues, the international gold standard for tissue sample 
storage. A proof of concept study recently showed that FFPE tissues provided a 




tissues can provide reliable bacterial DNA also, once the proper precautions are 
taken, not least distinguishing contamination inherent to this biobanking process. As 
with the low biomass characteristic, FFPE tissues would also present challenges to 
any bioinformatics analysis.  
When performing library preparation and bacterial DNA sequence analysis to 
investigate the tumour microenvironment, the issues raised in (i) and (ii) manifest in 
a number of ways. Introduced environmental contamination is likely to be inherent 
given the sampling process, which, given the low biomass nature of this tissue, has 
the potential to obscure tumour-originating bacteria. Similarly, there are other issues 
associated with low biomass such as PCR bias caused by the high ratio of host to 
bacterial DNA. If FFPE samples are used, errors in the sequence data will occur due 
to DNA damage during the formalin fixation process (112,113). 
In summary, as more research is carried out into the tumour microbiota, it is 
important to address the many potential pitfalls involved to ensure that these 
environments are reliably characterised, the scale of the problem is shown in Figure 
1. The credibility of this field and other low biomass fields has been affected by 
recent publications highlighting methodological mistakes in previous research 
characterising the microbiome of tumours and other low biomass environments (23). 
Therefore, a robust strategy needs to be established to ensure that future results are 






Figure 2.1: The scale of the problem. Low biomass environments are considerably 
more susceptible to biological signal alteration arising from contaminant DNA than 





Research on the Tumour Microbiome to date 
The recent work characterising the microbiomes of solid tumours is outlined in Table 
2.1 below. Due to the challenges posed in characterising the tumour microbiome, it 
is likely that some or all of the studies referenced have been negatively impacted in 
some way, reducing their accuracy. This caveat must be kept in mind when assessing 
the results, and reinforces the need for the introduction of a best practise 





Table 2.1: Tumour sites with suspected bacterial communities 
Tumour site Description Bacterial 
Community 
Reference 
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Is there an aetiological relationship between tumours and bacteria? 
Considerable research has been conducted to demonstrate links between microbiota 
and a variety of proximal and distal cancers. Some associations were found to be 
directly causative, such as H. pylori and Gastric Adenocarcinoma (114) In other 
circumstances, reports suggesting certain bacteria being elevated in specific 
instances of cancer along with a variety of potential mechanisms for 
causing/progressing the cancer make a strong case, even if the final confirmation has 
yet to be found. An example of this is the constantly developing picture of the role 
Fusobacterium plays in colorectal cancer (115). Mycoplasma infection has also been 
shown to transform normal lung cells, affecting cell proliferation and differentiation 
(116). In many tumours, it may be that bacteria are simply opportunistic inhabitants 
(21,117). Tumours are uniquely amenable to bacterial colonisation, and unlike 
healthy tissues, conceivably provide a refuge for circulating bacteria, including non-
invasive species (Figure 2.2). A collection of phenotypes unique to tumours which 
have been proposed to explain the phenomenon of selective tumour colonisation by 
bacteria are as follows: i) Angiogenesis associated with tumour growth is an 
imperfect process, resulting in disorganised or “leaky” vasculature. This could allow 
circulating bacteria to embed themselves in the tissue. ii) Tumours are immune 
privileged regions of the body. This characteristic means that bacteria which may be 
cleared by the host immune system at other body sites are able to proliferate within 
tumours. iii) Many solid tumour regions are hypoxic, this lower level of oxygen 
compared with healthy surrounding tissue provides an environment that suits the 
proliferation of facultative and anaerobic bacteria. iv) Necrotic regions within the 
tumour are nutrient rich, promoting bacterial proliferation.  
What is the significance of endogenous bacteria residing within tumours? Beyond 
ongoing research into any causal relationships between bacteria and tumours, there 
are several other benefits to fully understanding these habitats. Understanding what 
bacteria colonise tumours could help with the development of more personalised or 
targeted treatment regimens for many tumours, maximising effect on the tumour and 
minimising the impact on the patient. A number of potential influences (both 
positive and negative) of resident intratumoural bacteria on tumour growth and 




effects on therapeutics, potential cross-talk between cancer cells and bacteria, and 
the potential for intratumoural bacteria to mediate therapy. For example, we were the 
first to report that a variety of unmodified bacteria found in tumours, with natural 
levels of endogenous enzymes can either positively or negatively affect the efficacy 
of various chemotherapeutics, such as gemcitabine, as evidenced by in vitro and in 
vivo cancer models (108). In parallel, given their unique capacity for selective 
growth in tumour tissue, therapeutics may be locally produced within the tumour by 
administered engineered bacteria (118,119). However, considerable challenges stand 
in the way of an approach such as this becoming a reality.  
 
Figure 2.2: Tumours are uniquely hospitable environments for bacteria. i) Leaky 
vasculature allows circulating bacteria to embed in tumour tissue; ii) Tumours are 
immune privileged regions; iii) Solid tumours possess low oxygen regions suitable 
for the proliferation of facultative and anaerobic bacteria; iv) High-turnover regions 






Formalin-fixed paraffin-embedded tissue (FFPE) represents a resource that, if 
correctly harnessed, could exponentially increase the sample sizes and sites available 
for tumour microbiota studies. Crucially, these do not have to be obtained at the time 
of surgery, like fresh frozen tissue, although both fresh frozen and FFPE tissues 
involve difficulties. 
Patient sample logistics  
The realities of patient sample acquisition must be taken into account by researchers 
in this field.  
• Sampling-related contamination e.g. from the patient, the operating theatre, 
or the pathology lab (tissue handling and processing) must be considered in 
the design of research workflows (see later).  
• Broad-spectrum antibiotic administration can be routine in many hospitals 
immediately prior to tumour resection operations. While interfering with the 
clinical standard of care is difficult, antibiotic administration should be 
considered and reported in such studies.  
• An under-considered parameter is that tissue is heterogenous within a 
tumour, and bacterial profiles are likely to differ (quantity and quality) 
intratumourally, with some tumour tissue providing different growth 
conditions to other regions. Hence, typical pathologist-preferred tumour 
regions required for diagnosis (e.g. ‘margins’) may not be representative of 
the holistic tumour microbiome. 
Low biomass   
Tumours represent low bacterial biomass samples. This poses a variety of challenges 
to the data generation process. This is a situation where the bacterial DNA that is the 
target of the study, is outnumbered by orders of magnitude by host DNA. Due to the 
targeted PCR amplification of bacterial DNA in 16S rRNA gene sequence analysis, 
this heavy ratio of host to bacterial DNA is commonly considered unimportant. This 
is not the case, with many studies demonstrating a reduction in PCR amplification 
efficiency in circumstances of high human nucleic acid and low bacterial 16S rRNA 




effective host DNA depletion strategy is an important component of a 16s rRNA 
gene sequencing library preparation.  
Commercial kits for microbial enrichment by host DNA depletion were recently 
compared by Marotz et al (112). These included MolYsis, QIAamp and lyPMA kits. 
All were found to significantly improve the microbial yield. lyPMA was the most 
effective, having a mean of 8-10% of reads aligning to the human genome, and 
MolYsis the least, with an average of 60% of reads aligning to the human genome. It 
is inevitable that the microbial DNA would also be affected. For example, the 
MolYsis approach is suspected to degrade bacteria with weak cell walls, or cell walls 
that have been previously weakened by exposure to certain antibiotics, so a balance 
between host depletion, and bacterial degradation must be found. 
 
Contamination  
A recurring issue with low biomass samples is contamination, which poses a 
significant challenge in sequence analysis and interpretation. Often, the true 
microbiota can be masked by confounding bacterial DNA found in library 
preparation and DNA extraction kits. This feature is then often exacerbated by 
subsequent intensive amplification via PCR. Typical sources of contamination 
include environmental (surgery- and pathology-related), contaminants during the 
library preparation, and, as has been recently described, contamination from within 
the extraction kit itself (23). Since Salter et al published on this, there has been a 
general increase in awareness that reagent, laboratory and human contamination can 
have a serious impact on microbiome analysis (12). As water and soil associated 
bacteria are well documented contaminants associated with DNA extraction kits and 
PCR reagents, some contaminants are easily identified if they make it through the 
sample preparation, sequencing and bioinformatics contamination removal process. 
Genera such as Bradyrhizobium, which function in nitrogen fixation, are unlikely to 
be legitimate constituents of any human microbiome. The problem becomes more 
complex when sequences from Escherichia spp. and Bacillus spp. are found. Both 
have been shown to be artefacts of the library preparation process, but both are also 
common human pathogens (12). In 16S rRNA gene sequence analysis, taxonomic 




instance of Escherichia spp., which compounds the problem. 
 
Summary of contaminants affecting 16s rRNA gene sequence analysis  
The table below is a summary of recent articles addressing and discussing the 
problem of contamination in sequence analysis. It contains genera mentioned across 
all recent studies which include analysis of extraction and PCR kits, and also the 
ultra-pure water that is used in many kits and as a negative control.  
Table 2.2: Previously identified bacterial contaminants as per publications: 
(121),(12), (23), (122) . 
Phylum Genus 
Actinobacteria Actinomyces, Aeromicrobium, Agrococcus, Arthrobacter, 
Atopobium, Beutenbergia, Bifidobacterium, Blastococcus, 
Brevibacterium, Candidatus, Planktoluna, 
Cellulosimicrobium, Clavibacter, Collinsella, 
Corynebacterium, Curtobacterium, Dietzia, Eggerthella, 
Geodermatophilus, Gordonia, Janibacter, Kocuria, 
Microbacterium, Micrococcus, Microlunatus, Patulibacter, 
Pilimelia, Propionibacterium, Pseudoclavibacter, 
Rhodococcus, Rothia, Slackia, Tsukamurella 
Bacteroidetes Alistipes, Bacteroides, Bergeyella, Capnocytophaga, 
Chryseobacterium, Cloacibacterium, Cytophaga, 
Dyadobacter, Flavisolibacter, Flavobacterium, Gelidibacter, 
Hydrotalea, Niastella, Olivibacter, Parabacteroides, 








Firmicutes Abiotrophia, Anaerococcus, Anaerotruncus, Bacillus, 
Blautia, Brevibacillus, Brochothrix, Catenibacterium, 
Christensenella, Clostridium, Dialister, Dorea, 
Enterococcus, Erysipelatoclostridium, Eubacterium, 
Facklamia, Faecalibacterium, Fastidiosipila, Flavonifractor, 
Gemella, Geobacillus, Granulicatella, Halocella, 
Intestinibacter, Johnsonella, Lachnoanaerobaculum, 
Lachnoclostridium, Lachnospira, Lactobacillus, Listeria, 
Megasphaera, Moryella, Oscillospira, Paenibacillus, 
Papillibacter, Parvimonas, Peptococcus, Peptoniphilus, 
Pseudobutyvibrio, Pseudoflavonifractor, Quinella, 
Roseburia, Ruminococcus, Ruminosclostridium, 
Selenomonas, Solobacterium, Staphylococcus, Streptococcus, 
Trichococcus, Tumebacillus, Turicibacter, 
Tyzzerella,Veillonella 
Fusobacteria Fusobacterium, Leptotrichiaceae 
Proteobacteria Achromobacter, Acidovorax, Acinetobacter, Afipia, 
Alcanivorax, Alicycliphilus, Aquabacterium, Aquabacterium, 
Asticcacaulis, Aurantimonas, Azoarcus, Azospira, 
Beijernickia, Bosea, Bradyrhizobium, Brevundimonas, 
Burkholderia, Cardiobacterium, Caulobacter, Comamonas, 
Coprococcus, Craurococcus, Cupriavidus, Curvibacter, 
Delftia, Devosia, Diaphorobacter, Duganella, 
Enhydrobacter, Enterobacter, Eschericia, Geodermatophilus, 
Haemophilus, Herbaspirillum, Hoeflea, Janthinobacterium, 
Kingella, Klebsiella, Leptothrix, Limnobacter, Massilia, 
Matsuebacter, Mesorhizobium, Methylobacterium, 
Methylophilus, Methyloversatilis, Neisseria, Nevskia, 
Novosphingobium, Ochrobactrum, Oxalobacter, Paracoccus, 
Parasutterella, Pelomonas, Phyllobacterium, Polaromonas, 
Pseudomonas, Pseudorhodoferax, Pseudoxanthomonas, 




Roseateles, Roseomonas, Rubellimicrobium, Ruegeria, 
Schlegelella, Serratia, Sphingobacterium, Sphingobium, 
Sphingomonas, Sphingopyxis, Stenotrophomonas, 




FFPE tissue as a source of sample tissue  
With more developed screening methods and constantly improving medical care, 
particularly in the developed world, the size of tumours at the time of excision is 
rapidly reducing. The average size of a breast tumour has shrunk to less than 1 cm in 
diameter in the United States. As mentioned previously, this means fewer fresh 
‘surplus to diagnostic’ samples are available to research (123). Formalin fixation 
followed by paraffin embedding is the gold standard for preserving tissue samples 
after histological examination. FFPE blocks are stable at room temperature, and 
preserve the morphology and cellular details of tissue samples, along with the DNA. 
A unique problem when handling FFPE tissues is the degradation and mutation to 
which the DNA is subjected during the fixing and embedding process. FFPE blocks 
are undoubtedly a valuable resource due to the sheer quantity of samples available. 
However, there are several challenges involved in their effective use. Formalin 
fixation has been shown to cause cross-linking of histone-like proteins to DNA, 
DNA to formaldehyde adducts, and inter-strand DNA crosslinks (124). Generally, 
sequencing errors are caused by PCR mistakes, or miscalls during sequencing, but in 
a small set of circumstances, sequencing errors are caused predominantly by 
mutagenic DNA damage. These include ancient DNA from archaeological sites, 
circulating tumour DNA, and FFPE samples (125). The value of FFPE tissues as a 
sample type has begun to supersede the difficulty in their processing and analysis 
from a bacterial sequencing perspective. A recent study by Stewart et al successfully 
used formalin fixed, paraffin embedded tissue to characterise the intestinal 
microbiota of pre-term infants with necrotising enterocolitis, despite some of their 




Although the strategies for minimising and/or retroactively repairing this DNA 
damage mainly falls under the remit of the laboratory personnel carrying out the 
extraction and subsequent library preparation, there are some bioinformatics 
strategies that can be applied to lessen the impact of damaged DNA on the sequence 
data. Chen et al proposed a method of scoring the extent of the errors in sequencing 
caused by DNA damage, called the Global Imbalance Value (GIV) [41]. This 
method is based on the directional adapters used in Illumina sequencing. The 
principle behind this is that because the majority of DNA damage only affects one 
base in a pair, DNA damage caused by oxidation, for example, could cause G-T 
transversion errors when the forward read of sequence data is mapped to a reference 
genome, but the reverse read would show the reverse complement of this, so C-A 
errors. This causes a “global imbalance” (125). A slight modification of this method 
would allow for the user to screen the reads generated by 16S sequencing of bacterial 
DNA within the tumour and in a process similar to the quality filtering already 
employed, only retain reads that had a GIV score below a certain threshold. 
 
Bacterial DNA extraction from FFPE samples  
Despite these problems with using FFPE tissues for metagenomic analysis, there is a 
considerable history of bacterial identification in FFPE tissue in clinical settings, if 
not research settings.(127). The QIAamp DNA FFPE Tissue kit is a purpose-built kit 
for the extraction of total genomic DNA from FFPE blocks produced by Qiagen. 
This kit compensates somewhat for damage caused by formalin fixation by including 
an incubation at elevated temperature following a proteinase K digestion. However, 
the kit does not take into account the oxidative damage that can be caused, or the 
extreme ratio of host to bacterial DNA, both of which can affect marker gene 
sequence analysis such as 16S rRNA gene sequencing (128).  
If reliable characterisation of the bacterial communities within tumours is to extend 
to FFPE samples, then a protocol for bacterial DNA extraction, repair and 
purification from these tissues is required to improve downstream analysis.  A 











Detection of microbial communities   
The two sequencing strategies employed in metagenomics analysis are WGS and 
amplicon sequencing. WGSWGS provides a high-resolution overview of all (or the 
most abundant, dependent on sequencing depth) DNA present in a sample. Bacterial 
genomes present will be characterised base by base, providing insights into bacterial 
taxonomy, function and rates of mutation, among other aspects. Host DNA present 
in the sample is also sequenced. Amplicon sequencing is a targeted approach 
allowing the targeting of specific regions within genomes, generally amplified by 
PCR. It is a two-stage process where primers are used to capture the target region, 
which is followed by high-throughput sequencing. Amplicon sequencing in bacterial 
microbiota studies typically targets the 16S rRNA gene subunit. This is the 
component of the 30S small subunit adjacent to the Shine-Delgarno sequence, a 
region noted for its slow rate of evolution, containing nine “hypervariable regions” 
which can be used to differentiate between bacteria with varying degrees of 
effectiveness (129). 
Whole genome sequencing has several advantages over 16S rRNA gene sequencing, 
such as increased species and strain level resolution, enhanced ability to detect rare 
species, and the ability to detect organisms in other kingdoms of life, such as viruses 
and fungi (130). At present 16S rRNA gene sequencing may be more technically 
suitable to metagenomics analysis of low biomass environments, in addition to being 
significantly more cost-effective. In a typical sequencing run of a non-tract biopsy in 
humans, 97% of the reads generated can be expected to align to a human reference 
genome (131). This makes it extremely expensive to get sufficient sequencing depth 
of the bacterial DNA present in a sample (131). As mentioned earlier, 16S rRNA 
gene sequencing is still affected by the low ratio of bacterial DNA, but to a lesser 
extent than whole genome sequencing methods. This can be improved upon by 
incorporating the previously mentioned host depletion strategies. 
Removal of Chimeric reads  
Chimeras arise as aborted extension products from earlier PCR cycles and can end 
up being taken up as a primer in a subsequent cycle. Undetected chimeric DNA 
sequences can be misinterpreted as novel species, particularly in 16S rRNA gene 




formation (132). Given the low bacterial concentrations expected in tumour samples, 
the generation of chimeric reads is logically a significant cause for concern, and a 
robust protocol should be employed for their removal. Chimeras can be 
computationally identified and removed using one of a variety of programmes that 
fall into two groups. De novo methods usually work by identifying sequences which 
contain half of one abundant read and half of another, as evidenced by a difference in 
abundance between the start and the end of a sequence. Alternatively, reference-
based methods compare reads identified to a curated database known to be chimera 
free, and attempts to find sequences that may have arisen from multiple samples 
(133). In this situation, where there is an elevated proportion of chimeras present, 
combining both methods would give the best chance of effective clearance of 
chimeras. Some of the most cited examples of chimera removal programmes across 
both categories include Chimera Slayer which is a referenced based method, 
Is.Bimera.Denovo which is the de novo chimera removal programme within the 
DADA2 pipeline, and UCHIME within the QIIME environment which has both 
reference based and de novo capabilities (133). 
Removal of contamination  
Two bioinformatics utilities have been developed recently, to retroactively solve this 
problem. SourceTracker, and Decontam (134,135). These methods have different 
functionality but can be used in conjunction to remove contaminant taxa. The 
SourceTracker algorithm utilises a Bayesian approach to provide an estimate of the 
proportion of contaminants that arise from possible source environments. Decontam 
looks for unusual relationships between DNA concentration in the original sample, 
and proportional abundance of sequence variants, and can add another layer by 
comparing samples with negative controls.  
Analysing the outputs The traditional method of analysing 16S rRNA gene 
sequencing data by clustering reads together based on a pre-defined threshold of 
similarity is no longer necessary due to recent advances. New methods of error 
modelling allow for sequence variants to be distinguished by a single base, 
generating amplicon sequence variants (ASV) which are comparable to OTU’s, but 
where OTUs are clustered by percentage sequence identity, ASV’s correspond to an 
exact amplicon sequence variant in the sample (48). A major consideration when 




DNA. As mentioned earlier, it is possible to measure this based on global imbalance 
value (125). DNA damage could cause ASV generating methods may be unsuitable 
as mutations, caused by formalin fixing for example could be incorrectly classified 
as different strains of bacteria. In these circumstances, the clustering-based OTUs 
may prove the more reliable method. Several of these are contained within the 
QIIME environment, such as Usearch (136). Samples can be analysed with both 
clustering and ASV methods, and a comparison of the number of observed species 
identified could inform the user on the level of damage. When combined with 
experimental knowledge for example laboratory based culturing from tumours, a 
large amount of closely related species reported by ASV generating methods but not 
clustering methods could indicate unrepaired DNA damage.  
  
Best Practice 
As there is currently no established best practice for sequence analysis of bacteria 
residing in tumour tissue, fresh or formalin fixed, the primary objective of this article 
is the proposal of such. The section below, along with Figure 2.3, summarises a 
methodology that falls in line with what is currently accepted for 16S rRNA gene 
sequence analysis, incorporating sample-specific modifications as outlined earlier.  
Pre Analysis  
During the extraction process, microbial enrichment and DNA repair, if the sample 
originates from FFPE tissue, should be carried out if possible. Since, in low biomass 
samples, the biological signal can be significantly altered by the presence of 
contaminants, extreme ‘aseptic’ care must be taken when preparing the samples for 
sequencing. A variety of controls to account for introduction of contamination 
should be used. Given the documented effects that a lack of controlling for 
contamination has had on previous tumour microbiota studies, this is of paramount 
importance. Eisenhofer et al recently published a comprehensive description of a 
robust strategy to control for contamination in low biomass studies (22). This 
suggests using a variety of negative controls to assess the degree of contamination 
introduced during the processes of sampling, DNA extraction and amplification. 
Positive controls are also recommended, such as mock communities of known 




sequencing from FFPE tissues, with some additional steps as outlined below in 
Figure 2.4.  
 
 
Figure 2.4: Overview of suggested sample preparation with appropriate control for 
contamination and bias. 
Bioinformatic analysis Figure 2.5 summarises the key points outlined 
previously in this article in relation to the required modifications to a bioinformatic 












Typically, hypervariable regions within the 16S rRNA gene fragment are targeted by 
primers, the most commonly targeted is the V3-V4 region as it is thought to provide the 
best resolution. While this method is effective to genus level in most cases, species level 
classification is often unsuccessful. An obvious solution would be to simply increase the 
length of the reads, as sequencing technologies such as Oxford Nanopore sequencing are 
capable of producing reads that are hundreds of kb in length, it should be 
straightforward to simply sequence the entire 16S rRNA gene fragment (137). 
Specifically in the case of sequencing samples from formalin fixed samples however, 
this is currently not possible, as the DNA will often be fragmented, preventing long read 
sequencing. A potential solution to this is to combine multiple, independently sequenced 
short regions within the 16S rRNA gene fragment. One way this has been implemented 
is in the Short Multiple Regions Framework (SMURF) method, by Fuks et al (39). This 
entails independent amplification and sequencing of multiple regions along the gene 
fragment, these are then computationally combined to provide a significantly more 
accurate assessment of the microbial community. When tested on a Human Microbiome 
Project “Mock” community, it was found that the increase in resolution was a function 
of the number of regions analysed. Using two different regions resulted in a two-fold 
increase in resolution, while using 6 resulted in a ~100 fold increase in resolution (39). 
A further improvement was not directly related to the bioinformatic analysis but to 
sample preparation. As was mentioned earlier, while there are extraction kits for DNA 
in FFPE tissues, these do not take into account damage that may have occurred to the 
DNA during the fixation process, or the high ratio of host to bacterial DNA. To make 
metagenomic analysis of tumour samples from FFPE tissues a reliable and crucially 
reproducible option, there is a genuine need for the establishment of a validated protocol 
to extract bacterial DNA from FFPE tissues, repair the damage, and deplete the host 
DNA.  
Concluding remarks 
In conclusion, taking advantage of the presence of bacteria in tumours has the potential 




important for data to be as truly representative as possible. It is the objective of this 
article to provide a guideline for more effective bioinformatic analysis of the tumour 





SECTION 3: UTILISING BACTERIA FOR THERAPEUTIC INTERVENTION 
 
Regardless of whether or not a consistently present and detectable tumour microbiome 
exists, tumours are undeniably hospitable environments for bacteria to colonise. Where 
the unique physiology of tumours is seen as an obstacle for traditional cancer treatments, 
they represent an opportunity for bacterial-mediated solutions. 
The use of bacterial cellular machinery to secrete proteins is far from novel. In the 
biotechnology industry, bacteria have been exploited for their ability to produce 
recombinant proteins such as human growth hormone and insulin (118). Industry and 
academia have also been exploring the potential for in vivo production of therapeutic 
proteins from bacteria. In this scenario, bacteria would either naturally, or through 
inducement, locate to the body site where they are required, for example a tumour, and 
once there would colonise the niche and produce therapeutic agents (118).  
This are two considerations in this context, requiring two very different applications of 
bioinformatics. i) The first is to identify which bacteria colonize the desired niche in 
body; this can be a ‘foreign’ body such as a tumour, or parasite, or a distal niche such as 
the gut. ii) The second, often under-considered parameter, relates to what these bacteria 
produce. Synthetic biology presents enormous scope for sophisticated medical therapy 
mediated by novel synthetic proteins. However, the task of getting a bacterial cell to 
successfully express and secrete a stable protein that it does not produce naturally is far 






Microbiome research as an R&D tool 
An appropriate workflow to develop such targeted therapeutic strategies involves 
combining the knowledge gained from microbiome analysis with the machinery 
available within bacteria. From a viewpoint of bacterial-mediated therapy, this is 
achieved by: 
• Using microbiome research as an R&D tool to conduct an ecological 
survey of the target niche, the aim being to find candidate taxa which 
selectively colonise the niche in question (138). 
• Modulation of an existing microbiome to create a niche for the bacterial 
vehicle to colonise.  
• Artificially inoculate the same niche(139). 
The desired end-result of an ecological survey of this kind is to be able to state with a 
degree of confidence that if a given bacterium is introduced into the host, it has a high 
probability of locating to the target niche. Following this, the niche-targeted bacterium, 
can be engineered to produce a therapeutic agent directly within this niche. Bacteria can 
produce toxins to directly kill tumour cells, release cytokines to attract immune cells to 
the niche, or produce synthetic proteins to interact with receptors on/in tumour cells 
(140). This workflow of researching what bacteria are present in a niche of interest and 









Figure 3.1: The convergence of microbiome research and in silico protein design for 
R&D. (A) Shows the process of identifying bacteria that selectively colonise a foreign 
body of interest through bioinformatic analysis. (B) Shows a workflow for making use of 
the information learned in (A). A protein is designed for a specific purpose in silico, 
after which a bacterial candidate derived from A is genetically engineered to produce 
this protein, thus exploiting them as delivery vehicles for protein therapeutics. 
 
Examples of successful bacterial production of functional molecules in situ, but 
potentially distal to the site of action, include the production of cytokines, monoclonal 
antibodies and other molecules by Lactococcus lactis in the gastro-intestinal tract (141). 
A summary of recent developments in bacterial-mediated cancer therapies can be seen 






Table 3.1: Summary of studies of bacterially mediated cancer therapy. (Adapted from 
(142)) 






Streptococcus pyogenes; intentional 
infection of cancer patient with 
erysipelas.  
 
Rapid tumour progression 
 Attenuated Salmonella Typhimurium; 
vaccination of B16F10 tumour-bearing 
mice by derivatives of Salmonella 




 Listeria monocytogenes; vaccination 
via recombinant Listeria 
monocytogenes (Lm-NP); breast, 
melanoma and cervical cancer. 
Regression in growth of all 
types of tumours 
 Clostridium spp; concurrent gas 
gangrene in patients with tumours 
Tumour Regression 
Bacteria as vehicles 
to produce 
tumouricidal agents 
Clostridium novyi; IV injection of C 
novyi NT spores and a single IV dose 
of liposomal doxorubicin (Doxil) 
administered into mice bearing 
colorectal cancer 
Elimination of tumours 
 C. novyi NT and C. sporogenes, 
conjunction of pMTL-555-VHH 





construct of a VHH-AG2 expressing 
vector (an anti HIF-1a) into these 
bacteria 
 Bifidobacterium longum 105-A and 
108-A, IV injection of the pBLES100 
(constructed by cloning a B. longum 
plasmid and a gene encoding 
spectinomycin adenyltransferase AAD 
from Enterococcus faecalis into the E. 
coli vector pBR322) to B16-F10 
melanoma tumour-bearing mice 
Increase in specific gene 








Salmonella enterica Serovar 
Typhimurium, orally administered 
construction of Salmonella-based 
surviving vaccine into BALB/c, colon, 
DBT and GL261 glioblastoma-bearing 
mice 
Vaccine as an adjuvant 
against different types of 
cancer 
 Streptococci and Serratia marcescens, 
injection of bacterial concoction 
derived from heat-killed streptococcal 
and Serratia marcescens (Coley’s 
Toxin) into body, sarcomas 
A severe erysipelas 
infection led to the cure of 
cancer 
 Clostridium perfringens, intratumoural 
injections of either 2, 10 ug of 
Clostridium perfringes entereotoxin 
(CPE) in xenografts of T47D breast 
cancer cells in mice.  
Rapid and dose dependent 
cytolysis 
 Pseudomonas aeruginosa, IV injection 






(IL4-PE) into GMB induced in nude 
mice and intratumour administration 
of IL4 PE in malignant astrocytoma in 
a phase I clinical trial 
activity 
 
A more precise approach of this kind has the potential, at a minimum, to limit side 
effects of traditional treatments that occur due to systemic administration, and to 
increase efficacy of treatments (140). Although considerable progress must be made 
before bacteria can be used clinically for cancer treatment and detection, it is hoped that 
the mainstream incorporation of microbiome research into research and development 
pipelines may accelerate this process.  
 
In silico platforms for protein analysis and design 
Many of the factors that attribute to the successful production/behaviour of a protein fall 
beyond the remit of computational biology, but some can be controlled for by 
bioinformatic analysis and prediction.  
Foremost among these is the protein folding problem. The proteins used are rarely in 
their native state, and can at the very least expect to have additional functional ‘parts’, 
such as secretion sequences, detection tags etc., while at the other end of the spectrum, 
novel proteins are being developed with increasing regularity and confidence facilitated 
by in silico design tools. Predicting the expected 3D structure can inform the user as to 
something as simple as its predicted stability in nature, or whether a functional peptide 
‘part’ is buried within the structure, rendering it non-functional. There are laboratory 
methods for characterising the 3D structure of a protein, such as Nuclear Magnetic 
Resonance spectroscopy, X-ray crystallography and Cryo-Electron Microscopy. In 
addition to the cost and expertise these methods require, they also need physical protein 




The prediction of the three dimensional structure of a test sequence in isolation would be 
of minimal experimental value without accompanying functional information. 
Fortunately, these two features are inherently related, as a protein’s structure is the 
determining factor in its function. Once a model has been generated, predictions of 
features such as binding sites, interactions with other proteins, and transport machinery 
can be made, with the caveat that they are only as reliable as the underlying structural 
prediction.   
 
Secondary to this initial question, other features that can be predicted or modified using 
in silico tools which can benefit research include: 
• Sequence based parameters 
• De novo Protein Design 
Predicting protein 3D structure 
The field of in silico protein structure prediction has expanded dramatically since 1994 
when the first Community Wide Experiment on the Critical Assessment of Techniques 
for Protein Structure Prediction (CASP) was held, but remains one of the more 
challenging approaches in the field of computational biology. Levinthal’s paradox tells 
us that due to the large number of degrees of freedom in an as yet unfolded polypeptide 
chain, the number of possible conformation of this protein is enormous. The given 
example is that a polypeptide with 100 residues, and therefore 99 peptide bonds and 198 
different phi and psi bond angles, would have 3e198 different conformations. The 
paradox is that although small proteins fold almost instantly, on a microsecond 
timescale, if a protein were to arrive at its correct fold structure by sequential sampling, 
this process would take longer than the age of the universe to complete (15). 
Computational methods provide a tentative solution to this problem, but major concerns 
over the reliability and accuracy of these methods remains, particularly when analysing 
larger proteins.  
Nevertheless, several research groups have dedicated themselves to this problem and 
similar ones. The leading in silico protein prediction software currently available for 




SWISS-MODEL (145). An indication of the growth in awareness of the value and 
importance of this field is that Google entered the 2018 edition of CASP with A7D, a de 
novo structure prediction method with deep-learning based scoring (146). Protein 
structure prediction protocols can be broadly separated based on methodology, into 
homology modelling methods, and ab initio methods, although many leading tools 
combine the two approaches. Homology modelling, or comparative modelling, relies on 
sequence similarity between the test sequence and the sequences of already 
characterised proteins. This can be carried out either through global alignments of entire 
primary protein sequences or local alignments of smaller fragments in a process referred 
to as “threading.” The fact that three dimensional structure is more conserved than 
amino acid composition amongst proteins makes this modelling method very effective 
for proteins that share medium to high levels of sequence similarity with those in the 
PDB database. If a test sequence has less than 20% identity with those in the PDB, this 
method becomes unreliable (147,148). 
Predicting a protein’s structure from its amino acid sequence alone, with no reference 
template structures, is still an unsolved problem despite any advancement over the 
previous ~50 years. This process is called ab initio folding. A simplification of this 
process is a search of possible conformations that the test sequence could take, which is 
supervised by an energy scoring function, usually related in some way to Gibbs free 
energy. A review by Lee et al states that there are three factors required for a successful 
Ab Initio prediction protocol (149): (i) An accurate energy function, where native 
protein structure correlates with thermodynamic stability, (ii) a computationally efficient 
method for conducting the conformational search and identifying low energy states, (iii) 
a protocol for identifying near-native models from a large number of conformers (149). 
To reiterate, both methods have strengths and weaknesses. Homology modelling 
requires sequence identity with already characterised proteins, and ab initio modelling 
is, at the time of writing, ineffective for larger constructs, although this is likely to 
change in the future as computational power increases. These limitations mean that the 
most successful modelling protocols must incorporate aspects from both ab initio and 




I-TASSER is primarily a homology based modelling tool, but does incorporate limited 
ab initio functionality, primarily to fill in gaps left by its threading tools in aligning 
sequences to reference databases. It works by initially searching for structural templates 
of fragments of the input sequence with a technique called threading or fold recognition. 
These are then assembled into full length models using replica exchange Monte Carlo 
simulations - this is the homology modelling method. Any unaligned regions of the test 
sequence are built by ab initio modelling. Further clustering and refinement steps result 
in five candidate models by default, each with a corresponding confidence (C-score) 
score (143). This tool is available as a web server, but can also be downloaded as a 
stand-alone tool.  
Similarly to I-Tasser, the Rosetta Commons also maintains a web server for protein 
structural prediction called Robetta (150). Contrasting with I-TASSER, standalone tools 
within the Rosetta Suite provide many more functional options to the user when 
approaching the problem of protein structural prediction. AbInitoRelax provides a 
general framework for ab initio modelling of proteins, with different version available 
for membrane and metalloproteins. There are also facilities for homology modelling. 
RosettaCM allows the user to select templates themselves, either from the PDB database 
or previously ab initio modelled proteins. As with all standalone tools within the Rosetta 
suite, manual intervention is possible to tweak functionality to suit a particular target 
protein (151).  
A comparison of workflows between I-TASSER, ostensibly a homology based 





Figure 3.2: Comparison of workflows between homology and ab initio protein 
prediction algorithms. Adapted from (152). 
 
A7D focusses exclusively on the challenging task of ab initio modelling, without the aid 
of any homologous template structures. This method of modelling is likely to increase in 
importance with the advent of de novo protein design exploring hitherto un-sampled 
protein fold space. The predictions are made by an automatic free modelling structure 
prediction system guided by a scoring system based on two different neural networks, 
both of which are deep convolutional neural networks. Convolutional neural networks 
are used predominantly for the processing of images. A deep residual convolutional 
neural network, trained on a non-redundant subset of the PDB database, builds a 
distribution of expected distances between the C-beta atoms of adjacent amino acids in 
proteins, and a second network trained to output a score as a function of multiple 
sequence alignments, and predictions from the first network (146). 
A selection of the tools available for research involving the prediction of protein 3D 




Table 3.2: Platforms for in silico protein modelling 
  
*In practise I-TASSER and 
Rosetta incorporate both 
Homology and ab initio 
methods. Prediction Tool 
Platform Method 
I-TASSER(143)* Web-based and 
Standalone 
Homology 
Modeller(153)  Standalone Homology 
SWISS-MODEL(154) Web-based Homology 
Phyre2(155) Web-based Homology 
Fragfold(156) Standalone Ab-Initio 
Rosetta(151)* Web-based and 
Standalone 
Ab-initio 
Predicting protein function 
Predicting the function of an in silico designed protein primarily relates to predicting its 
interactions with other proteins, ligands or other biomolecules and predicting the 
location of the active sites facilitating these interactions. As the majority of in silico 
designed proteins are either de novo or redesigned existing scaffolds, it is rarely 
necessary to investigate the overall function of a protein from first principles. When 
necessary, this can be done by aligning the amino acid sequence to annotated functional 
databases such as Swiss-Prot, or by comparing the three dimensional structure of the 
query protein to an annotated experimentally derived 3D protein structure database such 




Predicting Protein active sites 
Identification of protein active sites facilitating binding to targets is a crucial step in 
protein annotation or design. At present there is no one gold standard method predicting 
these sites, thus a common approach among the more successful strategies is to combine 
complementary prediction algorithms. As per the Continuous Automated Model 
EvaluatiOn community wide survey (CAMEO (157)), the top performing strategy for 
active site prediction is COACH (158), within the I-TASSER suite. COACH combines 
outputs from five different active site prediction algorithms including TM-SITE which 
employs reference based substructure comparison, S-SITE based on sequence 
alignments, and COFACTOR which threads sequence fragments through the BioLIP 
(158) protein functional database providing insights such as Gene Ontology and Enzyme 
Commission annotation in addition to binding site prediction.  
An alternative strategy for binding site identification, if using a novel protein that makes 
database reliant methods ineffective, is to use global protein-protein docking tools which 
will be described later in this text. These can suggest likely interaction sites between a 
protein and its target based on protein conformation and an in-built energy function.  
Predicting Protein-Protein interactions 
Protein-Protein interactions, commonly referred to as ‘docking’, are the physical 
interactions that occur between two or more proteins. This physical contact should be 
specific, in that it involves active sites directed at each other, and care must be taken to 
eliminate chance interactions. This is one of the biggest challenges to the exploration of 
these inter-protein dynamics. While it is relatively easy to show in silico that two 
proteins have some affinity towards each other in certain conformations, it is much more 
difficult to show conclusively that two or more proteins do not interact (28).  
Many tools, both standalone and web-based, exist for this purpose, but range from 
extremely basic tools that only give an overview, to more in-depth tools that have the 
ability to completely characterise the relationship between two proteins, but require 
considerable manual intervention. Broadly speaking, web-based servers can provide an 
overview of potential interactions between proteins. Web-based servers such as ClusPro 




confidence scores (159).  Other web based servers include HADDOCK (160) and 
SWARMDOCK (161). At the minimum level of user involvement, all three of these 
servers can take as input two pdb files and predict the interactions that occur between 
them. They do offer limited levels of advanced usage - for example, ClusPro allows for 
the removal of unstructured protein regions, and consideration of small angle X-ray 
scattering data among others. HADDOCK allows the user to provide interaction 
restraints which can guide the search, but if these are not provided, the accuracy of the 
algorithm regresses (159).  
These web-based docking algorithms are convenient as they can give an outline of 
potential interactions with no requirements for expertise or computing power. If user 
expertise and computing power are available, standalone tools such as Autodock and 
Rosetta are considerably more powerful. Autodock is a suite of molecular modelling 
tools, initially designed to predict interactions between proteins and small molecules. 
Adaptations of these algorithms have led to their use in full protein-protein interaction 
prediction. Although still supported, Autodock has largely been superseded by 
Autodock vina, which delivers improvements both in accuracy and speed (162). 
Autodock vina still retains the focus of Autodock, which is the docking of proteins to 
small molecules, and although it can be used to predict interactions between two full 
proteins, it is a very slow process. The advances in speed that the heuristically modified 
QuickVina2 brings over Autodock Vina (163) allow for the prediction of interactions 
between full size proteins, provided that some information is known regarding binding 
sites.  
 
A recurring feature in any review of tools for in silico protein analysis, Rosetta has an 
extensive range of bespoke tools for the analysis of protein interactions. The general 
protein-protein interaction prediction framework within the suite is RosettaDock (164), 
which also exists as a web-server. In addition, numerous tools for the prediction of more 
specific interactions exist: 
• RosettaLigand (165) is the premier tool within the suite for prediction of 




• RosettaMP (166) is a tool specifically for the design of membrane-spanning 
proteins, and predicting their interactions. 
• The RosettaScripts scripting language allows for the generation of job-specific 
docking pipelines and scoring functions (167).  
 
Sequence-dependent information 
When confidence in the model is high, the predicted protein structure is extremely 
useful when attempting to predict function. As mentioned earlier, it is not always 
possible to predict the protein structure with any such confidence when the protein is 
greater than 150AA in length. There are other in silico parameters available to help 
assess a test sequence. The ProtParam tool hosted by ExPASy/Swiss institute of 
Bioinformatics is extremely useful for providing sequence-dependent data, as opposed 
to model/structure prediction-dependent data such as that provided by I-Tasser or 
Rosetta. Examples of the information available include the “Instability Index” of a 
protein as defined by Guruprasad et al (168). This provides an estimate of the expected 
stability of a protein in vitro, based on correlations identified between specific 
dipeptides and either stability or instability. The formula takes as input an amino acid 
sequence, and gives a score between 0-100, with an instability index below 40 
indicating a stable protein. The grand average hydropathicity (GRAVY) of a protein 
calculated on the Kyte-Doolittle scale is also offered on this web server, as well as 
several other descriptive features such as the Aliphatic Index and extinction coefficients 
(169). Given the huge amount of variables implicating the production of a protein and 
its subsequent structure and function, as many as possible should be controlled for. 
Towards in silico Protein Design 
The three dimensional structure of a protein determines its function in most cases, and 
this is a function of the primary amino acid sequence of a protein. When we consider 
that there are 20100 possible variations of a 100 Amino Acid long protein sequence, the 
scale of possibility in protein design becomes apparent. The figure below, adapted from 
work by Huang et al, demonstrates the considerable gap between protein conformations 




extent of conformational and therefore functional potential still unexplored, a priority 
should be to design novel proteins to combat currently unsolved problems in medicine 
and human health.  
 
 
Figure 3.3: The scale of possibility within protein conformational space. The small dots 
represent the fold space explored by native, naturally occurring proteins, the larger 
spots represent the conformational possibilities arising from directed evolution, and the 
blue background represents the entire conformational space. 
 
Despite the immense potential of rational de novo protein design, more than 95% of 
protein engineering is still carried out by inserting random mutations and selecting those 
which confer an advantage (171). The rational design of proteins falls into two 
categories, the redesign of existing proteins in a process analogous to directed evolution, 
and the de novo design of completely novel proteins. Protein redesign uses naturally 
occurring proteins as scaffolds, and then engineers them to introduce desired changes, 
such as increased stability or new functional properties (172). This will produce novel 
proteins, but their origins will be firmly based in the naturally occurring protein fold 
space. The majority of protein engineering to date has been of this nature. This method 
is convenient as it provides a protein backbone starting block, particularly if the desired 
effect represents a minor alteration in the protein’s function. This becomes complicated 
when large numbers of amino acids are altered, since it becomes inevitable that the 
structure will also be altered. Native proteins are only marginally stable in many cases, 




unfolding (170). Major advances in medical science directly resulting from this degree 
of protein design include the humanisation of antibodies from other animal species, 
which entails modifying the wild type antibody to resemble human antibodies while 
retaining the original function. Two examples are Alemtuzumab (173) and 
Mepozulimab (174) for the treatment of multiple sclerosis and eosinophilic asthma 
respectively.  
True de novo protein design explores the entirety of protein sequence space, guided only 
by the physical interactions that control protein folding. The scale of possible protein 
conformations, once naturally occurring proteins are left behind is enormous. De novo 
protein design is based on the hypothesis that a protein will always fold into the shape 
associated with the lowest free energy state allowable by the amino acid sequence. 
Therefore, if an accurate method for measuring the energy of protein chains is available, 
in addition to a method to sample different structures and sequences it should be 
possible to identify sequences that fold into novel structures (170). Once the desired 
shape has been reached, the stability of the novel protein can be improved by making 
minor adjustments, maximising the difference in free energy between the desired 
conformation and alternatives. 
There are few if any intuitive protocols for de novo protein design available, and 
generally speaking, expertise in computational biology and protein structural sciences is 
a minimum requirement before proceeding. Some programmes exist which make use of 
existing knowledge to create a framework within which non-expert design of de novo 
proteins is possible.  
Intelligent System for Analysis, Model Building And Rational Design (ISAMBARD) is 
a suite of tools developed by Wood et al with the aim of facilitating the rational design 
of de novo proteins and structures, and subsequently assessing their viability. In the 
words of the authors, it provides “a starting point for going into the dark matter of 
protein fold space (172).” Geometrically regular protein structures such as α-helical 
coiled coils have been parameterised mathematically starting with Crick in 1953, and 




design of repeat structures which can be used as scaffolds for further design in 
combination with other available tools and software.  
The Rosetta Suite has vast capabilities for the experienced user in terms of de novo 
protein design. This includes accounting for both L and D amino acids (175), reliably 
designing both structure and function (176), and the design of protein switches where a 
de novo protein can change shape in response to external stimuli (177). For the non-
expert user, some protocols exist for fragment-based design. This involves combining 
sections of several protein regions of known structure to form a new backbone. As this 
method uses already characterised proteins as building blocks, it is limited in the 
conformational space it can sample (172). This fragment-based design can be performed 
using tools such as RosettaRemodel (178).  
Conclusion 
The most apparent advantages of incorporating in silico analysis of protein structures 
into any synthetic biology pipeline are speed and cost. Thousands of potential constructs 
can be screened using combinations of the tools mentioned in this text, condensing 
possibilities down to a selection deemed most likely to be successful for the more 
expensive and time consuming laboratory work. In addition to this, the results of any 
laboratory work can be fed back into the in silico pipeline, thus improving any future 
simulations. The potential for expanding this in silico screening into the design of 
bespoke protein conformations tailored to a specific task has also been demonstrated and 
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“Assessing bioinformatic amplicon sequencing contamination control strategies via 
mock bacterial communities” 
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Background Alterations in the microbiological signal caused by the presence of 
contaminant DNA are a major issue in microbiome studies. Considerable effort has gone 
into developing strategies and tools to identify and bioinformatically stop environmental 
bacterial contamination from distorting biological signal.  
Aim A consistently effective contamination control strategy incorporating biological 
and bioinformatic methods, and the ability to validate this method, particularly when 
sampling from new environments for the first time would be of considerable benefit to 
future microbiome research.  
Methods This study compares options for the removal of contaminant DNA and 
proposes an optimal approach. The effect of these on the results of a sequencing study 
were validated through the use of a mock community. The effectiveness of 
contamination control at the extreme end of the spectrum is demonstrated, using 
samples featuring low levels of bacterial biomass, which are then formalin fixed and 
embedded in paraffin. This required the samples to be subjected to a number of different 
reagents during the DNA extraction and purification process, as is necessary for 
bacterial sequence analysis of FFPE samples, providing many potential sources of 
contamination.   
Results Even in samples that consisted mainly of contaminant DNA, it was possible to 
reliably isolate the true sample DNA with a retroactive bioinformatics method based on 
the use of negative controls, to an extent where the effect on any downstream 
microbiome analysis would be negligible, as verified by the mock community.  
Conclusions  All labs carrying out sequencing experiments, but particularly those 
dealing with low biomass or otherwise challenging samples, should carry out a similar 
analysis validating their own biological and bioinformatic contamination control 
methods to gauge the degree to which environmental contaminants may affect future 






Increasingly affordable culture-independent microbial surveys have sparked a surge in 
research furthering the understanding of the relationships between bacteria, but also 
viruses and fungi, and their hosts. This can be done primarily through the sequencing of 
amplified marker genes such as the 16S rRNA gene region in bacteria and ITS region in 
fungi or by non-specific sequencing of all DNA in a community using whole genome 
sequencing (1,2). Despite the advances that these new methods have yielded, there has 
been a realization within the field of sequence-based microbiome analysis of the threat 
posed by environmental contaminant DNA to the accuracy and reproducibility of 
research in this area. This has progressed to the extent that the validity of many 
microbiome surveys of low biomass environments have been rightly questioned(2,3). In 
response several groups have published both wet- and dry-lab methodologies for 
mitigating the impact of this contaminant DNA. These range from suggested protocols 
for negative controls(4), to bespoke bioinformatics tools for the retrospective 
identification and removal of contaminant sequences.  
Two advances in bacterial contamination removal are SourceTracker(5) and 
Decontam(6). SourceTracker predicts both the proportion of contamination and its 
origins, using a Bayesian approach combined with Gibbs sampling. The results of a 
sequencing experiment are divided into “sink” samples, and negative controls denoted 
as “source” samples. The algorithm divides “sink” samples into individual reads, each of 
which can be assigned to one of the “source” environments, or an unknown source if it 
is not predicted to have originated from a negative control sample. In summary, 
SourceTracker provides a clear picture of the extent to which negative controls have 
affected samples, but does not identify the taxa in question. The Decontam algorithm is 
more direct in its approach, and removes contaminant sequences based on two 
assumptions; (i)that sequences of contaminant origin are likely to inversely correlate 
with sample DNA concentration, and (ii) that contaminant DNA will have a higher 
prevalence in negative control samples(6).  
DNA contamination typically arises from DNA extraction kits, PCR reagents and the 




samples are particularly susceptible. These can be contaminated to a degree where the 
true microbial composition of the sample is completely altered(2). In addition to 
contamination from extraction kits and enzymes used in PCR reactions, certain samples 
require the use of additional buffers and reagents in order to extract bacterial DNA 
suitable for sequencing experiments. Two examples that are becoming much more 
prevalent in microbiome analysis are: 
• Samples with an overwhelming ratio of host DNA to bacterial DNA, such as non-tract 
biopsies. These need to be treated with bacterial enrichment solutions, many of which 
are not sterile(8).  
• Formalin Fixed, Paraffin Embedded samples. The formalin fixing process damages and 
crosslinks the DNA, and several steps must be taken to account for this(9,10).  
 
In both these cases enzymatic action is required, for purposes such as the depletion of 
host DNA, repair of DNA damaged by the formalin fixing process, or to lyse more 
resilient bacteria. Enzymatic action means that the reagents used cannot be autoclaved 
and therefore are not sterile.  
Several groups have recommended a more all-encompassing negative control strategy, 
incorporating many possible sources of contamination as well as positive controls or 
standards(11). It may seem logical to sequence every possible source of contamination if 
the circumstances allow, to be as thorough as possible. In practice this can lead to 
additional problems if not combined with correct retroactive bioinformatics-based 
contamination removal. This is because cross contamination between samples may 
occur, when DNA originating from the sample environment is transferred between 
samples. There are several causes for this but excluding human error during pipetting 
these are often very difficult if not impossible to control for in situ. Bacteria can become 
aerosolized when samples are being loaded into wells in PCR plates, or when the cover 
is removed from the PCR plate following the PCR reaction(12). There is a phenomenon 
known as “Tag switching” where sample barcodes migrate between wells(13). Barcodes 
can also be mistaken between samples as a result of sequencing miscalls due to poor 




of all reads in a sequencing run(15). Cross contamination has a negligible impact on  
samples unless they are of extraordinarily low biomass, but negative controls with low 
quantities of input DNA are particularly susceptible to artefacts of this nature as they 
may have very few microbes and so can appear to be dominated by an microbial 
sequence that is in reality just highly abundant in samples. This is of particular concern 
when carrying out the conservative contamination removal by subtraction method such 
as the one possible to implement in the QIIME pipeline(16). Other commonly used 
solutions include filtering out low abundance taxa below an arbitrary threshold(17), this 
method would run the risk of also removing rare genuine taxa from the dataset. More 
importantly, if a source of contamination was abundant enough to have a significant 
impact on downstream analysis, it would not be removed by this method(6). 
Of the recent 16S rRNA gene sequencing surveys present in the literature, the most 
challenging sample type that stands out is formalin-fixed paraffin embedded (FFPE) 
tissue(18). Here we test if samples having both low biomass and numerous plausible 
sources of contamination, could be reliably and reproducibly explored. We were able to 
isolate the endogenous biological signal, using a variety of negative controls as 
suggested by Eisenhofer et al (12), combined with bioinformatic contamination 
elimination, and crucially were able to validate the effectiveness of our approach by 
using mock bacterial communities in FFPE. We show that when a robust negative 
control strategy is combined with an effective bioinformatic contamination removal 
strategy, the effect of contamination on the overall biological signal can be almost 
entirely eliminated. This opens the door for microbiome investigations into a wide range 
of samples types, not limited to FFPE, many of which are currently treated with some 





MATERIALS AND METHODS 
All laboratory work was carried out by other members of the Tangney lab. This study 
simulated a challenging sample condition by creating a bespoke mock sample of mouse 
tumor cells and 4 different bacterial taxa. These were then formalin-fixed and paraffin 
embedded in the same way as genuine patient samples. Following this they are treated 
with a number of reagents and solutions to decrosslink the DNA, enrich and repair 
bacterial DNA and ultimately prepare a 16S sequencing library (8,19,20). 
 
Mock Community Design 
Four known bacterial species were used in this mock community. They were E. coli – 
K12 MG1655, Salmonella Typhimurium 7207, Staphylococcus aureus newman, and 
Streptococcus agalactiae COH1. To replicate a clinical FFPE sample, which is typically 
a biopsy, as closely as possible, Mus musculus mammary gland cancer cells (4T1) were 
also added. These cells were pelleted and suspended in formalin, before being added to a 
sterile mould with an equal volume of sterile agar. This was then dehydrated and 






FFPE sample preparation 
The formalin fixed biological standards were then treated in the same way as FFPE 
samples and processed according to an in-house protocol (for further details, see 
Chapter IV) 
 
V3-V4  16S rRNA sequencing  
Genomic DNA was amplified using 16S rRNA gene amplicon polymerase chain 
reaction (PCR) primers targeting the hypervariable V3–V4 region of the 16S rRNA 
gene: V3–V4 forward, 5′-TCGTCGGCAGCGTCAGATGTGT 
ATAAGAGACAGCCTACGGGNGGCWGCAG-3′ and V3–V4 reverse, 5′-
GTCTCGTGGGCTCGGAGATGTGTA 
TAAGAGACAGGACTACHVGGGTATCTAATCC-3' (Illumina 16S Metagenomic 
Sequencing Protocol, Illumina, CA, USA). A 35-µl PCR was performed for each sample 
per the following recipe: 3.5 µl of template DNA, 17.5 µl of KAPA HiFi HotStart 
ReadyMix (Roche), 0.7 µl of both primers (initial concentration, 10 pmol/µl), 0.1 µg/µl 
bovine serum albumin fraction V (Sigma), and 8 µl of 10 mM TrisCl (Qiagen). Thermal 
cycling was completed in an Eppendorf Mastercycler per the directions in the 
‘Amplicon PCR’ section of the ‘16S Metagenomic Sequencing Library Preparation’ 
protocol (Illumina). Amplification was confirmed by running 5 µl of PCR product on a 
1.5% agarose gel at 70 volts for 80 min, followed by imaging on a Gel Doc EZ System 
(Bio-Rad). The product was ~450 base pairs (bp) in size. PCR-positive products were 
cleaned per the ‘PCR CleanUp’ section of the Illumina protocol, with the exception that 
drying times were reduced to half the prescribed duration to account for the additional 
drying that occurs in a laminar airflow hood. Sequencing libraries were then prepared 
using the Nextera XT Index Kit (Illumina) and cleaned per the Illumina protocol. 
Libraries were quantified using a Qubit fluorometer (Invitrogen) using the ‘High 
Sensitivity’ assay. Sample processing was subsequently completed at Genewiz inc. 
Samples were normalised, pooled and underwent a paired-end 300 bp run on the 




Bioinformatics analysis  
The quality of the paired-end sequence data was initially visualised using FastQC 
v0.11.6, and then filtered and trimmed using Trimmomatic v0.36 to ensure a minimum 
average quality of 25. The remaining high-quality reads were then imported into the R 
environment v3.4.4 for analysis with the DADA2 package v1.8.0. After further quality 
filtering, error correction and chimera removal, the raw reads generated by the 
sequencing process were refined into a table of Amplicon Sequence Variants (ASVs), 
which can be considered analogous to OTU’s, and their distribution among the samples. 
The ASVs were classified using the classify.seqs function in Mothur and the RDP 
database.  
Reference Data Generation  
The sequences present in samples were blasted against a database of the 16S rRNA gene 
regions of the known input bacteria. Only reads with 97% sequence similarity were 
retained, this was to allow for sequencing miscalls, and DNA damage due to the 
formalin fixing process. The database was formatted using the makeblastdb facility and 
the search was carried out using blastn, both programmes are contained in the BLAST+ 
toolkit. This reference table will be referred to as the “Reference table”. BLAST was 
used with the exact reference sequences as opposed to relying on the classification from 
Mothur, as most species classification algorithms have a degree of trade-off between 
accuracy and speed(21).  
 
Statistical analysis  
All statistical analysis was carried out in the R environment v3.6.0. The Vegan package 
v2.5.2, Phyloseq package v1.2.4 and the Ape package v5.1 were used to calculate beta 
diversity. All statistical comparisons between grouped samples were carried out using 







Bioinformatic  retrospective contamination removal 
Three different approaches to contamination removal were compared in this study based 
on options often used in relevant sequencing studies. 
• Contamination removal by subtraction: 
Negative controls and samples were divided into two separate count tables, and any 
sequence present in the negative controls is removed from the dataset.  
• Decontam algorithm(6) 
Use of Decontam with default settings, using negative control samples as a guide.  
• Combined guided approach 
Combination of two published bioinformatic contamination control tools, Decontam and 
SourceTracker(22). This is the recommended method and is described in greater detail 
in Figure 1.  
 
These methods were validated biological standard mock community instead of patient 
samples, allowing for a quantifiable measure of their effectiveness by comparing them 





 Figure 1: Proposed workflow for contamination removal and subsequent validation. This involves preparing the positive controls 
in a manner consistent with the patient samples, extracting DNA, and sequencing.   Resulting data is assessed for contamination, 
using negative controls and bioinformatic techniques. The entire process is then validated by comparison with a reference table 





Figure 2 shows a comparison between all bacterial sequences in the dataset, and the 
Reference table. It is clear that contaminant bacterial DNA has had a major influence on 
the true biological signal as there is considerable difference between the two groups in 
terms of sample composition. Many obvious contaminant families such as 
Xanthomonadaceae (members of which are typically environmental organisms(23)) are 
present in the “Test” group only. The three families found in the Reference table are all 
significantly decreased in the “Test” group in this instance (p = < 0.001). Finally, figure 
2B models the effect this contamination would have on any downstream analysis by 





Figure 2: Comparison of (A) Reference table (obtained by BLASTing known input sequences against ASV table generated by 
DADA2) vs (BB) full count table with no contamination based modifications. The impact contamination has on sample beta 




The following figures highlight the effectiveness of different negative control strategies.  
Figure 3 shows the results of a contamination removal by the commonly used 
subtraction approach, where any sequence found in the negative controls is removed 
from the count table, which is then compared to the Reference table. While the sample 
composition tables look more similar than in Figure 2, there are statistically significantly 
lower levels of Enterobacteriaceae (p= 7.2e-6) and higher levels of Staphylococcaceae 
(p = 0.013). Despite the apparent visual similarity seen in terms of sample composition, 
the euclidean distance between paired samples indicates that contamination in 
combination with the heavy-handed contamination removal strategy would impair the 





Figure 3: Comparison of (A) Reference Table vs (C) count table with contamination removed by subtraction.  All ASV’s found in 
negative controls are removed from entire dataset.. The impact contamination has on sample beta diversity is shown in (B), with the 




Figure 4 shows the results of a generic implementation of the Decontam algorithm, 
using the negative control samples as a reference. In this instance the algorithm has no 
tangible effect, as we can see from the marked differences in sample composition at the 
family level with statistically significant reductions in the levels of Enterobacteriaceae 
(p = 7.2e-6), Staphylococcaceae (p = 7.6e-6), and Streptococcaceae (p = 7.6e-6). In 
addition and the euclidean distance between paired samples on the PcOA plot shows 






Figure 4: Comparison of (A) REFERENCE table vs (BB) count table with contamination removed by blind use of Decontam 





Results of proposed contamination removal workflow 
Figure 5 shows the output of the SourceTracker algorithm, which is used to assess the 
proportion of bacteria originating in the surrounding environment (i.e. negative controls) 
present in the samples when applied to the test data. The grey shaded region in the pie 
charts is the proportion bacteria not attributable to environmental contamination by 
source tracker. Thus contamination was ubiquitous among the samples analysed, with 
the highest contributions coming from “extraction negative” and “Negative control 
solution 3”. This information was used to inform the next step in our contamination 
removal strategy.  
 
 
Figure 5: Sourcetracker output, mapping the sequences detected in samples to 
sources of contamination. Grey shaded region indicates suspected genuine bacterial 
sequences of sample origin, other shaded regions correspond to different negative 
controls. The negative controls impacting on samples that should be used for 
contamination removal are identified in bold with stars.    
 
Figure 6 compares the REFERENCE table with the count table resulting from this 
contamination removal strategy, involving both SourceTracker and Decontam, as 
outlined in Figure 1. The sample composition plot in this case is very similar to the 
reference table, with the only difference being low levels of the common contaminant 




Comparisons of sample composition at the family level of taxonomy found no 
difference in the levels of any of the taxa originating in the samples.  Here, unlike in the 
case of the contamination removal by subtraction, we see that there is no significant 
difference in beta diversity between paired samples, suggesting that contamination is 






Figure 6: Comparison of (A) REFERENCE table vs (C) count table with contamination removed by Decontam, and guided by 





The effectiveness of this strategy was validated by re-analysis with the 
SourceTracker algorithm (Figure 7). This time the algorithm shows that the level of 
contamination in the samples has decreased significantly. Most samples show only 
trace amounts of contamination, with only one sample still having a level of 
contamination comparable to pre-contamination removal levels. A second 
verification step is shown in the same figure. As contamination control inevitably 
involves the removal of reads, care should be taken to ensure that sufficient sampling 
depth remains to accurately characterise each sample, as evidenced by a plateauing 







Figure 7: (A) SourceTracker algorithm run on new count table following 
contamination removal. Grey shaded region represents the true biological signal. 






In summary, Table 2 below shows the mean Euclidean distance between matched 
samples following the different contamination removal strategies outlined up to this 
point to mathematically assess their effect on any further analysis.  The manually 
supervised contamination removal approach incorporating both SourceTracker and 
Decontam significantly improves on all the other methods examined (p = < 0.001).  
Table 1: Table showing the mean Euclidean distance between paired samples for 
each ASV table vs the reference table, on PcOA plot. Guided method is statistically 
significantly closer to reference method than any of the other groups. (p = < 0.001 












REFERENCE table vs No Contamination Control 0.070 
REFERENCE table vs Contamination removal by 
Subtraction 
0.062 
REFERENCE table vs Generic implementation of 
Decontam 
0.070 







The choice of approach to contamination removal was shown to have a marked 
effect on the composition of the samples analysed, and thus on any downstream 
analysis. As expected from samples of this nature, there was considerable 
contamination present. The initial comparison between the REFERENCE table and 
the untreated count table show that the sample composition was completely altered 
by environmental contaminants. That this would also affect any downstream 
diversity analysis was confirmed as the paired samples diverge significantly on a 
PcOA plot calculated with Bray-Curtis dissimilarity (Figure 2). It must be concluded 
that carrying out a microbiome survey samples of this kind, and potentially many 
low biomass or FFPE samples, without accounting for this contamination would 
have been untenable.   
The problem of contamination control is not as simple as removing any sequence 
variant that appears in the negative controls. This approach is shown in Figure 3. 
Although the sample composition plots looked similar, the paired samples showed a 
high degree of between sample variation. The reason for the difference in beta 
diversity between the REFERENCE table and the untreated count table in this 
instance was that several high abundance sequences were erroneously removed from 
the dataset as they appeared in low quantities in some of the negative controls. This 
does not necessarily mean that they are contaminants, but rather could be artefacts of 
the sample preparation or sequencing process, as a result of cross contamination 
within a run as previously reported (14). So while a blanket removal of these 
potential contaminant sequences does show an improvement over making no 
intervention, it is not a perfect solution.  
The previous example showed a contamination control method that was too 
conservative, with many falsely identified contaminants. The approach highlighted 
in Figure 4 was the opposite in that many true contaminants were allowed to remain 
in the ASV table. This strategy is included as a warning that simple “black-box” use 
of many bioinformatic tools, and Decontam in particular can lead to erroneous 
results negatively impacting further research. The inclusion of negative controls 
blindly without assessing their impact on the samples, or whether the number of 




contaminant has a significant impact on the accuracy of the Decontam algorithm. 
Equally important is setting the threshold to a level that matches the degree of 
contamination presentpresent in samples, to ensure that the contamination removal 
process is not too lax or too strict. SourceTracker can assist in this. If 
decontamination tools are run blindly, it is shown here that they have little if any 
beneficial effect on the accuracy of results, manual supervision of this process is 
necessary.  
SourceTracker should be used to assess the relationship between samples and 
negative controls before attempting to remove contaminant sequences. This allows 
for contamination control to only be based on those negative controls that have a 
clear and significant effect on the samples. This lowers the possibility of false 
positives as seen in Figure 3, or false negatives as seen in Figure 4. While this 
manual approach does still show some contamination, indicating a higher false 
negative rate than the contamination removal by subtraction method, it has a 
considerably lower false positive rate in terms of contaminant identification. The 
effectiveness of this strategy is shown by the fact that there is minimal difference 
between paired samples on PcoA plot or sample composition plot. The method 
issignificantly more accurate than others tested (p < 0.001), and appears to negate the 
impact of contamination on downstream analysis.  
We have shown that when properly combined, a robust negative control strategy 
along with manually supervised bioinformatic retrospective removal of known 
contaminants can limit contamination to an extent where the effect on any 
downstream microbial analysis is inconsequential. There is always room for 
improvement, and in a similar fashion to many recent publications that have 
published tables of bacterial taxa known to be environmental contaminants in 
sequencing experiments, labs should strive to develop in house databases of 
contaminant reads identified in commonly used reagents. These could be used as an 
initial screen of any count tables generated, working in a similar manner to the many 
reference-based chimera removal tools that exist today (24).  
One final consideration when undertaking contamination removal is the fact that 
reads must be discarded during this process. This must be taken into consideration 




expected to produce 13.2-15 million paired end reads, which are roughly evenly 
distributed among samples (25). The sequencing library should be generated with 
this in mind to ensure sufficient sampling depth remains after the contamination 
removal process, which can be simplified using the sequencing coverage calculator 
found on the Illumina website(26). This can be assessed after the fact using 
rarefaction curves, which the number of reads checked vs the number of new species 







When combined with positive and negative controls, it is shown that even samples 
with heavy contamination can be restored to a state where they can give accurate and 
reproducible information. The recommendation is that all future sequencing studies 
involving samples vulnerable to contamination be accompanied by both a wide 
variety of negative controls, and a number of positive controls that closely resemble 
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Bacteria in breast tumours 
This manuscript is currently being prepared for submission in combination with 







Background Although the existence of a bacterial community in both breast 
tumour tissue and healthy adjacent tissue has been reported by numerous groups 
since 2014, it remains a contentious issue. Tumour samples provide many obstacles 
to carrying out robust and reliable microbial surveys, primarily due to the anticipated 
low bacterial biomass of these samples. This feature of breast tumour samples has 
stifled research in this field as previous studies analysing low biomass data such as 
breast tissue have been cited for taking insufficient precautions in limiting the effect 
environmental contamination has on the results. While the debate continues over the 
presence or absence of bacteria in niches of low biomass, no further research can be 
conducted on how bacteria could be utilised for therapeutic purposes if they are 
indeed present.  
Aim This study set out to definitively assess the presence of endogenous bacterial 
communities in breast tumours and the associated healthy adjacent tissue.  
Methods The study incorporated a robust negative control strategy, makes use 
of the recent developments in bioinformatic contamination removal, and examines 
choice of primer site for amplification or presence of extracellular DNA playing a 
role in the outcome.   
Results  The presence of a detectable tumour microbiome was evident in the 
majority of tumour samples, and was similar in community structure to that of the 
skin and normal adjacent tissue with some statistically significant differences, 
amounting to a distinct microbial signature unlikely to be due to sample or kit 
contamination.  
Conclusions This study indicates the presence of bacterial communities in both 
malignant and non-malignant breast tissue in the majority of cases, and that the two 





According to the World Health Organisation, breast cancer affects 2.1 million 
women worldwide annually, which resulted in 627,000 deaths in 2018, constituting 
15% of all cancer deaths among women that year. While incidence rates increase 
3.1% globally, they still vary considerably between high income countries such as 
the United States (92 per 100,000) and lower income regions such as eastern Asia 
(27 per 100,000) (1). This is reflective not only of the increased likelihood of risk 
factors such as hormonal contraception, lack of breastfeeding, obesity and alcohol 
use, but also of the lower rate of detection in poorer regions so these rates may be 
closer together than currently thought (1). Potential avenues towards the 
development of improved treatment and detection strategies come from a myriad of 
sources, and one that should not be discounted, despite early setbacks, is the 
possibility of utilising endogenous bacterial communities within breast tumours for 
therapeutic or diagnostic purposes. There are four key physiological features shared 
by solid tumours which theoretically should promote bacterial colonisation: (i) 
Leaky vasculature which could allow circulating bacteria to embed in tumour tissue, 
(ii) the immune privileged nature of tumours, (iii) solid tumours possess low oxygen 
regions suitable for the proliferation of facultative and anaerobic bacteria, and (iv) 
high turnover regions of tumours are nutrient rich, promoting bacterial growth (2).  
Research has been conducted assessing the viability of using bacterial colonisation 
of tumour environments as a diagnostic or therapeutic tool (3).  Further research 
would benefit from high quality reproducible work to definitively confirm the 
natural presence of bacteria in tumour tissues. Unfortunately, features inherent of 
tumours and adjacent tissue have hampered progress. Firstly, the quantities of 
bacteria present are often so low that it becomes difficult to differentiate between 
any bacteria genuinely originating in the sample, and those arising from 
environmental contamination during the extraction, or library preparation process. 
This issue has plagued numerous recent studies of low bacterial biomass 
environments, including work done by our own group. Related to this, human 
biopsies, particularly those from “non-tract” locations can be expected to have 
overwhelming ratios of host to bacterial DNA. In these circumstances, 16S rRNA 
gene-specific primers have been shown to amplify human reads in addition to 




the idea of bacteria living within healthy and malignant breast tissue was first 
theorised (5), tumours at a variety of other body sites have been examined in the 
hope of discovering a bacterial microenvironment. Many of these have been 
beleaguered by the problems outlined above, but recent studies (6,7) have shown that 
at least some tumour sites do appear to contain a detectable bacterial 
microenvironment and that the tools, both laboratory and bioinformatic, exist to 
reliably analyse these microenvironments.  
Such samples have only become accessible to researchers due to the increased 
emphasis in recent years on reproducibility and quality control in microbiome 
research, primarily centred on contamination control. The fact that the majority of 
reagents and extraction kits used in sequencing library preparation are not sterile and 
can therefore alter the microbial profile of a sample was first brought to light by 
Salter et al in 2014 (8) and confirmed repeatedly by several high impact publications 
such as De Goffau et al (9). In response to this, guidelines have been published for 
effective negative control strategies to quantify the effect of these kit contaminants 
(10), and bioinformatics tools developed to retrospectively mitigate the effect they 
have on eventual analysis (11,12).  
Here, we account for potential sources of error that have been highlighted in 
previous research of a similar nature. This begins with a robust contamination 
control strategy outlined here in considerable detail. Following this, the effect of the 
16S rRNA gene region targeted, and the potential presence of extracellular DNA in 
samples is also investigated. There has been considerable debate over which 
hypervariable region to target, and two of the most common regions (V1-V2 and V3-
V4) were compared to assess what effect, if any, choice of hypervariable region had 
on sequencing results.  The phylogenetic variability within the V4 region shows the 
strongest correlation with the phylogenetic variability of the 16S rRNA gene 
fragment overall, and the combined length of the V3-V4 region of 439 bases yields a 
large region for discrimination between taxa while still allowing for trimming due to 
poor sequencing quality. Conversely, the V1-V2 region is only 298 bases in length in 
E. coli, but this allows for a near total overlap of forward and reverse reads, which 
ensures for considerable noise reduction from sequencing errors (13). The V1-V2 




biomass samples as this shorter length has been shown to allow more efficient 
amplification of low abundance template sequences (14). 
Determining the presence of bacteria in tumours as distinct from environmental 
contamination is approached here by combining a robust negative control strategy 
with effective bioinformatic removal of contaminant reads. Two recent bioinformatic 
tools, Sourcetracker(11,12) and Decontom(11) were used to facilitate this. 
Sourcetracker uses Bayesian statistics to predict the proportions of bacteria in 
samples that may have originated from designated source environments, which in 
this case were negative controls. When used in this way, it works well as an initial 
screening tool to assess the degree of contamination present. Decontam removes 
contaminant reads, either by eliminating reads that have an inverse correlation with 
input DNA, or based on their abundance negative controls. In both cases Decontam 
requires that a threshold is set, and this can be dictated by the results of 
SourceTracker.  
One of the limitations of DNA sequence analysis is that it gives no indication of 
whether the DNA present in a sample is contained within living bacteria, dead intact 
bacteria, or extracellular DNA originating from biofilms or dead bacteria. A pre-
treatment step with DNAse, an enzyme that non-specifically cleaves DNA is often 
incorporated into metagenomics workflows to remove this extracellular DNA prior 
to amplification, ensuring that only intact bacteria contribute to the microbial 
profiling of an environment (15).  
With these confounding factors controlled for, the ultimate aim of this study is to 
provide a highly reproducible and reliable survey of the bacterial communities 





Sample Collection to reduce contamination 
‘Fresh’ specimens were provided directly from the operating theatre, as opposed to 
sectioning in histology laboratory, in order to minimise exposure to environmental 
contaminants. All samples were provided by a single surgical team under a single 
consultant ensuring consistency. Tumour tissue was biopsied using a 14 French 
ACHIEVETM programmable automatic biopsy system. Additionally, a skin swab 
(SS), a normal adjacent (NA) sample were taken from each patient to complement 
the tumour sample (TS), to ensure that any variability found in the diversity or 
composition of different sample types was down to the niches themselves and not 
confounded by person to person variation in the microbiome.  
 
Sequencing Library Preparation 
DNA extraction and library preparation work was performed by other members of 
the Tangney lab. 
Genomic DNA was amplified using 16S rRNA gene amplicon polymerase chain 
reaction (PCR) primers targeting the hypervariable V3–V4 region of the 16S rRNA 
gene: V3–V4 forward, 5′-TCGTCGGCAGCGTCAGATGTGT 
ATAAGAGACAGCCTACGGGNGGCWGCAG-3′ and V3–V4 reverse, 5′-
GTCTCGTGGGCTCGGAGATGTGTA 
TAAGAGACAGGACTACHVGGGTATCTAATCC-3' (Illumina 16S Metagenomic 
Sequencing Protocol, Illumina, CA, USA).  
A 35-µl PCR was performed for each sample per the following recipe: 3.5 µl of 
template DNA, 17.5 µl of KAPA HiFi HotStart ReadyMix (Roche), 0.7 µl of both 
primers (initial concentration, 10 pmol/µl), 0.1 µg/µl bovine serum albumin fraction 
V (Sigma), and 8 µl of 10 mM TrisCl (Qiagen). Thermal cycling was completed in 
an Eppendorf Mastercycler per the directions in the ‘Amplicon PCR’ section of the 
‘16S Metagenomic Sequencing Library Preparation’ protocol (Illumina). 
Amplification was confirmed by running 5 µl of PCR product on a 1.5% agarose gel 
at 70 volts for 80 min, followed by imaging on a Gel Doc EZ System (Bio-Rad). The 




the ‘PCR CleanUp’ section of the Illumina protocol, with the exception that drying 
times were reduced to half the prescribed duration to account for the additional 
drying that occurs in a laminar airflow hood. Sequencing libraries were then 
prepared using the Nextera XT Index Kit (Illumina) and cleaned per the Illumina 
protocol. Libraries were quantified using a Qubit fluorometer (Invitrogen) using the 
‘High Sensitivity’ assay. Sample processing was subsequently completed at Genewiz 
inc. Samples were normalised, pooled and underwent a paired-end 300 bp run on the 
Illumina MiSeq platform. 
 
Bioinformatic analysis 
The quality of the paired-end sequence data was visualised using FastQC v0.11.6, 
and then filtered and trimmed using Trimmomatic v0.36 to ensure a minimum 
average quality of 25. The remaining high-quality reads were then imported into 
the R environment v3.4.4 for analysis with the DADA2 package v1.8.0. After further 
quality filtering, error correction and chimera removal, the raw reads generated by 
the sequencing process were refined into a table of Amplicon Sequence Variants 
(ASVs) and their distribution among the samples. It is recommended that ASVs 
(formerly called ‘Ribosomal Sequence Variants’) are used in place of ‘operational 
taxonomic units’ (OTU). OTUs are clustered at a pre-determined threshold of 
similarity, typically 97%, which distances them from the ecological reality present in 
a sample. As the name suggests, an ASV represents an existing biological sequence 
variant found in the sample.  
Alpha diversity calculated as Chao1 species richness, and Bray-Curtis distances, for 
analysis of beta diversity, were calculated using the PhyloSeq package v1.24, and the 
Vegan package v2.52. Beta diversity calculations produce distance matrices with as 
many columns and rows as there are samples; thus, beta diversity is often 
represented using some form of dimensionality reduction, in this case, using 
principal co-ordinates analysis (PCoA) with the Ape package v5.1. Hierarchical 
clustering, an unsupervised method that can reveal key taxa that distinguish their 
respective environments, was performed with the heatplot function in the made4 
package v1.54. Differential abundance analysis was carried out using Deseq2 v1.2.0, 




Tests of means were performed using the Mann-Whitney U test unless otherwise 
stated, and correlations were calculated using Spearman’s rank correlation 
coefficient. Where applicable, false positive rates were controlled below 5% using 
the FDR procedure. Random forest classification trees were built using the 
RandomForest(v4.6.15) and pROC(v1.15.3) packages in R. Developed in 2001(16), 
this tool is particularly suitable for classification based on sequence data as it is 
computationally efficient, gives an estimate of the importance of each predictive 
variable (in this case ASV’s), and limits model overfitting by making decisions on 
splitting of samples at a particular node on a randomly sampled subset of the dataset, 
rather than all available sequences. As thousands of trees are created with each 
implementation of the algorithm there is no risk of loss of information(16). 
Despite not identifying the contaminant taxa themselves, the source tracker utility is 
invaluable in estimating the proportion of a sample (“Sink”) that may have 
originated in a negative control (“Source”) Decontam can remove taxa, based on 
presence or absence in negative controls, or inverse correlations with input DNA but 
requires a threshold to be set, which can be dictated by SourceTracker. The 





Table 1: Samples analysed. Multiple samples per patient in some cases to account 
for possible sources of error.  
*Indicates >500 reads remaining after removal of environmental contamination and 
non-microbial reads. 
 Tumour Normal Skin 
Swab 
Total 
Sequenced samples (including 
replicates) 
37 40 31 108 
Surviving Contamination  
Removal* 
29 40 30 99 
DNase – replicates (No DNAse 
treatment of samples) 
2 10 3 15 
V1-V2 Primer Pair replicates 8 0 0 8 
Final analysis 19 30 27 76 
 
1. Contamination control 
The full breakdown of comparisons performed to control for sources of error, and as 
part of the final analysis can be seen in Table 1. Figure 1A shows the composition at 
family level of the samples, prior to any contamination removal. The samples are 
grouped by sample type (Ductal tissue, Normal Adjacent tissue, Skin Swab, Tumour 
tissue) and within this by DNAse status. Some sample were treated without DNAse 
to investigate the effect of DNAse treatment on the levels of environmental 
contamination. In addition, the family level taxonomic composition of each sample 
and the number of reads associated with each sample can be seen above the plot (i). 
Figure 1B shows a sample composition pie chart at a per sample level, showing the 
estimated proportion of reads within each sample originating in one of the negative 




Some samples show contamination in excess of 50 %, but the majority show little to 
no effect by environmental sources, which is encouraging for downstream analysis.  
 
Figure 1: Sample overview prior to contamination removal. (A) (i) Family level 
composition of patient samples, ordered by sample type and DNASE status 
consecutively. (ii) indicates the number of reads present in each sample. (B) 
SourceTracker output using the negative controls as “Source” samples, and the 




among samples, with only 3 samples showing in excess of 50% contamination, as per 
SourceTracker.  
 
The effectiveness of the contamination strategy can be seen by comparing the results 
shown in Figure 1 with those in Figure 2 below, which show the same samples in the 
same order, but following removal of reads identified as environmental contaminants 
by a combination of SourceTracker and Decontam. As the initial iteration of 
SourceTracker only implicated the kit control samples in introducing contamination 
to the samples, the PCR controls were dropped prior to contamination removal. The 
low number of reads in these samples also made them high risk samples for false 
positive identification of contaminants due to cross contamination between patient 
samples and negative controls, either during the library preparation or sequencing 
stage. As can be seen in Figure 2, the contamination removal strategy was effective, 





Figure 2: Sample overview following contamination removal. (A) (i) Family level 
composition of patient samples, ordered by sample type and DNASE status 
consecutively. (ii) indicates the number of reads present in each sample;;   (B) 
SourceTracker output using the negative controls as “Source” samples, and the 
patient samples and “Sink” samples. Consensus plot shows clearance of reads 
originating in negative controls as per SourceTracker.  
 
Contamination removal saw a reduction in the average reads per sample from 9084 
to 6934, but the overall structure of the bacterial community remains unchanged. 
Although some trace amounts of contamination do remain in a few samples, it is safe 




biological signal present in the samples, and should not significantly impact any 
downstream analysis.   
Due to the susceptibility of these samples to contamination, and the fact that trace 
amounts of contamination are still present as per SourceTracker, post retrospective 
contamination removal, the decision was made to employ the conservative strategy 
of removing any ASV appearing in the negative controls from the dataset.  
 
2. Target region of choice 
As mentioned earlier, several groups have suggested a shift to the V1-V2 
hypervariable region of the 16S rRNA gene fragment, from the more widely used 





Figure 3: Pairwise comparison of samples using V1-V2 and V3-V4 primer pairs. 
(A) (i) Reads per sample following the contamination removal outlined previously. 
(ii) Sample composition at the family level of paired samples. (B) Average Chao1 
species richness between samples amplified using V1-V2 primers (red) and V3-V4 
primers (blue). (C) Comparison reads per sample pre and post removal of 
contaminant and human aligning reads. In both (B) and (C) statistical testing is 





Samples amplified using primers targeting the V1-V2 hypervariable region showed a 
consistently increased number of reads per sample after the removal of contaminant 
and non -bacterial reads (as per Mothur classifier) (Figure 3A) and also a decreased 
reduction in overall reads when comparing samples before and after this removal of 
reads. More than 90 % of the reads that did not classify as bacterial representative 
sequences were confirmed as human reads by BLAST. This tells us that the V1-V2 
region is undoubtedly more suited to samples presenting with low biomass and an 
extremely high ratio of human reads. In the context of this study, the disparity in 







3. Effect of DNase treatment 
  
Figure 4: Pairwise comparison of samples using with and without DNase 
treatment. (A) (i) Reads per sample following the contamination removal outlined 
previously. (ii) Sample composition at the family level of paired samples. (B) Bray-
Curtis dissimilarity between Dnase + and – samples, showing no significant 
difference between groups as per PERMANOVA (p = 0.98). (C) Alpha diversity 
boxplots calculated using Chao1 species richness. Significance detected using 
wilxocon signed-rank test. The three panels of this figure show conclusively that no 





No significant difference was seen between samples with or without DNase 
treatment in terms of alpha diversity, calculated using Chao1 species richness. Beta 
diversity, calculated using Bray-Curtis dissimilarity and visualised on a PcOA plot 
showed no observable separation based on DNAse status, which was confirmed 
statistically using Permanova analysis. This is mirrored by the sample composition 





4. Diversity Overview 
 
Figure 5: Diversity based comparison of the three patient environments. (A) Bray-
Curtis dissimilarity comparing Tumour, Normal Adjacent and Skin swab samples 
types. Ellipses represent 80 % confidence interval for sample type. (B) Alpha 
diversity boxplots visualising differences in Chao1 species richness between 
samples. Significant decrease in diversity as per Kruskal-Wallis test (p = 0.021). (C) 
Elimination of potential confounding factors. Same ordination, due to Bray-Curtis 
dissimilarity as (A) with points overlaid with colouring by reads per sample, with 
paired samples joined by line. Neither of these causes any significant clustering. (D) 
Same ordination, due to Bray-Curtis dissimilarity as (A) with points coloured by 












The three environments assessed were broadly similar, with the significance implied 
by Permanova testing likely to relate to the tighter clustering of tumour samples 
compared to normal adjacent tissue and skin swab samples. The fact that the tighter 
clustering of tumoural samples occurs within the broader confidence regions for the 
other two sample types suggests that the dissimilarity is caused by an absence of 
ASVs more than the presence of tumour unique ASVs. This is reinforced by alpha 
diversity analysis using Chao1 species richness, which shows tumour samples 
having a significantly lower alpha diversity. As always, but particularly in the case 
of low biomass samples, confounding factors affecting the accuracy of results must 
be ruled out. Figure 7C shows the same ordination plot but with samples from the 
same patient connected by dashed lines, and rules out a clustering of samples by 
patient origin. Figure 7D again shows the same ordination plot, but overlaid with the 
extraction kit used, showing that kit bias played a minimal role in the outcome of 






Figure 6: Clustering analysis of samples with corresponding sample composition. 
Hierarchical clustering carried out using Ward’s method, and 1-Pearson correlation 
distance used to calculate distance between rows and columns. The sample 








Unsupervised hierarchical clustering was performed to detect discrete differences 
between samples that were not obvious using principal co-ordinates analysis. This is 
visualised in a heatmap where each column represents a sample and each row a 
unique ASV. In this instance, it shows that the majority of tumour samples appear in 
the right most cluster, while the skin swab and normal adjacent samples are more 
randomly dispersed throughout the heatmap. The basis for this clustering is evident 
when the composition plot is examined, with sixsix families having significantly 
different mean proportions between tumour and normal samples, and fivefive 
between tumour and skin swabs. There were no significantly different families when 
comparing normal and skin swab samples.  
Following on from this, Deseq2 was used to detect differentially enriched taxa at the 





Figure 7: Deseq2 based investigation of differentially enriched taxa between sample types. (A) Normal adjacent vs Tumour. (B) Skin swab vs 
Tumour.  Both (A) and (B) show log fold change of taxa between the two environments, and phylogenetic relationship between them as per 





Overall, 14 ASVs were found to be differentially abundant between tumour and 
normal adjacent samples, and 16 between tumour and skin swab samples, while there 
were no significantly different ASVs between Skin Swab and Normal Samples. 
Their evolutionary relatedness was explored phylogenetically, with each node 
labelled with its highest scoring BLAST hit in an attempt to gain more information 
about these closely related ASV’s. The differences are predominantly in 
Staphylococcus spp. with S. hominis, S. caprae and S. saprophyticus all significantly 
elevated in skin swab and normal adjacent samples vs tumour samples. Tumour 
samples showed significant enrichment of S. aureus, Methylobacterium spp., C. 
pillbarense and K. palustris.  
 
Figure 8: Random Forest-based classification of sample type. (A) accuracy of 
classification represented as area under the curve of receiver operating 
characteristic curve. True positive rate is plotted on the X axis and false positives 
are plotted on the Y axis. (B) Mean decrease in accuracy of prediction when ASV is 





Having detected significantly differentially abundant taxa at both the family and 
ASV level, the next step was to see if the ASV distribution between samples could 
be used to classify as either tumour, normal adjacent or skin swab. The 
RandomForest package in R was implemented for this purpose, using only the ASVs 
that appear in at least 5 % of samples. The algorithm was able to effectively 
differentiate between tumour and both normal and skin swab samples at a rate 
significantly higher than the random chance of correct classification, (AUC 0.801 
and AUC 0.805 respectively) as seen in Figure 8. This was not the case when 
attempting to classify skin swab and normal adjacent samples, where the AUC was 
0.553. As the receiver operating characteristic curve plots the true positive rate 
against the false positive rate, the worst possible score for a model is in fact 0.5 not 
0, this means that the chances of the model correctly predicting whether a sample is 





Tumour histology analysis 
The effect of any histological differences between tumours on their bacterial content 
was also examined (Table 2).  
 
 
Figure 9: PcOA comparison of tumour samples, via alpha and beta diversity. (A) 
Bray-Curtis dissimilarity between sample variations within the tumour samples. (B) 
Alpha diversity boxplot showing Chao1 species richness in tumour samples is 





Table 2: Statistical analysis of the effect of histological features on alpha (Chao1) 




Chao1 Bray Curtis 
Surgery 0.43 0.714 
Tumour Grade 0.46 0.803 
Probiotic 0.92 0.578 
Antibiotic 0.019 0.507 
Necrosis 0.68 0.683 
Metastases 0.77 0.091 
Skin Involvement 1 0.707 
Age 0.805 0.988 
Tumour Size 0.59 0.902 




When viewed in isolation in Figure 9, the tumour samples are not clustered as 
closely as when visualised in conjunction with normal adjacent tissue and although a 
considerable amount of metadata was available to attempt to explain this 
distribution, the only significant association detected was between patient antibiotic 






Considerable recent research urging caution when undertaking sequence-based 
analysis of low biomass ecological niches particularly with regards to environmental 
contamination dictated the starting point of this study. An important aspect of any 
analysis into the bacterial composition of tumour tissue is to show that 
environmental or kit contamination is not the driving determinant of any bacterial 
community identified. Any microbiological survey is susceptible to contamination, 
but low biomass samples are disproportionately affected. In this instance, through 
the use of a robust negative control strategy and cutting edge bioinformatic tools for 
retrospective removal of contaminant sequencing reads, it can be stated that any 
potential contamination of samples used in this study has been contained, to the 
extent possible with bioinformatic software.  
The community structure in samples amplified with V1-V2 primers was grossly 
similar to those amplified with V3-V4 primers upon visual inspection of sample 
composition plots, and there were no significant difference in terms of Chao1 species 
richness. This is reassuring, in that the choice of primers did not have any adverse 
effect on the downstream results. Of considerable interest to any groups carrying out 
low biomass research in the future, is the huge discrepancy in the number of reads 
yielded once human and bacterial contamination had been filtered out. As can be 
seen in Figure 3, samples amplified with primers targeting the V1-V2 region have a 
consistently and significantly higher number of reads. This is not the case at the end 
of the DADA2 pipeline, but once the unclassified reads are filtered out, most of 
which are shorter in length and align to the human genome, there is a significant 
reduction in the number of reads in the V3-V4 samples that is not seen in the V1-V2. 
This stems from an underreported problem in low biomass microbiome research, in 
that when the ratio of host DNA is overwhelming, human mitochondrial DNA can 
be amplified by primers targeting the 16S region. While human contamination is a 
very common problem in amplification-free WGS sequencing strategies (17), it is 
rarely reported as an issue in amplicon based sequencing strategies. In this instance, 
this has been particularly acute as the two most abundant ASVs in the entire dataset, 
when blasted, give as their top scoring hits the GenBank sequence MN516694.1 
which is defined as “Homo sapiens isolate S90_f1_ath haplogroup W1b1 




be learned from this is that while we were fortunate that our samples were of low 
complexity, relative to faecal samples for example, the impact of primer choice on 
eventual read depth must be considered if undertaking a survey of a “tract” biopsy 
such as the respiratory tract or digestive tract, which may require a greater 
sequencing depth to fully characterise (18). 
The comparison of paired samples with and without DNAse treatment can be 
expected to reveal the extent to which extracellular DNA is distorting the detected 
bacterial community structure of an environment through sequencing. In this 
instance, as can be seen from Figure 6, DNase treatment had no effect on the 
composition of the samples. This can be seen visually in the sample composition 
plot, but also statistically in that there is no significant difference between the two 
groups in either alpha diversity or beta diversity. This informs that any bacterial 
DNA found in the samples originates either from live or dead but still intact bacteria.  
The key aim of this study was to definitively confirm or deny the presence of 
bacteria within breast tumours, and surrounding tissue, and if present, hypothesise 
where these communities could have originated. Our initial alpha and beta diversity 
analysis, as shown in Figure 7, indicates that tumour samples have a significantly 
lower alpha diversity than their paired normal adjacent or skin swab samples, and 
while they samples do not cluster separately on a PcOA plot, the clustering is 
considerably more concentrated for tumour samples than the other two. When this 
information is combined with the hierarchical clustering and sample composition 
plots in Figure 8, we can see that the samples are all broadly similar in overall 
structure, with the skin-associated Staphylococcaceae (19) and Corynebacteriaceae 
(20), the dominant families present overall, providing a suggestion as to the origin of 
the bacteria found in these normal adjacent and breast tumour biopsies. This is 
unsurprising, as microbiome samples from closely proximal body sitescommonly 
share taxonomic traits (21). Despite this broad similarity, the clustering of samples 
does indicate that differences do exist particularly between the tumour samples and 
the non-tumour samples. This is of considerable interest due to the diagnostic and 
therapeutic potential that bacteria selectively colonising tumours over the 
surrounding tissue would have. Analysis of the mean proportion of a sample that a 
particular family occupied showed significant differences between the tumour and 




using Deseq2-based analysis of differentially enriched taxa at the ASV level. This 
further highlighted that differences exist between tumoural and non-tumoural 
samples.  
At both family and ASV level, the skin swab and normal adjacent samples have no 
significantly enriched taxa, and both show increases in the classically skin-associated 
taxa of Staphyloccus(aceae) and Corynebacterium(aceae) which dominate the 
dataset, when compared with tumour samples. The tumour samples present with a 
more varied range of enriched taxa. Interestingly, the Fusobacteriaceae family, 
which has previously been implicated in a variety of human cancers, most notably 
colorectal cancer (22), was found to be elevated in tumour samples when compared 
with both non-tumour sample types. While at the ASV level it should be noted that 
while S. capitis, S. hominis and S. caprae are all elevated in skin swab and normal 
adjacent samples, and are either aerobic in the case of S. capitis or shown to 
considerable more suited to aerobic conditions than not, as is the case for S. hominis 
and S. caprae, it is the truly facultative S. aureus that is elevated in the tumour 
samples. Given that members of the Fusobacteriaceae family are all either 
facultative or anaerobic, this lends credence to the theory that the hypoxic regions 
known to be characteristic of tumours but absent in normal adjacent tissue or skin 
swabs, could have a determining impact on bacterial community composition 
(23,24). One caveat of the conclusions drawn, particularly from the different species 
of Staphylococcus, is that while they can be discriminated using regions of the 16S 
rRNA gene fragment (25), the differences are at most a few base changes over an 
entire variable region, meaning sequencing errors could lead to false speciation 
events. In this instance, the sequencing data were quality-filtered to ensure a 
minimum per base quality of 30 according to the Phred scoring system, which 
equates to 1 error in every 1000 bases meaning we can be confident of the accuracy 
of the results. That being said, a more comprehensive analysis of the complex 
staphylococcal community present in these samples using a different marker gene 
such as the tuf region could yield additional valuable information (26,27). 
Finally, the Random Forest ensemble learning method was employed in an attempt 
to reveal unique microbial profiles between the sample groups undetected by 
standard multivariate techniques. A distinct microbial signature was detected for 




was evidenced by the area under the receiver operator curve being significantly 
higher when differentiating tumoural from non-tumoural samples (0.801 and 0.805) 
than when attempting to distinguish skin swab. 
The origin of the bacteria in these tumours is of considerable interest. For this 
reason, it is important to investigate all possible relationships between groups, 
exploring whether bacterial profiles hold true within patients, within sample types, or 
within the culture status of the samples. Unfortunately, the only significant 
interaction detected was between antibiotic administration and alpha diversity, which 
is unsurprising. We suspect that due to the well-documented heterogeneity of 
tumours (28), there is no guarantee that the section of the tumour sent for sequencing 
matched any of the histological indications provided at the time of tumour removal 
and clinical assessment. 
This study indicates the presence of endogenous bacterial communities in both 
malignant and non-malignant breast tissue in the majority of cases, and that the two 
can be differentiated based on their bacterial composition. Future work focusing on 
bacterial biomarker discovery would benefit from strain level analysis of these 
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Background The role of the microbiome in health status is an expanding research 
area and in recent times, body sites classically considered sterile have been found to 
harbour an endogenous microbiome. One of the key rate limiting factors in 
progression of such research is difficulty in accessing sufficient tissue samples for 
statistically significant analysis to be carried out or to perform retrospective analyses. 
FFPE tissue represents the biggest repository of human tissue samples and could 
represent a vital resource for expanding microbiome research. Currently, there are 
several key features which limit bacteria related data generation from this material: i) 
DNA damage inherent to formalin fixation; ii) a high ratio of host to bacterial DNA, 
impairing sequence and PCR-based analyses; iii) inefficient DNA extraction 
methods, leading to poor sensitivity and data bias; and iv) vulnerability to 
contamination.  
Aims We sought to develop a method for processing of FFPE samples to yield 
improved quantity and range of bacterial DNA present in samples than currently 
available methods, of the quality required for 16S sequencing and whole genome 
sequencing.  
Methods  A laboratory process was developed where samples undergo host 
DNA depletion, bacterial lysis, formalin crosslink digestion, DNA purification and 
DNA repair. The method was developed and validated using bespoke FFPE mock 
community models, FFPE murine samples, and clinical human tissue samples. DNA 
quantity and quality in terms of fragment length and sequence fidelity was assessed 
by qPCR and whole genome shotgun sequencing. The method was validates as a tool 
for microbiome research using 16S rRNA gene sequencing with the results 
compared against paired samples extracted with the current gold standard QIAGEN 
QIAamp FFPE tissue kit.  
Results  i) First, a mock community study model was developed and validated 
bioinformatically. This ‘Protoblock’ permitted a precise representation of biological 
material ‘before and after’ FFPE treatment, enabling the study to relate the outputs of 
laboratory analyses to reality. ii) This was used to characterise the nature and 
severity of FFPE-induced damage in bacterial DNA, followed by development of 




Analyses of outputs from qPCR, high resolution melt analysis, Sanger Sequencing 
Shotgun Sequencing analysis were used to determine the most effective DNA repair 
strategy. iii) Bioinformatic validation of the combined method shows a significant 
improvement over the current gold standard QIAGEN QIAmp FFPE tissue kit, using 
both mock communities and FFPE murine faecal samples.  
Conclusion This novel method may precipitate the reliable use of standard clinical 






As DNA sequencing sensitivity and accuracy increases, sites previously considered 
sterile have also presented detectable microbial profiles. These discoveries have led 
to a greater demand for patient samples to undertake sequencing and other 
qualitative experiments such as qPCR for particular bacterial species. In an attempt 
to satisfy this increased demand, the use of formalin fixed paraffin embedded tissue 
for research involving bacterial DNA has been explored, with several recent studies 
published using FFPE samples as a starting point [1-6]. FFPE blocks are considered 
the gold standard for post-operative tissue storage in hospital settings and their 
reliable use for DNA analyses could open up a trove of potential samples for 
research. However, at present, no specific method exists for bacterial DNA in FFPE 
samples. There are a plethora confounding features present when carrying out 
sequence-based analysis of bacterial communities [7], and when coupled with the 
criticisms levelled at recent sequencing experiments targeting similarly challenging 
sample types (8) it is unlikely that large scale metagenomics studies using FFPE 
samples will remain tenable without the development of dedicated methodologies 
and biological standards. The key characteristics of FFPE samples that impair 
effective microbial analysis are: 
• Formalin-derived crosslinks and damages to DNA present in the sample(9) 
• A high ratio of host to bacterial DNA(10) 
• All FFPE DNA extraction methods to date are optimised for human cells  
• The extent of processing necessary leaves samples vulnerable to contamination  
• No standards exist to validate the effects of the above on downstream analysis.  
Many studies have characterised FFPE-induced damage in human DNA, yet the 
effects on bacterial DNA remain uncharacterised. The impact on data generation 
from FFPE-induced DNA damage is expected to be much more significant in 
bacterial studies when compared to human studies. Where human studies benefit 
from high DNA quantities in samples and a well-known reference genome, in 
metagenomics research, the DNA template is often minimum and concealed in a 
high human DNA background, and the sequences studied are not limited to one 




analysis, needs to be accurately characterised. This will inform on requirements for a 
method to repair DNA damage, improving the fidelity of future analyses.  
To repair the damaged DNA, reconstitution of the intrinsic Base Excision Repair 
(BER) pathway in vitro shows considerable potential. This involves the excision of a 
damaged base by a DNA glycosylase enzyme, backbone incision facilitated by AP 
lyase, Ends processing by Polynucleotide Kinase, Gap filling by DNA Polymerase 
and nick ligation by DNA ligase. 
In low bacterial biomass biopsy samples, such as most non tract human biopsies, 
host DNA constitutes in excess of 99 % of total DNA. This severely limits 
metagenomic studies, as the vast majority of sequencing reads available are invested 
by this background human DNA. This is of critical concern, particularly for whole 
genome shotgun (WGS) methods (11). It has been also shown to affect the outputs of 
16S rRNA amplicon sequencing, since in reactions of low bacterial to human DNA 
ratios, human DNA can be annealed and amplified during 16S PCR (12). 
Furthermore, a reduction in bacterial diversity and particularly rare bacterial taxa can 
occur during dilutions made to avoid overloading DNA in PCR reactions [13]. For 
these regions, any reduction in the ratio of background mammalian to target bacterial 
DNA would improve readout. DNAse treatment can reduce the quantity of intact 
background DNA, if it’s activity can be targeted to mammalian cells, e.g. by 
restricting access of the DNAse enzyme to only mammalian cells. Mammalian 
specific-membrane permeabilisation may achieve this. 
Bacterial lysis is a critical step in sample processing for metagenomic analysis. It can 
be major source of bias in community composition, as lysis methods that favour 
particular taxa will cause overrepresentation in the final analysis [12, 14-18]. Many 
methods for unbiased bacterial lysis of non-fixed samples have been proposed and 
applied, including bead-beating, enzymatic lysis, detergents and denaturing agents 
[15, 16, 19]. Recently, several studies have agreed that bead-beating is the lysis 
method that yields higher uniformity of bacterial lysis and have shown that 
combining bead-beating with other methods shows further improvements in 
uniformity [19, 20].  
FFPE samples are characterised by DNA damage that includes high levels of 




DNA [21, 22]. As previously mentioned, FFPE samples typically have low bacterial 
biomass concealed by large quantities of DNA from the larger human genome. 
Bead-beating decreases DNA yields by causing DNA fragmentation leading to the 
formation of chimeras during PCR [23-25], which would be particularly detrimental 
for FFPE samples. For this sample type, lysis must be performed under conditions 
that do not negatively affect the integrity of DNA, such as enzymatic lysis. 
Accordingly, the Association of Biomolecular Resource Facilities Metagenomics 
Research Group developed a mix of six lytic enzymes (achromopeptidase, chitinase, 
lyticase, lysostaphin, lysozyme, and mutanolysin) that target the cell wall of bacteria, 
yeast, and fungi, and is able to lyse recalcitrant endospores [26]. The incorporation 
of this enzyme, known as Metapolyzyme (Sigma-Aldrich), in sample preparation has 
been shown to increase the recovery of spheroplasts or protoplasts, and improve the 
overall DNA recovery across taxa in multiple sample types [25, 26]. Recently, a 
metagenomic study was performed on ancient DNA specimens (with similar levels 
of DNA damage as FFPE), validating the efficacy of Metapolyzyme over traditional 
bead beating methods in this sample type (27).  
The issue of biological standards was largely overlooked in the early years of 
microbiome research. As 15 years have passed since the seminal work by Craig 
Venter in 2004 [28], several publications have taken stock of progress so far, and 
highlighted areas for improvement. A recurring theme within these publications has 
been the lack of standards available [29-32]. Given the numerous potential sources 
of error associated with FFPE samples outlined previously, more than perhaps any 
other sample type, FFPE tissue urgently requires the development of standards to 
ensure the validity of results and to promote reproducibility. 
With this in mind, it was deemed appropriate to initiate this study with development 
of such an FFPE study model, to  
• inform on the extent and nature of DNA damage due to FFPE, guiding the 
development of a DNA repair strategy  
• inform on any possible bias arising from ineffective bacterial lysis for example  
• inform on the incorporation of environmental contaminant bacteria into the DNA 






Portions of this project fall beyond the remit of bioinformatics research. This chapter 
focuses on different approaches incorporating bacterial sequence analysis during the 
design and validation stages of both the Protoblock FFPE biological standard and the 
DNA repair strategy. Following this, an assessment of the final protocol as a tool for 
metagenomics/metataxanomic analysis was carried out. This was performed using 
the Protoblock biological standard and formalin fixed mouse faeces as a higher 
biomass sample. In these cases the newly designed protocol was compared with the 
current gold standard, the Qiagen QIAmp FFPE kit. Lastly, low biomass samples of 
malignant formalin fixed patient breast tissue were processed using the novel 






A full description of the novel protocol developed can be found in appendix 1 of this thesis. 
A summary is displayed in Figure 1. All lab work was performed by other members of the 
Tangney lab.  
Tissue Dissociation 
Without off-target activity on bacteria 
 
Host Depletion 





Sample Digestion & Decrosslinking 
Complete digestion of proteinic content and crosslinks 
 
DNA purification 
Silica column based 
 
DNA repair 
Base Excision Repair Pathway 
 
 
Figure 1: Full Protocol for bacterial DNA isolation from FFPE samples – 





Bioinformatic  methods  for  data analysis 
qPCR data analysis   
Statistical analysis was performed in the base R environment (v3.6.1). Visualisations 
were carried out using the ggplot2 package (v3.2.1). 
WGS sequence analysis  
All metrics relating to sequence data were calculated in the Linux environment, and 
using the QUAST tool (v5.0.2) and statistical analysis performed in the base R 
environment (v3.6.1). Visualisations were carried out using the ggplot2 package.  
Method for variant calling 
Filtering HiSeq sequence data was quality filtered. Only very high quality 
bases were considered, to minimise the risk of sequencing errors causing false 
positive variants. Short fragments were also removed to reduce the likelihood of 
spurious alignments of regions from contaminant bacterial genomes. Trimmomatic 
(v0.38) was used to remove all reads shorter than 60bp in length, and to trim reads 
when the average per base quality in a sliding window of size 4 dropped below 30.  
Alignment Of the three possible Burrows-Wheeler alignment tools, the BWA-
mem aligner was used as the average read length was 150 bp, and BWA-mem 
(v0.7.17) is recommended when reads are over 70 bp in length. Default settings were 
used with the exception of allowing alignments with a minimum score of 0, rather 
than the default 30. Given the stringent parameters used for read length and quality 
filtering, relaxing the minimum alignment score gave the best possible chance of 
variant detection.  All samples were aligned to the original reference genomes. 
Variant Calling Variant calling was done with BCF tools, using the BCF call 
function. The variants were then filtered using the norm and filter functions within 
BCF tools. Filtering was done to remove variants when the read depth was below 10, 
the quality was below 40, or when the variant identified was not supported by both 
the forward and reverse read of a read pair.  The number of variants identified was 
then normalised between samples based on the read coverage in the initial alignment 




Validation Using the Picard tool within the GATK suite, all samples were down-
sampled to ensure SNP: Coverage ratio remained constant when coverage was 
reduced to lowest level present in samples. 
 
 
16S sequence analysis 
The quality of the paired-end sequence data was initially visualised using FastQC 
v0.11.6, and then filtered and trimmed using Trimmomatic v0.36 to ensure a 
minimum average quality of 25. The remaining high-quality reads were then 
imported into the R environment v3.4.4 for analysis with the DADA2 package 
v1.8.0. After further quality filtering, error correction and chimera removal, the raw 
reads generated by the sequencing process were refined into a table of Amplicon 
Sequence Variants (ASVs) and their distribution among the samples. It is 
recommended that ASVs (formerly called ‘Ribosomal Sequence Variants’) be used 
in place of ‘operational taxonomic units’ (OTU), in part because ASVs give better 
resolution than OTUs, which are clustered based on similarity.  
The following statistical analyses were carried out in R: Shannon alpha diversity and 
Chao1 species richness metrics, and Bray-Curtis distances, for analysis of beta 
diversity, were calculated using the PhyloSeq package v1.24, and the Vegan package 
v2.52. Beta diversity calculations produce distance matrices with as many columns 
and rows as there are samples; thus, beta diversity is often represented using some 
form of dimensionality reduction, in this case, using principal co-ordinates analysis 
(PCoA) with the Ape package v5.1. Hierarchical clustering, an unsupervised method 
that can reveal key taxa that distinguish their respective environments, was 
performed with the heatplot function in the made4 package v1.54. Differential 
abundance analysis was carried out using Deseq2 v1.2.0, which identifies 
differentially abundant features between two groups within the data. Tests of means 
were performed using the Mann-Whitney U test unless otherwise stated, and 
correlations were calculated using Spearman’s rank correlation coefficient. Where 




Despite not identifying the contaminant taxa themselves, the source tracker utility is 
invaluable in estimating the proportion of a sample (“Sink”) that may have 
originated in a negative control (“Source”) Decontam can remove taxa, based on 
presence or absence in negative controls, or inverse correlations with input DNA. 
This tool requires a threshold to be set, which can be dictated by SourceTracker. The 






Table 1: Bacterial load of protoblocks used for 16S and WGS sequencing 
 
 
Validation of the biological standard 
DNA was obtained from Protoblocks containing a mix of the five bacterial strains 
specified in Table 1, and was purified with the QIAGEN QIAamp FFPE tissue kit as 
described the methods provided in Appendix 1. qPCR recovery was determined by 
quantifying long DNA fragments (450 bp) specific for each bacterial strain and 
normalised to a loaded concentration of 105 cells. Bacterial quantities in qPCR 
reactions are as specified in Table 1. The outputs of these reactions show a clear bias 
of sample prep toward Gram-negative bacteria, with an average recovery 2.5 log-
fold higher (p<0.001) than Gram-positive bacteria. Recovery determined by qPCR 
was 0.17% for Staphylococcus, 1% for Lactobacillus, 1.5% for Bifidobacterium, 
3.3% for E. coli and 15% for Bacteroides (Figure 2B (iii)). This was further 
confirmed with 16S rRNA gene sequencing (Figure 2B (iv)). As seen in Figure 2B, 
the composition plot shows a clear bias towards Gram-negative bacteria. For 
example, while equal quantities of Bacteroides (29%) and Staphylococcus (27%) 
cells were present in the Protoblocks, DNA analyses (16S rRNA gene sequencing 
and qPCR) reported Bacteroides  represent more than 50% of the sequences 
recovered, while the more difficult to lyse Gram-positive Staphylococcus is almost 
 
Counts in microscope / 
volume measured for each 
type of FFPE block [single 
strain to mixed strain] 







































































































lost from the plot. Therefore, even in FFPE samples, a mechanism for the lysis of 
Gram-positive bacteria must be considered for metagenomics studies. Furthermore, 
the use of standards such as the Protoblock is essential when working with FFPE 
samples, and even more so when using protocols that are not designed for this 
sample type and study purpose. 
The Protoblock is susceptible to contamination in a similar way to clinical FFPE 
samples. The priority of the fixing process is to preserve the tissue for later 
histological analysis, not to prepare a sample suitable for high throughput bacterial 
sequencing. In this instance, contamination was detected as shown by the number of 
reads in the negative controls (Figure 4B (v)). It is unlikely to have had a significant 
effect on the overall biological signal. Given that the bacterial reads detected and 
their taxonomic classifications differ completely from those of the protoblocks 
analysed. However, it remains a threat for low biomass samples. 
 
  
Figure 2: Evaluation of impacts on downstream analysis. Measuring bias 
introduced by the DNA extraction process. Sample composition Bar plot of: i) Cells 
added to protoblock, ii) Confirmed bacterial counts per block, iii) Strain specific 
qPCR, iv) Pooled sample composition as per 16S rRNA gene sequence analysis, v) 
Composition of an empty protoblock (sterile agar only) processed in parallel with 
loaded protoblocks. 
 
The presence of DNA sequence artefacts as a result of FFPE was assessed in a 




concentration determined by qPCR and normalised to 106 genome copies. HRM was 
performed in three contiguous DNA fragments (length  100 bp) that make up a 
region of the InsH1 gene (See figure 3B (ii)). To determine the presence of any 
sequence aberrations in Protoblock FFPE DNA, their melting temperature (Tm) was 
compared with that of Non-fixed (NF) DNA and the differences measured. Figure 
3B (i) shows the final Tm for each fragment investigated. Tm shifts with variable 
levels of significance were observed in all fragments. This is indicative of a change 
in the underlying DNA sequence, as would be expected in a clinical FFPE sample. 
To confirm these results, DNA from both samples was analysed by whole genome 
sequencing. Findings from the DNA melting temperature analysis correlated with the 
results of WGS, with statistically significant variations between the FFPE genome 





Figure 3: Assessment of DNA damage in Protoblocks. A) Evaluation of DNA 
integrity with Bioanalyser high-sensitivity tape station. DNA concentration (boxes) 
is plotted on the y-axis and fragment length (dotted line) on the z-axis. Results were 
extracted from 2 peak-regions in the electropherograms (72-744 bp and >1,292). 
Here, the short fragment region FFPE samples had an average fragment length of 
207 bp and an average concentration of 0.06 ng/µl, while its non-fixed counterpart 
had an average length of 462 bp and a concentration of 1.86 ng/µl. In the larger 
region fragment, FFPE samples had an average concentration of 0.099 ng/µl and an 
average fragment length of 13,119 bp, whereas NF sample had a concentration of 
10.57 ng/µl and an average length of 31100 bp. B) Evaluation of DNA sequence 
aberrations by high-resolution-melt analysis. i) Box plots of normalised DNA 
quantities from protoblocks populated with E. coli (blue) and NF E. coli (red). Clear 
shifts in the melting temperatures in 2 of the 3 sequences were observed, with 
temperature shifts that were on average 0.1-0.5oC apart from NF counterparts. ii) 
Schematic of sequences used for HRM analysis: 3 DNA fragments with an average 
length of 100 bp were analysed, for each test and each sample type, n = 6. C) 
Confirmation of sequence alteration by WGS. DNA from the same protoblocks as B 
was analysed by whole genome sequencing and subsequent variant calling against 
the reference genome E. coli K12 MG1655. Here, the rate of their occurrence is 






Validation of DNA repair strategy by WGS 
The reconstitution of a BER system, targeting different types of DNA damage found 
on FFPE samples was addressed by mixing the pathways for the glycosylases treated 
in the system. Since FPG-BER (Figure 4a) yielded the best results for single 
glycosylase-BER reactions, this enzyme was combined with ENDO VIII and UDG 
and their efficiency in reducing sequence artefacts tested by HRM. As shown in 
Figure 4b, all combinations resulted in sequences with ΔTm lower than those of 
untreated FFPE DNA. The FPG + UDG mix showed the best performance at 
reducing the ΔTm (31 %), followed by FPG + Endo VIII (18 %). However, in terms 
of improving the PCR readability of a 500 bp fragment, FPG + Endo VIII (47% 
increase, p < 0.01) outperformed FPG + UDG (30% increase, p < 0.01), as measured 
by Taq qPCR. To confirm these results, normalised DNA concentration from 6 
replicates for each BER mix and 6 unrepaired samples were pooled into one (n = 6) 
and sent for analysis by WGS (Figure 4c). At this level of resolution, it is evident 
that the repair mix with FPG + Endo VIII offered the highest improvements in 
sequence quality in terms of providing (i) a coverage 4X higher than unrepaired, (i) 
4X more total reads and quality filter (QF)-passed reads, and (iii) a 50% reduction in 
the number of variants detected per sequence coverage. This repair mix was thus 






Figure 4: Reconstitution of BER pathway repairing FFPE DNA damage. a) 
Single glycosylase BER. The BER pathway was reconstituted first as single 
pathways triggered by either UDG, FPG or Endo VIII. The efficiency of each system 
in correcting DNA damage was tested by HRM (n = 7 for each line). The more 
similar a DNA sequence is to the NF reference, the lower the difference in melting 
temperature (ΔTm closer to 0). FPG showed the highest efficiency in correcting 
FFFPE DNA damage as evidenced by the lowest ΔTm of 0.054. b) Multiple 
glycosylase BER. Mixes containing FPG show improved sequence quality as 
evidenced by reduced ΔTm vs untreated. c) WGS. To further confirm these results, 
six replicates treated with each mix were pooled (n = 6) and analysed by WGS. 
Data validated that all mixes improved the sequence (i) coverage, (ii) number of 
reads and QP reads and reduced the amount of SNPs (iii). The best performance in 
all cases was observed in the BER mix with FPG and Endo VIII.  
 
The sum of the above treatment strategies (decrosslinking and DNA repair) was 
tested by WGS in DNA sourced from Protoblocks containing the same 5 bacterial 
strains as previously described, fixed for 48 h and stored for 2 months. The dewaxed 
and lysed contents of the blocks were decrosslinked at 80 oC with a chaotrophe salt 
based buffer (Appendix 1). The purified DNA was repaired with the BER mix based 




sent for WGS analysis. Results for this analysis are shown in Figure 5. The results 
obtained from exposing bacterial FFPE DNA to the proposed new protocol are 
compared with those from DNA from paired-samples treated with the reference 
Qiagen protocol (decrosslinking at 90 oC, without DNA repair), and paired NF DNA. 
These results indicate that bacterial FFPE DNA treated with the proposed method 
shows an improvement in integrity, readability, and sequence quality, as evidenced 
by: (i) Integrity [Average fragment length (a, b)]: Plotted in Figure 5a, are the 
average fragment lengths measured by bioanalyser. Fragment length of DNA treated 
with the new protocol (444 bp) is 3.3X longer than that treated with the reference 
protocol (136 bp). Importantly, this raises the average fragment length to that of 
fragments typically desired for 16S sequencing (460 bp). The same effect was 
observed in the length of fragments read by WGS, where fragment lengths were 2-3 
bp longer on average (Figure 5b). (ii) Readability: With the new protocol, the 
number of Total Reads and (QF)-pass reads per layer of coverage were increased by 
24 % and 34 % respectively, and the ratio of QF-passed to Total reads increased by 
8.4 %. (iii) Sequence quality: This was measured in terms of number of sequence 
artefacts detected. The number of chimeric reads per coverage detected in samples 
treated with the new protocol was reduced by 57 % (p = 0.37) (Figure 5e). Similarly, 
the number of SNPs detected was reduced by 58% (p = 0.41) (Figure 5f). All of 
these findings are supported by results from quantitative PCR and Tm analysis. 
Although these improvements are not supported by statistical significance, given the 
considerable effect size, we are confident that this lack of significance is due to 
sample size alone. Altogether, the sum of strategies proposed here were thoroughly 
investigated by PCR/sequencing. These results consistently indicate an improvement 







Figure 5: Combined protocol – bacterial DNA. Outputs of Bioanalyser and whole 
genome sequencing for bacterial FFPE DNA exposed to the combined treatment 
(blue, labelled as New Protocol, n = 6). This was compared with that obtained 
from six pooled paired-samples decrosslinked with the reference protocol and 
unrepaired (grey, Labelled reference protocol, n = 6) and that from DNA obtained 
from NF samples with the same bacterial and DNA content (orange, Labelled NF, 
n = 3). Improvement in DNA readability, sequence quality and integrity was 
measured by: Integrity (fragment length): (a) bioanalyser (b) WGS. Readability: (c) 
Quantity of reads and filter pass reads per coverage. (d) % Breath of genome 
coverage. Sequence quality: (e) Number of chimeric reads per layer of coverage. (f)  





Validation of the protocol by 16S sequencing 
The level of processing required when creating a sequencing library from FFPE 
samples, coupled with the anticipated low biomass of the samples, makes them 
highly susceptible to contamination. Figure 6 shows a representative sample from 
each sample group, and each library preparation method. The “In House methods” 
are consistently more susceptible to contamination than the gold standard Qiagen 
method, and a controllable level of contamination is present in all sample types with 
the exception of FFPE breast samples, which are overwhelmingly contaminated. The 
output of the SourceTracker algorithm also indicates which negative controls were 
implicated in the contamination, and Figure 6A, shows the composition of these 
samples at the family level.  
 
 
Figure 6: Summary of environmental contamination. (B) Shows the output of the 
SourceTracker algorithm, with one representative pie chart per sample type 
indicating the degree of contamination present. (A) Shows the sample composition of 
the three negative controls implicated by the SourceTracker algorithm. Data 
indicate that although contamination is present in most samples only FFPE breast 
samples are overwhelmingly affected by environmental contaminants. In addition, 




The use of Protoblocks with known bacterial composition allowed for accurate 
quantification of the number of sequencing reads lost due to contamination between 
the three different treatment groups. As seen in Figure 7, in both the Qiagen protocol 
(Q) and the In house with host depletion (HDP) protocols, the proportion of reads 
removed as part of the contamination control workflow was less than 5%. With the 
in house without host depletion (HDN) protocol almost a quarter of all reads 
obtained from these samples had to be removed.  
 
Figure 7: Proportion of reads lost due to environmental contamination introduced 
during processing. The data indicates that while only a marginal percentage of 
reads are consumed by environmental contaminant DNA in the Qiagen and HDP 
samples, just under 30% of reads on average are lost in HDN samples.  
 
Samples labelled as HDP went through the DNA protocol (bacterial lysis, sample 
digestion, DNA purification and repair) plus a host depletion step, and HDN 
samples, did not include a host depletion step. The precise quantities of bacteria 
added to the FFPE mock communities can be seen in Table 1. This information 
allowed a robust analysis of methodological bias in terms of under or over-
representation of different bacteria. As shown in Figure 8, the Q protocol, which is 
not optimised for bacterial DNA, showed statistically significant under or 
overrepresentations in all five genera present in the Protoblock, particularly in the 




more than 20% respectively. In the HDN method, no significant bias was observed 
with lactobacillus, the deviation in Bacteroides was marginally significant, while all 
other genera were significantly under or overrepresented. The HDP method was the 
least susceptible to bias, with only the proportion of E. coli presenting as 






Figure 8: Assessment of bias in terms of bacterial community composition between 
methods. (A) Shows the percentage deviation of bacterial composition per genera, 
per extraction method, from the original quantities input into the protoblock. (B) 
Shows sample composition of all samples merged by extraction kit, with the right 
most column representing the ideal proportions as dictated by the input quantities. 
Visually HDP has the least degree of bias over the five bacterial genera. This is 





Faecal samples  
The comparisons facilitated by the protoblocks were complemented by mouse faecal 
samples, which were formalin fixed and paraffin embedded as described in methods 
(murine models) and their protocol included bacterial lysis, sample digestion, DNA 
purification and DNA repair, with host depletion + tissue dissociation (DT-P) or 
without any of these two treatments (DT-N). The community structure in these 
samples was considerably more complex than in the Protoblock. 
Beta diversity analysis using Bray-Curtis dissimilarity shows no significant 
difference between the IHN and Qiagen methods. This can be seen visually as the 
samples cluster together, and is confirmed by PERMANOVA analysis, (p = 0.231). 
Both Qiagen and DT-N are significantly dissimilar to DT-P as per PERMANOVA, 
(p = <0.001) (Figure 8).  
The driving factors behind the distinct clustering were assessed by searching for 
correlations between the dominant bacterial families seen in the samples, and either 
of the two principal coordinate axes. The correlations were carried out using 
Spearman’s method, and multiple testing was controlled for using the FDR method. 
This was expanded upon in Figure 9, with a direct comparison of sample 














Figure 9: Principal coordinate analysis of matched murine samples. Points 
coloured by extraction method, and shaped by host depletion status. PcOA plot 
supported by correlations of major bacterial families present in dataset with PC1 
and PC2 values used to generate plot. Only significantly correlating families show, 
with significance tested for using Spearman’s method. False discovery rate 
controlled for using FDR method. Data indicates that host depletion strategy has an 
effect on Gram negative bacteria.  
 
Figure 10A compares Q and DT-P paired samples. In this instance, the Gram 
positive Coriobacteriaceae and Lactobacilliceae were significantly elevated in terms 
of mean proportion in the DT-P samples, while the Gram negative 
Porphyromonadaceae, Rickenellaceae, Prevotellaceae and Bacteroidacaeae were 
elevated in samples treated with Q. Figure 10B compares the paired samples 
prepared using the Q and DT-N methods respectively. In this instance, the there was 
no significant difference in the Gram positive families, while the two previously 
indicated Gram negative families Coriobacteriaceae and Lactobacilliceae were 
elevated in the DT-N group. Also elevated were the Pseudomonadaceae and 
Promicromonosporaceae families, which are likely to be residual environmental 
contaminants missed by the retrospective bioinformatic contamination removal. 




dissociation, where the difference was in the Gram negative families, which were 
elevated in the DT-N samples. 
 
Figure 10: Mouse faecal sample composition comparison between methods. Mean 
abundance of major families between groups tested using Wilcox signed rank test, 




the direction if increase in cases of significant difference. (A) Compares Qiagen with 
HDP. (B) Compares Qiagen with HDN. (C) Compares HDN with HDP.  
 
The final assessment of the method was the analysis of FFPE malignant breast tissue 
samples. The accuracy was verified by comparing the FFPE samples with their 
matched freshly frozen samples. As was suggested by the representative pie chart of 
the FFPE breast samples in Figure 6B, the quantity of environmental contamination 
was overwhelming, this was unsurprising given the low level of microbial biomass 
present in the samples. Even after contamination removal, leaving all other sample 
types with little to no contamination, the FFPE breast samples in Figure 11B are 
dominated by the Pseudomonadaceae and Xanthomonadaceae families seen in the 
negative control samples and bear little resemblance to their fresh frozen 
counterparts in Figure 11C. However, when Figure 11B is recreated in 9D, with all 
Pseudomonadaceae and Xanthomonadaceae associated sequences manually 
removed, there is resemblance between the two groups that begins to justify what the 
Venn diagram in Figure 11A indicates in terms of shared bacterial families. In total 
24.6% of the total bacterial abundance in Figure 11D is accounted for by bacterial 








Figure 11: Sample composition comparison between matched patient samples. (A) 
Venn diagram visualising the observed families in (B) FFPE breast tissue and (C) 
Matched fresh frozen breast samples processed using Molzym Ultra-Deep 
Microbiome kit. (D) FFPE samples with the two obvious contaminant families, 






Given the potentials that FFPE material could bring to the field of metagenomics, a 
method that allows access to this material is essential. Currently, there are no 
methods available to process this sample type for metagenomics. This research 
presents novel strategies to treat these samples in order to guarantee a truthful 
representation of the bacterial communities inhabiting tissues.    
Protoblock  
It is well-established that DNA from FFPE samples is damaged [33]. The extent of 
this  damage can increase with the length  of exposure to formalin, sample storage 
time and the pH of the formalin used for fixation (34,35). DNA damage found in 
FFPE samples spans from cross-links, fragmentation, loss of bases and point 
mutations [22, 33, 36, 37]. With this in mind, an adequate control for this sample 
type must undergo the same extent of damage for it to be representative of the 
samples being treated (38). 
All Protoblock DNA sequences analysed by HRM exhibited a profile indicative of 
the presence of sequence artefacts, with aberrant profiles typical of heteroduplexes 
with deviations in Tm of up to 0.1oC from that of non-fixed template. This correlates 
with previous studies where FFPE DNA displayed aberrant melting profiles which is 
indicative of low-level, non-identical changes randomly distributed in the template 
[39]. Given the random distribution of these artefacts, their presence in undetectable 
by Sanger sequencing as they are masked by the abundant correct sequences. 
However, the reduced number and lengths of fragments that can be sequenced are 
indicative of alterations that lead to sequencing failure [40]. The presence of “true 
mutations” (identical nucleotide changes at an exact position in >2 independent 
sequences) was investigated here by WGS. As seen in figure 3C, the majority of 
variants detected corresponded to C>T and G>A transitions. This again, is in line 
with findings in human tissue FFPE samples and in accordance with HRM profiles 
with low-level, heteroduplex sequence changes [39, 40]. 
The impact of bacterial lysis strategies in sample prep has been documented, but not 
fully characterised as a source of introduced bias. The use of standards has been 
suggested as a tool to account for this and other storage or sample prep bias [41, 42]. 




standard for bacterial prep of FFPE samples in order to ensure the accuracy of a 
metagenomic project, especially in determining abundance. Findings shown in 
Figure 4B demonstrate that the QIAGEN QIAamp FFPE tissue kit (currently the 
gold standard for FFPE DNA isolation, developed for mammalian FFPE DNA) is 
biased towards Gram-negative bacteria. This is not surprising, since the method does 
not include a bacterial lysis step. Given  the lack of a standardised method to process 
FFPE samples for metagenomic studies, the use of standards such as the Protoblock 
is essential to guarantee the accuracy, precision, and limit of detection of the sample 
processing workflow.  
Contamination is a considerable threat to the accuracy of low biomass samples such 
as biopsies, even prior to any formalin fixing or eventual pre-processing of these 
fixed samples for high throughput sequencing. Steps such as deparaffination and 
DNA repair require the use of enzymatic solutions that are difficult to keep sterile, 
and contamination from these sources could easily obscure the true results in cases 
of low microbial load. Use of the Protoblock can inform users as to the level of 
contamination introduced by any processing of FFPE samples required in advance of 
a sequencing experiment. 
DNA Repair  
While the HRM melting curve analysis provided a valuable guide, confirmation was 
provided by qPCR and sequencing data.  This shows significant improvements in the 
integrity, readability and sequence quality after treatment with the reconstituted BER 
reactions, thus confirming its efficacy. In this sample-type, it is evident that targeting 
DNA damage derived from oxidation with FPG and Endo VIII, within the enzyme 
mixes tested here, yields the most significant improvements. After exhaustive 
comparisons of different approaches to the problem, the strategy found to be most 
effective involves decrosslinking using a chaotrophic agent such as Guanidine 
hydrochloride, and a slightly reduced temperature of 80 oC. This is followed by 
removal of damaged bases by using a combination of Formamidopyrimidine DNA 
glycosylase and Endonuclease VIII, and repair through the short-patch BER repair 
pathway (triggered by both of this glycosylases) by combining T4-PNK, DNA 
polymerase and DNA ligase.  




Most, if not all host depletion strategies report some off target effects on bacteria 
[43]. To fully explore the effects that this would have on downstream sequence 
analysis, paired protoblock samples treated with (HDP) and without (HDN) host 
depletion were analysed by 16S sequencing and compared to the gold standard 
Qiagen QIAamp FFPE tissue kit (Q). The results from this analysis indicate, that 
while there might be a loss of Gram negative bacteria, this does not significantly 
affect the outputs of 16S sequencing. 
In this analysis the Q method, which is not optimised for bacterial lysis, showed 
statistically significant deviation from the input proportions across all five bacterial 
species present in the Protoblock. The HDN method showed improvement on the Q 
method, with the HDP method being the best performing approach in this instance. 
This improvement in performance is related to incorporation of a host depletion step, 
since it is the only variable tested here. It can be hypothesised that this may be due to 
(1) a reduction of contaminants (as shown in Figure 7) that improves the ratio of 
bacteria present in the samples being sequenced and (2) the reduction of mammalian 
DNA positively affects the PCR reaction, by improving the access to target 
sequences. 
This was further explored in murine FFPE faecal samples were exposed or not to a 
combined treatment with tissue dissociation and host depletion. Based on the 
evidence from the Protoblock-based comparison of the three methods, the 
expectation would be for the DT-P (in house with host depletion and tissue 
dissociation) and DT-N (in house without host depletion and tissue dissociation) to 
cluster together on a PcOA. However, in this instance, it was the DT-N and Q 
methods that clustered, showing no statistically significant difference in terms of 
their Bray-Curtis dissimilarity. Both are significantly different to the samples 
processed using the DT-P method. Subsequent spearman correlation of the dominant 
bacterial families identified across the samples with the PC1 and PC2 axis reveals 
that this separation on the PcOA plot is driven by Gram status. Gram positive 
bacteria correlate significantly with the direction of the DT-P samples, and Gram 
negative samples correlate significantly with the two other groups (Figure 9). These 
findings are corroborated by results in Figure 10. Altogether, these results confirm a 
significant loss of G- bacteria after the combined treatment with tissue dissociation 




bacteria, exposing the phospholipid bilayer, which can be then accessed by Saponin, 
leading to G- bacteria loss. However, this is a necessary step in processing tissues, 
and thus a further optimisation of this step is necessary. This could be addressed by 
incorporating a short decrosslinking step that will allow tissue dissociation enzymes 
to be more effective, leading to a reduction on incubation times or enzyme units used 
in the reaction. This could lead to less off-target effects in G- bacteria.  
By a process of elimination, the best net performing method in this instance appears 
to be the DT-N method. The DT-P method shows significantly increased Gram 
positive bacterial family abundance such as Lactobacillaceae and Coriobacteriaceae 
when compared with the Qiagen method; conversely the Qiagen method shows 
significantly more Gram negative bacteria such as Prevotellaceae and 
Bacteroidaceae. The DT-N method shows significantly more Gram negative 
bacterial families vs DT-P (Figure 10C), and significantly more Gram positive 
families such as Coriobacteriaceae vs Q, with no families significantly reduced in 
abundance vs either group. confirmingThis ed that the tissue dissociation strategy 
needs to be optimised. 
Despite major efforts on maintaining an aseptic technique, there are still numerous 
potential sources of contamination, ranging from the wax used to embed samples, 
through all the DNA purification solutions and enzymes, which are unsuitable for 
sterilisation or could not be gamma irradiated at our facilities. Thus, it is 
unsurprising that there was a considerable amount of contamination present in the 
samples. The biomass in the Protoblock and murine faecal samples is sufficient to 
ensure that the majority of the reads are of sample origin according to the 
SourceTracker algorithm, but the FFPE breast samples appeared to consist almost 
entirely of bacterial reads attributed to one or more of the negative controls. The 
SourceTracker output in Figure 6B indicates that all contamination is attributable to 
three negative control samples, namely the Wax control, taken from the edges of the 
blocks of patient samples, the “In House method” negative control, and the non-
bacterial control, which is an empty Protoblock FFPE processed at our facilities.  
The first two negative controls were dominated by the genera Stenotrophomonas, 
Pseudomonas and Clostridium, all of which count among the most abundant genera 
in the dataset. The presence of both high and low abundance environmental 




methods, and highlights the value of using both positive and negative controls to 
assist in contamination removal [44]. In this instance, we are provided with a much 
clearer picture of the contamination induced during the process by the use of the 
Protoblock in conjunction with negative controls. This allows us to conclude that in 
the case of the Protoblocks and the mouse faecal samples, any contamination 
introduced by the method can be controlled to below any level where it would affect 
downstream analysis. Figure 6 also provided us with evidence of a phenomenon that 
is gaining more attention in microbiome research, cross contamination, which 
originates within the pool of samples(45). This phenomenon is known to affect lower 
biomass samples, and can be clearly seen in the non bacterial control where five of 
the common bacterial families across the dataset also appear in the negative controls. 
This is particularly dangerous when undertaking established, but conservative 
contamination removal by subtraction approaches.  
Non gastro-intestinal tract biopsies are notoriously low in microbial biomass (46), a 
fact that is further compounded in analysis of FFPE biopsies by the fact that the 
formalin fixation process accounts for a log fold reduction in the quantity of 
recoverable DNA (47). These challenges clearly manifest in the comparison of 
paired fresh and FFPE breast samples. Once the major contaminant ASV’s and those 
suspected of aligning to the human genome are removed, the FFPE breast samples 
are still dominated by known contaminant families, seen in the negative controls in 
Figure 6. Encouragingly, there are some common families to both the FFPE breast 
samples shown in Figure 11B and the fresh frozen breast sample shown in Figure 
11C. As mentioned in the results, manual removal of the Pseudomonadaceae and 
Xanthomonadaceae families reveals a sample composition plot where 24.6% of the 
total bacterial abundance in FFPE breast tissue is accounted for by the bacterial 
families also present in the fresh frozen breast samples (Figure 11A).  
The reason for Figure 11D is that it is a crude retrospective imitation of a potential 
improvement to make this method a viable option for low biomass FFPE studies. 
With the main contaminants inherent to the In House FFPE protocol now identified, 
these can be biologically removed from the sample by blocking their amplification 
from the 16S PCR pool. Numerous methods have been developed to achieve an 
asymmetric PCR reaction that will favour the amplification of certain target regions 




detection or to reduce off-target capture during sequencing library enrichment. This 
is achieved by: (1) Blocking extension with DNA probe/oligo that has high affinity 
towards a specific DNA sequence (on either DNA strand) that includes a 3’ end (i.e. 
phosphate, inverted dNTP). (2) Inhibiting primer annealing with a homologous 
peptide nucleic acid (PMA) or locked nucleic acids (LNAs), which have increased 
thermal or base stacking stability, respectively and will inhibit PCR [48-50].     
 
Conclusion  
Strategies for the unbiased treatment of FFPE samples for metagenomic analysis are 
presented in this work validated by a variety of approaches on mock bacterial 
communities, murine models and human breast tissue samples. The results shown 
here confirm that most of these strategies would have a positive effect in the 
treatment for metagenomics. However, key areas that need to be addressed are the 
optimisation of a tissue dissociation strategy that does not lead to G- bacterial loss 
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Background The relationship between bacterial communities and their host is 
being extensively investigated for the potential to improve the host’s health. Little is 
known about the interplay between the microbiota of parasites and the health of the 
infected host.  
Aim Using nematode co-infection of lambs as a proof-of-concept model, the aim 
of this study was to characterise the microbiomes of nematodes and that of their host, 
enabling identification of candidate nematode-specific microbiota member(s) that 
could be exploited as drug development tools or for targeted therapy. 
Methods Deep sequencing techniques were used to elucidate the microbiomes 
of different life stages of two parasitic nematodes of ruminants, Haemonchus 
contortus and Teladorsagia circumcincta, as well as that of the co-infected ovine 
hosts, pre- and post-infection.  
Conclusions Bioinformatic analyses demonstrated significant differences between 
the composition of the nematode and ovine microbiomes. The two nematode species 
also differed significantly. Data indicated a shift in the constitution of the larval 
nematode microbiome after exposure to the ovine microbiome, and in the ovine 
intestinal microbial community over time as a result of helminth co-infection. 
Several bacterial species were identified in nematodes that were absent from their 
surrounding abomasal environment, the most significant of which included 
Escherichia coli/Shigella. The ability to purposefully infect nematode species with 
engineered E. coli was demonstrated in vitro, validating the concept of using this 
bacterium as a nematode-specific drug development tool and/or drug delivery 
vehicle.  
To our knowledge, this is the first description of the concept of exploiting a 





Nematode infection is of major concern to human health in middle and low-income 
countries, particularly in cases of foodborne disease (1). Additionally, animals 
infected by pathogenic nematodes are a serious health, welfare and economic burden 
for countries reliant on agriculture (2). Effective interventions are therefore 
necessary to promote human health, protect livestock, and ensure production 
efficiency. Current standard practices for eradicating helminthic disease focus on the 
routine and frequent administration of anthelmintics, small-molecule drugs, to 
infected hosts. However, as with many chemicals, the development of resistance 
means that these drugs’ effectiveness is reducing (3), and alternative treatments are 
of paramount importance (4). Large numbers of new chemical drug classes are 
unlikely to be synthesised and licensed to combat growing drug resistance in 
nematodes in the near future, given the large time commitment required for drug 
research and development (5). Admittedly, a small number of compounds are at the 
early stage of investigation for controlling human whipworm infections (6,7). Yet, 
contingency strategies and tools to help expedite drug development are still 
desirable.  
In parasitic disease, attempts have been made to characterise the interplay between 
helminths and the bacterial populations inhabiting the mammalian gut, elucidating 
the ways in which the activity of the parasite affects the constituency of the gut 
microbiota and vice versa (8-10). These studies have suggested that the co-evolution 
of these two communities has established a relationship wherein the survival of 
either population is impacted by the other. Susceptibility and resistance to helminth 
infection in humans have been linked with certain bacterial taxa, suggesting that 
there may exist an ideal host microbial profile that guards against such disease (11). 
In fact, it has recently been discovered that parasites themselves have a microbiome. 
The nematode microbiome has become an increasingly popular area of study and has 
seen considerable advancement over the past two years due to 16S rRNA gene 
sequencing accessibility: the microbiomes of Caenorhabditis elegans (12), the 
ruminant parasite Haemonchus contortus (13), the murine parasite Trichuris muris 
(9), soil and beetle-associated nematodes (14), the marine nematode Litoditis marina 




High-throughput technologies are ideally placed to examine the interplay between 
the microbial communities within nematodes and the microbial communities of the 
animals they infect. However, while big data have been utilised to expand our 
understanding of the nematode microbiome, less consideration has been given to 
how this information might be applied to the therapeutic benefit of parasite-infected 
organisms. Defining the microbial communities of nematodes and their host opens 
opportunities for exploiting differences for drug development and/or treatment 
purposes. Identifying bacterial communities that uniquely colonise the nematode 
presents an opportunity to investigate their use as oral agents that specifically target 
the parasite, leaving the host unaffected.  
Exploitation of the host microbiota as a means of treating disease in the host is well 
studied across multiple species – from the use of faecal microbiota transplantation 
for inducing remission in ulcerative colitis in humans (17) to the treatment of 
laminitis in horses (18); however, exploitation of the parasite microbiome as an aid 
to drug development and treatment has not yet been described. We hypothesised 
that: i) nematode co-infection of the host would significantly alter the host 
microbiome over time; ii) the host microbiome would significantly alter the 
microbiome of the nematodes; and iii) despite interactions between host and parasite 
microbiota, key differences between the two would be apparent that would welcome 
their further investigation as aids to drug development and treatment.  
In this study, the microbiomes of the ovine abomasum and intestines were 
characterised following co-infection of lambs with the pathogenic nematodes H. 
contortus and Teladorsagia circumcincta. The abomasum is one of four 
compartments of the ruminant stomach, in which H. contortus and T. circumcincta 
live (19), and of the four compartments bears the closest resemblance to the anatomy 
and functionality of the simple stomach of non-ruminants (20). The microbiomes of 
both nematodes were also characterised at both the infective larval (L3) and adult 
stages of their development, marking this as the first report of the T. circumcincta 
microbiome and the first comparative study where different nematode genera are 
derived from the same host. The ovine model chosen is appropriate for a proof-of-
concept study, and the blood-feeding parasite H. contortus is a good model system 
for blood-feeding nematodes. This study also offers insights into the effects of 




monitoring changes in the ovine microbiome over the 28 days of parasitic co-
infection. Effects on the parasite are examined by comparing the microbiomes of 





MATERIALS AND METHODS 
All laboratory work was performed by other members of the Tangney lab.  
Ovine and parasite samples were collected at various timepoints over a 28-day 
infection (Supplementary Figure 1).   
 
Parasite material – adult nematodes 
Four lambs were artificially co-infected with 15,000 infective larvae (L3; 5000 H. 
contortus and 10,000 T. circumcincta). 28 days post-infection (i.e. at the point of 
culling), adult worms were collected from the abomasa of each lamb (21). The 
nematodes were sexed, staged, and species-identified using criteria described in the 
Ministry of Agriculture, Fisheries and Food document (22)[273][272][272][272] 
[22]. Separate pools of 100 adult male and 100 adult female worms were species-
identified, washed twice in sterile phosphate-buffered saline (PBS) to remove 
surface-adherent bacteria, snap frozen in liquid nitrogen, and transferred to -80 °C 
storage prior to deoxyribonucleic acid (DNA) extraction. Both worm species were 
processed separately. 
 
Parasite material – pre-infection and post-infection larvae 
To provide an indication of the microbial diversity present within the L3 population 
that were used to generate the adult material, sub-samples of ~10,000 infective 
larvae used in the artificial challenge doses were snap frozen in liquid nitrogen on 
the day of challenge and stored -80°C storage prior to DNA extraction. Faecal 
material containing eggs (both H. contortus and T. circumcincta) from the patent 
parasite infections were collected from the infected donor lambs at post mortem 
(d28) and incubated at 22°C for 14 days. Infective larvae derived from the d28 
faeces were extracted, enumerated and identified to species level, snap frozen in 
liquid nitrogen and stored at -80°C in pools of ~ 10,000 larvae. 
Figure 1 shows the nematode lifecycle, and its association with the ruminant 





Figure 1: The nematode life cycle and its association with the ruminant digestive 
system. 
 
Ovine faecal and abomasal sample collection 
Individual faecal samples were collected per rectum at days 0, 1, 2, 5, 7, 9, 14, 19, 
21, and 28 post infection from all donor animals. Faecal samples were transferred to 
-80°C storage prior to DNA extraction. Sub-samples of abomasal contents were 
collected at post-mortem from each lamb donor.  
 
Confirmation of bacterial presence within nematodes 
To validate the presence of bacteria within ovine nematodes, wax sections from H. 
contortus adult worms were Gram-stained following standard procedures (23). 
 
Genomic DNA extraction 
The adult worms were transferred to 2 ml Lysing Matrix B tubes (MP Biomedicals) 




were homongenised using a Precellys24 homogeniser (Bertin Technologies) at 6000 
rpm for 30 sec for three cycles. The DNA extraction was conducted using the 
DNeasy Blood and Tissue Kit (Qiagen). To homogenate tubes, 500 μl ATL buffer 
supplemented with 12 mAU proteinase K (Promega) was added, followed by 
incubation at 56 °C for 2 h. To pellet the 0.1 mm glass beads, the Lysing Matrix B 
tubes were centrifuged at 15,000 x g for 5 min. The supernatant was transferred to a 
clean 2 ml microcentrifuge tube and this step was repeated to ensure no glass beads 
were transferred to the DNeasy Mini spin columns. The DNeasy Blood and Tissue 
Kit guidelines for Animal Tissues (Spin-Column Protocol) were followed, eluting 
the DNA in 100 μl of Buffer AE before DNA quantification using a NanoDrop 
ND1000 UV-Vis spectrophotometer (NanoDrop Technologies) and the tubes were 
stored at -80 °C.  
   
Controls 
Negative control tubes were included to account for environmental contaminants 
present throughout the processing of the samples. These consisted of 1 ml PBS that 
was exposed to the equipment used during the post-mortem, lab environment, 
DNeasy Blood and Tissue Kits (Qiagen), and Lysing Matrix B tubes (MP 
Biomedicals) as well as a DNA extraction conducted on the diluent Ultrapure water.  
 
V3-V4 16S rRNA gene sequencing: PCR amplification  
Genomic DNA was amplified using 16S rRNA gene amplicon polymerase chain 
reaction (PCR) primers targeting the hypervariable V3-V4 region of the 16S rRNA 
gene: V3-V4 forward, 
5’TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWG
CAG3’; and V3-V4 reverse, 
5’GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTAT
CTAATCC3’ (Illumina 16S Metagenomic Sequencing Protocol, Illumina, CA, 
USA). A 35-µl PCR was performed for each sample per the following recipe: 3.5 µl 
template DNA, 17.5 µl KAPA HiFi HotStart ReadyMix (Roche), 0.7 µl of both 
primers (initial concentration, 10 pmol/µl), 0.1 µg/µl bovine serum albumin fraction 




Eppendorf Mastercycler per the directions in the ‘Amplicon PCR’ section of the 
‘16S Metagenomic Sequencing Library Preparation’ protocol (Illumina). 
Amplification was confirmed by running 5 µl of PCR product on a 1.5% agarose gel 
at 70 volts for 80 min, followed by imaging on a Gel Doc EZ System (Bio-Rad). The 
product was approximately 450 base pairs (bp) in size.  
PCR-positive products were cleaned per the ‘PCR Clean-Up’ section of the Illumina 
protocol, with the exception that drying times were reduced to half the prescribed 
duration to account for the additional drying that occurs in a laminar airflow hood. 
Sequencing libraries were then prepared using the Nextera XT Index Kit (Illumina) 
and cleaned per the Illumina protocol. Libraries were quantified using a Qubit 
fluorometer (Invitrogen) using the ‘High Sensitivity’ assay. Sample processing was 
subsequently completed at Macrogen Inc., Seoul, South Korea. Samples were 




The quality of the paired-end sequence data was initially visualised using FastQC 
v0.11.6, and then filtered and trimmed using Trimmomatic v0.36 to ensure a 
minimum average quality of 25. The remaining high-quality reads were then 
imported into the R environment v3.4.4 for analysis with the DADA2 package 
v1.8.0. After further quality filtering, error correction and chimera removal, the raw 
reads generated by the sequencing process were refined into a table of Amplicon 
Sequence Variants (ASVs) and their distribution among the samples. It is 
recommended that ASVs (formerly called ‘Ribosomal Sequence Variants’) are used 
in place of ‘operational taxonomic units’ (OTU), in part because ASVs give better 
resolution than OTUs, which are clustered based on similarity (24). ASVs were then 
exported back into Linux and a second stage of chimera removal was carried out 
using USEARCH v9 in conjunction with the ChimeraSlayer Gold database v6. The 
remaining ASVs were screened for contamination using the Decontam package in R 
v1.0.0. The ASVs were classified at genus level using the classify.seqs function in 




The following statistical analyses were carried out in R: Shannon alpha diversity and 
Chao1 species richness metrics, and Bray-Curtis distances, for analysis of beta 
diversity, were calculated using the PhyloSeq package v1.24, and the Vegan package 
v2.52. Beta diversity calculations produce distance matrices with as many columns 
and rows as there are samples; thus, beta diversity is often represented using some 
form of dimensionality reduction, in this case, using principal co-ordinates analysis 
(PCoA) with the Ape package v5.1. Hierarchical clustering, an unsupervised method 
that can reveal key taxa that distinguish their respective environments, was 
performed with the heat plot function in the made4 package v1.54. Differential 
abundance analysis was carried out using Deseq2 v1.2.0, which identifies 
differentially abundant features between two groups within the data (25). Tests of 
means were performed using the Mann-Whitney U test unless otherwise stated, and 
correlations were calculated using Spearman’s rank correlation coefficient. Where 
applicable, false positive rates were controlled below 5% using the Bonferroni 
procedure. 
The SourceTracker algorithm was implemented to ensure that any differences 
between pre- and post-infection nematode larvae were not due to the adherence of 
gut bacteria to the surface of the latter group, following their exposure to the ovine 
intestinal tract. The 15 larval nematode samples were treated as ‘sink’ samples and 
compared with five ‘source’ samples to investigate the level of contamination 
present, if any. SourceTracker v1.0 was implemented in the R environment.   
Phylogenetic analyses were carried out by downloading genomic data for well-
characterised laboratory and pathogenic bacterial strains from the SILVA database 
and creating multiple sequence alignments with our own relevant ASVs using the 
MUSCLE alignment tool, hosted by the European Bioinformatics Institute (EBI). 
The resulting alignment was then exported to PhyML, where a phylogenetic tree was 
constructed using the maximum likelihood method. Lastly, this tree was exported to 








E. coli larval feeding 
Eggs of H. contortus MHco3(ISE) were purified and isolated from faecal samples 
derived from mono-specifically infected donor lambs using a saturated NaCl 
flotation method. The eggs were washed and re-suspended in water before being 
added to NGM agar plates supplemented with E. coli OP50-1:GFP (pFPV25.1) and 
incubated at 22°C for 48 h to allow hatching of first-stage larvae and subsequent 





Bacterial presence within nematodes  
Figure 2A and 2B show cross sectional images of H. contortus gut with Gram-
positive bacteria visible throughout.   
 
Figure 2: Stained sections through gut of an adult H. contortus.   
Staining shows the presence of Gram-positive bacteria in cross-sections of the 
intestinal lumen of an adult H. contortus. Gram-positive organisms stain blue-
black;, Gram-negative organisms and nuclei stain red (images kindly generated and 











Several samples that proceeded to PCR were not sequenced (Supplementary Figure 
2) because either the amplicon PCR failed to amplify the target gene, or the 
concentration of the sample fell below the 5 ng/µl threshold for sequencing 
following the second PCR clean-up, indicating either an imperfect DNA extraction 
or a low abundance of bacteria in these samples. No amplification was evident in the 
diluent Ultrapure water, nor in the PBS exposed to the post-mortem laboratory 
equipment, laboratory environment, Lysing Matrix B tubes, and run through the 
DNA extraction kits; however, control samples proceeded to sequencing regardless, 
as it is now recognised that sequencing of control samples should be standard 
practice in microbiome work, especially with low-biomass samples, in which low-
level contamination may have a large impact on sample readout (26).   
 
Cohort characteristics 
Microbiome analysis was carried out on a total of 5,608,303 error-corrected, non-
chimeric ASV reads over the entire dataset, with an average read depth of 89,021 
reads per sample. This was broken down into a total of 14,351 unique ASVs 
identified across the four environments studied (Supplementary Figure 3). Of the 
four environments sequenced, the larval nematode microbiome was the most distinct, 
with 84.9% of the total ASVs detected belonging uniquely to the larvae, followed by 
the faecal microbiome with 73.4% unique ASVs. The mature nematode and 
abomasal microbiomes were considerably less distinct, with 38.2% and 30% unique 
ASVs, respectively. Six negative control samples were also sequenced: Ultrapure 
diluent water, lab environment PBS, post-mortem suite PBS and PBS run through 
two DNA extraction kits and lysing matrix tubes. Considerably fewer error-
corrected, non-chimeric ASV reads were generated, with an average of 649. Deeper 
analysis of these samples showed that there was no crossover between ASVs present 
in the negative controls and experimental samples (Supplementary Figure 4).  It was 
therefore concluded that the biological signal from the experimental samples was not 
influenced by contamination.  
 




The microbiomes of the four environments studied were initially classified at 
phylum level across all individual samples (Figure 3). Their average, grouped 
composition was as follows: The abomasum contained 49.5% Firmicutes, 36% 
Bacteroidetes, 2.9% Fibrobacteres, 1.2% Proteobacteria, 1.1% Actinobacteria, 1% 
Planctomycetes, 1% Candidatus Saccharibacteria, with the remaining fraction 
comprising either unclassified or negligible proportions. The lamb faecal 
microbiome contained 67% Firmicutes, 11% Bacteroidetes, 8.5% Candidatus 
Saccharibacteria, 3.4% Spirochetes, 2.9% Actinobacteria, 1.2% Verrucamicrobia, 
with the remaining fraction comprising either unclassified or negligible proportions. 
The larval nematode microbiome contained 67% Proteobacteria, 18% Bacteroidetes, 
8% Actinobacteria, 1.6% Planctomycetes, and 1.5% Firmicutes, with the remaining 
fraction comprising either unclassified or negligible proportions. Finally, the 
microbiome of the adult nematodes contained 68% Firmicutes, 16% Bacteroidetes, 
2.5% Actinobacteria, 2.5% Planctomycetes, 2.2% Candidatus Saccharibacteria, 1.6% 
Proteobacteria, and 1.1% Verrucomicrobia, with the remaining fraction comprising 
either unclassified or negligible proportions. The four environments are 
distinguishable even at phylum level. Nematode larvae have a microbiome 
dominated by Proteobacteria, a phylum that is not evident in the other environments. 
The microbiome of the mature nematode more closely resembles the two host sites 
sampled, suggesting that the host’s environment may influence the microbial 
populations within the parasite. Despite the resemblance of the adult nematode to the 
faeces and abomasum of the lambs at this taxonomic level, there are still several 
phyla that are significantly different in terms of their proportions between these 





Figure 3: Composition at phylum level of the ovine microbiome (abomasal lumen 
contents and faeces) and nematode microbiome (larval and adult nematodes). 
Each ‘Nematode Larvae’ sample contains ~10,000 pooled larvae, 5 of which are 
pre-infection larvae and 10 of which are post-infection larvae; each ‘Adult 
Nematode’ sample contains 100 pooled adult nematodes (five H. contortus (4 males, 
1 mixed sex) and seven T. circumcincta (5 females, 1 male, 1 mixed sex) samples); 
each ‘Abomasum’ sample is derived from the abomasal washings of one of four 
lambs; and each ‘Faeces’ sample is derived from one of four lambs across 10 
timepoints. Phyla constituting less than 1% of the total phylum distribution were 
labelled ‘Other’. ‘Nematode Larvae’ were omitted from statistical testing due to 
their obvious distinctiveness from the other sample groups. The other three samples 
were compared for proportions of the different phyla identified - initially with a 
Kruskal-Wallis test, and then a Mann-Whitney U test, making individual 
comparisons if warranted. Critical values for significance were adjusted using the 




Diversity of the ovine and nematode microbiomes 
Alpha diversity, measured using Chao1 species richness showed significant 
differences between all groups compared, excepting adult nematode and faecal 
samples, which were similar in terms of species richness (Figure 4). Larvae were the 
least diverse group, while the abomasum showed the highest diversity. Beta diversity 
using Bray-Curtis dissimilarity shows three clusters of samples: lamb faecal samples, 
nematode larvae, and one cluster comprising adult nematodes and lamb abomasa. 
Hierarchical clustering of the samples based on their composition at ASV level was 
also performed (Supplementary Figure 5). This was carried out using the Bray-Curtis 
distance matrix and the Ward-Linkage method.  The Ward-Linkage method revealed 
the same patterns within the data as those observed in the dimensional reduction of 
the Bray-Curtis dissimilarity matrix, corroborating these findings. Despite apparent 
similarities at phylum level between the adult nematode and ovine faeces, when 
individual ASVs are compared, the adult nematode bears the closest resemblance to 
the ovine abomasum indicating that individual ASVs do not overlap as much as 










Figure 4: Bray-Curtis dissimilarity of the ovine microbiome (abomasal lumen 
contents and faeces) and nematode microbiome (larval and adult nematodes), 
correlated with phyla, and Chao1 species richness. (A) Bray-Curtis dissimilarity of 
microbiomes studied. For the ‘Abomasum’ samples, each point on the plot is a 
sample derived from the abomasal washings from one of four lambs, collected 28 
days post-infection. For the ‘Faeces’ samples, each point on the plot is a sample 
derived from a stool sample collected from one of four lambs from one of ten 
timepoints over a 28-day infection period. For the ‘Nematode Larvae’ samples, each 
point on the plot is a sample derived from a pooled mixture of ~10,000 larvae, and 
for the ‘Adult Nematode’ samples, each point on the plot is a sample derived from a 
pooled mixture of 100 nematodes (five H. contortus (four males, one mixed sex) and 
seven T. circumcincta (five females, one male, one mixed sex) samples). Ellipses 
show 80% confidence intervals for their respective groups. Of the 13 different phyla 
identified, 10 correlate significantly with one or both of the components of the PCoA 
based on Spearman’s rank correlation coefficient.  By superimposing this over the 
PCoA plot, the relationship between these phyla and their environments is 
visualised. (B) Horizontal alpha diversity boxplots of microbiomes studied are 
representative of Chao1 species richness. Significance was determined per the 




Analysis of inter-sex and inter-species differences in the adult nematode 
microbiome 
The nematode microbiomes were probed for variation resulting from differences in 
sex and species. Alpha and beta diversity between male, female, and mixed-sex 
pools of adult nematodes were examined (Supplementary Figure 6). No significant 
difference was found in terms of alpha diversity based on Chao1 species richness, 
using the Mann-Whitney U test (p = 0.546). When beta diversity was visualised 
using a PcOA plot samples clustered based on the sheep of origin and not based on 
gender.  
The microbiomes of H. contortus and T. circumcincta adult worms were compared at 
family level (Figure 5). Due to the novel nature of the microbiomes of both H. 
contortus and T. circumcincta, 37.6% of ASVs present in H. contortus samples and 
34.1% of ASVs present in T. circumcincta samples were not classified to family 
level. The microbiome of H. contortus comprised the following families: 36.2% 
Ruminococcaceae, 27.4% Lachnospiraceae, 11.4% Prevotellaceae, 5.7% 
Acidaminococcaceae, 4.2% Planctomycetaceae, 1.8 % Acetobacteraceae, 1.4% 
Spirochetaceae, 1.2% Veillonellaceae, with the remaining fraction comprising 
negligible proportions. The microbiome of T. circumcincta comprised the following 
families: 37% Lachnospiraceae, 26% Ruminococcaceae, 6.5% Prevotellaceae, 3.5% 
Planctomycetaceae, 3.3% Acidaminococcaceae, 3% Coriobacteriaceae, 2% 
Bifidobacteriaceae, with the remaining fraction comprising negligible proportions. 
Veillonellaceae and Acetobacteraceae were present in significantly higher numbers 
in H. contortus (p = 0.01 and p = 0.005, respectively), while Coriobacteriaceae was 
significantly more abundant in T. circumcincta (p = 0.005). Significance was 






Figure 5: Adult nematode Microbiome composition at family level of H. contortus 
and T. circumcincta. The extent to which various bacterial families contribute to the 
overall make-up of the microbiomes of H. contortus and T. circumcincta. Each 
column is derived from a pooled mixture of 100 nematodes (five H. contortus (four 
males, one mixed sex) and seven T. circumcincta (five females, one male, one mixed 
sex) samples). Nematodes were taken from the ovine abomasum at post-mortem, 28 
days post-infection. Families constituting less than 1% of the total family 





Alpha diversity in H. contortus was lower than in T. circumcincta (Supplementary 
Figure 7). However, the significance of this comparison between the two nematode 
microbiomes must be considered in the context of sample size (H. contortus n = 5 
and T. circumcincta n = 7). Differential abundance analysis using Deseq2 revealed 
18 ASVs significantly elevated in one nematode: 5 in H. contortus, and 13 in T. 
circumcincta (Supplementary Figure 8). Unlike the Mann-Whitney U test, this 
method is applied to individual ASVs. Ruminococcaceae/Ruminococcus and 
Clostridiales dominate the differentially elevated ASVs in T. circumcincta and are 
absent from the differentially elevated ASVs in H. contortus.  
  
Effect of nematode infection on the faecal microbiome of the host over time 
Changes in alpha and beta diversity of the faecal microbiome of infected lambs were 
examined over several time points between day 0 and day 28 of infection (Figure 6). 
Post-infection, there is a decrease in species richness within the faecal microbiome, 
and an increase in dissimilarity over time, compared with the faecal microbiome pre-
infection. There is a significant negative Spearman correlation between alpha 
diversity and time (p = 0.03). Increasing dissimilarity over time is indicated by a 
strong positive correlation between principal component axis 1 and time. This same 
principal component, which explains the most variation in the PCoA, also has a 
statistically significant negative correlation with alpha diversity. This means that the 
more dissimilar the infected microbiome becomes compared with the pre-infected 
microbiome, the lower its alpha diversity becomes. Despite the positive correlation 
between beta diversity and time, when the mean beta diversity of samples at time 
points 0 and 28 were compared, there was no statistically significant difference (p = 





Figure 6: Changes in alpha and beta diversity of the ovine faecal microbiome over 
time, post-infection. Faecal samples were obtained from two-to-four lambs at 10 
timepoints over 28 days. All correlation tests used Spearman’s rank correlation 
coefficient. (A) Changes in alpha diversity of the ovine faecal microbiome over time. 
There is a statistically significant decrease in Chao1 species richness from day 0 to 
day 28 of infection. (B) Changes in beta diversity of the ovine faecal microbiome 
over time. There is a trend in the movement of the lamb faecal microbiome along the 
x-axis in a positive direction over time, thus becoming more dissimilar to the 




These diversity metrics inform on changes in the overall relatedness of samples but 
give no information about the individual microbes implicated in the faecal 
microbiome dysbiosis.  All ASVs detected were correlated against time using 
Spearman’s rank correlation coefficient. There were 39 significant ASVs based on 
this test, of which 11 showed a positive linear relationship with time and 28 a 
negative one, post-infection (Supplementary Figure 10). The two most prevalent 
ASVs associated with time were classified as Bifidobacterium spp. and Sharpea 
spp., both of which show a negative relationship with time. When blasted against the 
nr database, these two sequences had 100% identity with Bifidobacterium 
merycicum, and Sharpea azabuensis. Seven statistically significant ASVs were 
classified as Ruminococcaceae. Other ASVs, such as the six identified as Candidatus 
Saccharibacteria, have an ambiguous relationship with time, post-infection, as four 
of these ASVs show positive correlations, and two negative.  
Dialister spp. and Clostridium spp. have both been implicated in compromising the 
human host’s ability to clear nematode infection [11]. Conversely, many other 
bacterial genera and families are suspected to ‘immunise’ the host against nematode 
infection (e.g. Subdoligranulum spp., Acinetobacter spp., Paracoccus spp., 
Gemminger spp., Peptococcaceae, Moraxellaceae, Corynebacteriaceae and 
Hyphomicrobiaceae). Of these bacteria, we observed only Hyphomicrobiaceae in our 
data, which was significantly elevated in pre-infection larvae over post-infection 
larvae (p < 0.05). Moreover, it is known that helminth infection in mice results in 
increased abundance of  the Lactobacillaceae family, leading to the hypothesis that 
the anti-inflammatory activity of these bacteria may create permissive conditions for 
nematode survival in the gut (27). We found similar results with this family in our 
ovine model, in which a positive correlation with time was observed post-infection 
(rho = 0.43, p = 0.01). 
 
Effect of the ovine microbiome on the nematode microbiome 
In addition to defining the effect of nematode infection on the host, the effect of the 
host microbiome on the microbial composition of the nematode was also 
investigated by comparing the microbiomes of larval nematodes pre-infection and 




larvae that may have arisen from the ovine intestinal tract. (Supplementary Figure 
11).  
There is a significant increase in alpha diversity in the pre-infection larvae compared 
with post-infection larvae as measured by Chao1 species richness (Figure 7C). The 
two groups of larvae were also clearly differentiated based on their dissimilarity in 
the PCoA plot (Figure 7A), with the clustering by group confirmed statistically by 
PERMANOVA analysis. 
The families Planctomycetaceae and Hyphomicrobiaceae are significantly elevated 
in the pre-infection larvae, while Rhodocyclaceae and Methylobacteriaceae are 
elevated in post-infection larvae (Figure 7B). ASVs that were differentially abundant 
between the two groups were identified using DESeq2.  2037 unique ASVs were 
identified across all larval nematode samples, of which 97 were elevated in the pre-
infection larvae, and 190 in the post-infection larvae. In all cases this was 
statistically significant after correcting for multiple testing. A volcano plot depicting 






Figure 7: (A) Bray-Curtis dissimilarity between pre-infection and post-infection 
nematode larvae. (B) Microbiome composition at family level of pre-infection and 
post-infection nematode larvae. (C) Boxplot of Chao1 species richness of pre-
infection and post-infection nematode larvae. (A) Bray-Curtis dissimilarity between 
pre-infection and post-infection larvae. Each point on the plot is derived from a 
pooled mixture of ~10,000 larvae (5 pre-infection larvae and 10 post-infection 
larvae). Ellipses show 80% confidence intervals for their respective groups. The two 
groups separate based on the dissimilarity of their microbial composition. Statistical 
testing was performed by permutational multivariate analysis of variance. (B) 
Compositional boxplot of the 19 most-prevalent bacterial families. Each column is 
derived from a pooled mixture of ~10,000 larvae. Significance testing was performed 
by the Wilcoxon signed-rank test, with critical values adjusted for multiple 
comparisons using the Bonferroni method.  (C) Boxplot comparing alpha diversity 
between the two groups as measured by Chao1 species richness. The pre-infection 
boxplot is derived from five pooled samples of ~10,000 larvae each. The post-
infection boxplot is derived from 10 pooled samples of ~10,000 larvae each. 




Comparison of the nematode and ovine microbiomes 
We investigated the capacity for ovine-adapted bacterial taxa to persist in the 
nematode microbiome. Firstly, nematode larvae were compared with ovine faecal 
samples, and adult nematodes were compared with ovine abomasal washings on the 
basis that these samples originated from a common environment – i.e. the ovine gut 
and abomasum, respectively.  Relatively little convergence was evident between the 
nematode larvae and ovine faecal samples, with only 227 shared ASVs of a possible 
9422 unique ASVs identified across both groups (Supplementary Figure 13 and 14) 
Conversely, when comparing adult nematodes with ovine abomasal washings, 2494 
shared ASVs of a possible 6936 unique ASVs were identified across both groups. 
Samples clustered definitively based on the host animal of origin.  
Next, we reviewed several recent studies that have profiled the ovine microbiome at 
various sites in the digestive tract according to the abundances of endogenous 
bacteria present (28,29). We then examined our own nematode microbiome data for 
the presence of bacteria found in sheep in relatively high abundances. Virtually all 
taxa present in relatively high abundances in the ovine gut, such as Ruminococcus 
spp. and Bacteroides spp., were absent from the larvae; however the 
Peptostreptococcaceae family was identified in all 32 faecal samples and 14/15 
larvae. Abomasum-adapted taxa such as Oscillospira spp., Succinivibrio spp. and 
Bacteroides spp. were not found in the adult nematodes, but Prevotella spp., one of 
the most abundant genera in the ovine abomasum, was found in every ovine 
abomasum and adult nematode sample, along with the abomasally-adapted 
Fibrobacter spp.,  which was also found in all abomasal samples, and 10/12 
nematode samples (data not shown). 
Also of interest were potential differences between the adult nematode and the ovine 
abomasum. The adult nematode and the abomasal lumen content microbiomes were 
compared using Deseq2. Twelve ASVs were significantly differentially abundant 
between the nematode microbiome and that of the ovine abomasum (Figure 8A). The 
most prevalent differentially abundant ASV was classified as E. coli/Shigella spp. 
(the taxonomic resolution necessary to distinguish these bacteria is impossible using 
16S rRNA gene sequencing analysis (30)). Following this, ASVs classified as E. 




total. At least one ASVs appeared in every larval sample, and in seven of the 12 
adult nematode samples. ASV 75, the most abundant putative E. coli/Shigella ASV, 
was also present at low levels in some of the lamb faecal samples but all ASVs were 
absent from the ovine abomasum (Supplementary Figure 15A). Nematode 
colonisation by E. coli/Shigella did not appear to be specific for either species of 
nematode – the two ASVs 75 and 295 combined were found in 4/7 T. circumcincta 
samples and 3/5 H. contortus samples. 
Phylogenetic analyses were carried out, comparing the four E. coli/Shigella ASVs 
found in the dataset with other well-characterised and clinically relevant strains to 
provide evolutionary context (Supplementary Figure 15B). The bootstrapping values 
were provided over 1000 iterations. The more distantly related Klebsiella spp. and 
Salmonella spp. formed the outgroups, as expected; however, the evolutionary 
distance between E. coli/Shigella genera was limited, as can be seen by the low 
bootstrapping values at many of the branch points. ASV_295 appears most distantly 
related to the remaining species, and therefore it is reasonable to suggest that 
ASV_6240 and E. coli MG1655 form a distinct separate clade, although it is not 
possible to confirm that evolutionary distance exists between ASV_75, ASV_7656, 






Figure 8: (A) Differentially abundant ASVs between the adult nematode and the 
ovine abomasum, showing level of fold change between either environment. (B) 
Oral ingestion of engineered E. coli by larvae in vitro. (A) Metabarcoding data for 
the adult nematodes were derived from 12 pooled samples (five H. contortus (4 
males, 1 mixed sex) and seven T. circumcincta (5 females, 1 male, 1 mixed sex) 
samples) of 100 nematodes each. Metabarcoding data for the abomasum were 
derived from the abomasal washings of four lambs. Bacteria are labelled with the 
most accurate taxonomic classification available for that ASV. Differential 
abundance was determined with Deseq2. Additional classification to species level 
with SPINGO is provided. This classification was performed with no confidence cut-
offs; thus, it is revealing yet imperfect with respect to the identification of the 
bacteria. (B) Eggs of H. contortus MHco3(ISE) were hatched to first-stage larvae 
and developed to second-stage larvae on NGM agar supplemented with E. coli 
OP50-1:GFP (pFPV25.1). DIC image left, U.V. Image on right depicting ingestion 




Oral ingestion of engineered E. coli by larvae in vitro 
In vitro oral ingestion of engineered E. coli was investigated to assess the potential 
for exogenous bacteria to reside within the guts of these nematodes, and to locally 
express heterologous genes. First stage nematode larvae were grown on a plate 
seeded with an E. coli strain, genetically modified to express green fluorescent 
protein (GFP). Fluorescence microscopy showed GFP fluorescence in the pharynx 
and the entire length of gut, specifically within GFP-expressing, E. coli-fed 





The quality and depth of our sequencing analysis permits a thorough understanding 
of spatial, kinetic and organism-specific patterns of the microbiomes of helminth-
infected hosts. This approach is potentially applicable to parasitic disease at large, 
including helminthic and ectoparasitic infections, on the condition that differences 
exist between the host and parasite microbiome. Due to the preferential colonisation 
of the abomasum by H. contortus and T. circumcincta, it was pertinent to compare 
these compartments for identification of bacteria that favour nematode cohabitation. 
and the same rationale was used in the comparison of nematode larvae and ovine 
faecal samples.  The identification of differentially abundant taxa represents valuable 
knowledge to exploit in future research.  
A past study of the H. contortus microbiome with primers targeting both the V3-V4 
and V5-V7 regions of the 16S rRNA gene resulted in higher OTU capture using the 
former primer set, although the latter set contrastingly was capable of detecting the 
phylum Gemmatimonadetes, albeit in relatively low abundance (13). The V3-V4 
region of the 16S rRNA gene was sequenced for all samples in this study, rather than 
the V5-V7 because, while targeting the V5-V7 region would be necessary for 
mapping comprehensively the microbiome of H. contortus by facilitating 
identification of its less abundant taxa, here our objective was to identify nematode-
specific bacteria that are present in relatively high abundance, because these bacteria 
would be more amenable to concentrating within a nematode, were they 
administered exogenously. However, there are ways in which less abundant taxa 
may have important applications for treatment of parasitic disease. For example, 
there is evidence that bacteria can influence their environment considerably even if 
their abundance is low (31). Furthermore, it is known that some bacteria, such as 
Wolbachia spp., are essential for the development of filarial nematodes, and that 
antibiotics targeting Wolbachia spp. have filaricidal activity (32). Thus, the use of 
antibiotics to target nematode-essential bacteria present either in low or high 
abundance is a valid treatment strategy. An alternative method could involve feeding 
the infected host a modified diet that would deprive the bacteria in question of 




The commonalities and differences we observed between the ovine and nematode 
microbiomes (Figures 3 and 4, and Supplementary Figure 5) are interesting because, 
in the former case, it presents the possibility that the microbiota of either organism 
may be influencing that of the other and, in the latter case, it means that the 
differences between parasite and host could be exploited to the benefit of the 
infected animal. The abomasum and adult nematode microbiomes are by far the most 
closely related environments (Figure 4 and Supplementary Figure 5). This could be 
considered unsurprising because these environments are in intimate contact with one 
another; yet, nematode larvae and host faeces, from which the larvae derive, separate 
into two distinct clusters despite their proximity. We reasoned that there may exist 
differences between host and parasite amenable to exploitation despite their gross 
similarity.  
H. contortus and T. circumcincta have contrasting lifestyles, the former being a 
blood feeder and the latter a mucosal grazer (33). Thus, characterising both species 
simultaneously in a co-infection model could illuminate the effects of alternate 
feeding habits on the nematode and ovine microbiome. Analysing different species 
in isolation across separate studies could complicate the identification of the source 
of any variation, as inter-study differences in soil composition, animal feed, age and 
immune status of host and living conditions, for example, could affect the ovine 
microbiota and therefore the microbiota of the nematode. To our knowledge, this is 
the first report of a parasite-host microbiome study in ruminant livestock that 
incorporates a co-infection model. It is also the first characterisation of the 
microbiome of T. circumcincta. 
Co-infection models are important because it is accepted that different parasites co-
habiting the same host can affect each other profoundly in ways that would not occur 
were they infecting the host as lone pathogens (34). This can result in one parasite 
creating a permissive environment for the other parasite or, conversely, one parasite 
negatively affecting the other parasite’s growth. In some cases, parasitic cohabiters 
can have more influence on their host than on each other (35). Additionally, multiple 
studies claim that co-infection of humans and livestock with nematodes is common 
(36,37), meaning that more microbiome studies of host and parasite should 
incorporate co-infection models. Admittedly, this study does not examine the 




effects of H. contortus or T. circumcincta alone on the ovine microbiome may be 
different than what is observed here. In response to a critical lack of information 
regarding the effects of co-infection on cohabiting parasites, a recent study has 
successfully employed methodology to predict how two nematodes will influence 
each other in terms of survival, even when they are examined in different host 
species (34). Future research would benefit this field by attempting to predict how 
host co-infection influences the microbiome compared with single-strain infections.  
We discovered that the two species of nematode contain microbiomes that are in 
many ways comparable. This is not unexpected, given the finding that marine 
nematodes deriving even from different parts of the planet contain similar 
microbiomes (16). However, there are statistically significant differences that are 
worth noting, namely that the families Veillonellaceae and Acetobacteraceae are 
both elevated in H. contortus, and Coriobacteriaceae is elevated in T. circumcincta 
(p > 0.01) (Figure 5). The fact that different species of nematode living in the same 
host have quantifiable differences in their microbiomes suggests that the contrasting 
lifestyles between the two species may be directly responsible for significant 
changes in microbiome constitution. 
Microbiomes associated with improved host health are noted for having high levels 
of microbial diversity. As such, if parasitic nematode infections were to alter the 
host’s microbiome, they may have more a profound effect on the health of the host 
than what is currently appreciated. Infection with multiple parasitic species is a 
natural phenomenon and is underlined as a more crucial determinant of the effects of 
infection on host health than host-specific and environmental factors (38); thus, the 
effects of co-infection on the microbiome could be just as pronounced. We detected 
an obvious decrease in alpha diversity 21 days post-infection. H. contortus and T. 
circumcincta pre-patent periods are both approximately three weeks (39,40), 
suggesting that nematode infection has a lesser impact on the microbiome of the host 
in the initial stages of the nematode life cycle, and only begins to have a noticeable 
effect once the parasites mature and move into the abomasal lumen rather than 
residing within the tissue. However, the dose administered to the lambs in this study 
was sub-clinical, which also may explain why the decrease in alpha diversity was not 




microbiome diversity could become magnified and/or occur earlier if infections were 
more acute.  
Notably, previous work, albeit within goats, showed that H. contortus infection did 
not result in a shift in abomasal microbiome diversity; however, an effect was seen 
on the abundances of several bacterial species (41). Contrastingly, infection of lambs 
with H. contortus alone was found to increase microbiome diversity in the 
abomasum (42). Differences observed may be attributable to inter-species 
differences and/or inter-study differences. For example, although both studies 
administered the same dose of H. contortus, the latter study involved pre-treatment 
of its animals with the anthelmintics ivermectin and levamisole, which may have 
removed pre-existing infection that otherwise may have affected study outcome. A 
study of humans, many of whom were infected with multiple nematodes (most 
commonly Trichuris spp., followed by Ascaris spp., followed by hookworm), 
concluded that helminth infection resulted in an increase in diversity of the faecal 
microbiome (37). It could be the case that the effect of nematode infection on 
microbiome diversity within the host may be microbiome-specific (i.e. abomasal vs. 
faecal), and/or species-specific (i.e. ovine vs. caprine vs. human). It is perhaps 
relevant that Trichuris spp., Ascaris spp. and hookworm are each intestinal 
helminths, while H. contortus and T. circumcincta are abomasal helminths. It is 
reasonable to postulate that parasites will have varying impacts on body sites with 
which they are directly in contact, than if they were persisting remotely. 
Furthermore, changes that occur as a result of abomasal colonisation may have 
dramatically different effects on microbial viability and composition in other, 
downstream in vivo compartments (e.g. the intestines) that would not occur were the 
intestines colonised. For example, there is evidence that colonisation with H. 
contortus decreases the acidity of the ruminant stomach (42), potentially altering 
microbial growth patterns here and other areas of the gut. Further study is required to 
fully understand the extent to which parasite lifestyle and host-specific factors come 
to bear on microbiome diversity.  
In addition to a quantifiable decrease in diversity, the quality of the shift is also 
noteworthy. Bifidobacterium merycicum and Sharpea azabuensis, both of which 
become reduced over time, would be considered typical constituents of a healthy 




dominant ruminant bacterial family (45) and again, all associated ASVs show a 
negative correlation with time. Unlike the dominant ruminant bacteria which are 
clearly affected by nematode infection of the host, some other changes in the host 
microbiome not directly related to parasitic infection are inevitable due to 
interactions between bacteria. Bacterial species compete for resources in various 
ecological niches within the host, produce antibiotics, and often rely on syntrophy 
for their survival (46). Thus, it is cautioned that the results of microbiome studies 
must be considered against a potential background of inter-bacteria interactions that 
may confound precise interpretation of changes observed.  
Taxa that have suggested involvement in either maintenance or clearance of human 
nematode infection, such as Dialister spp. and Lactovum spp. (11), were largely 
unfound in the ovine microbiome in the present study, with the exception of the 
Hyphomicrobiaceae family, which was elevated in pre-infection nematode larvae 
over post-infection larvae. Thus, while these bacteria may have an important role to 
play in human infection, it is improbable that they are fundamental to the 
establishment or curtailment of nematode colonisation of the ruminant host, and at 
the very least might only facilitate the establishment or removal of infection. An 
increase in the level of anti-inflammatory Lactobacillaceae in murine models of 
others studies (10), and in the present ovine study, is suggestive of a symbiotic 
relationship between bacteria and parasite, wherein Lactobacillaceae thrive in the 
presence of nematode infection, while nematode infection is sustained by the 
dampened immune response effected by this altered microbial signature.  
The degree of overlap observed in this study between host and parasite microbiomes 
occupying the same environment within the host provides insight into the origination 
of the nematode microbiome and is suggestive of the ability of ruminant-adapted 
taxa to invade a new niche within the host. The data present a strong case for the 
mature nematode either feeding on or being passively colonised by constituent 
bacteria of the ovine abomasum. While many taxa associated with the abomasum are 
absent from the adult nematode microbiome, there is a significant degree of overlap 
between the two groups at an ASV level, especially by the highly abundant, 
abomasally-adapted genera Prevotella spp. and Fibrobacter spp. All adult 




suggesting that these common taxa were indeed acquired by the nematode upon 
reaching the abomasum.  
The identification of differentially abundant taxa presents future opportunities for 
use as research tools, or indeed therapeutic approaches. While invaluable in 
combatting helminthic disease, anthelmintic drugs have been the victims of their 
own success. Frequent and routine use of anthelmintic has led to the prevalence of 
anthelmintic resistance increasing globally, with multiple class anthelmintic 
resistance being commonplace in H. contortus and T. circumcincta globally (47). 
The development of anthelmintic resistance and consumer concerns over chemical 
residues in the milk and meat products of treated animals (48) are potentially 
limiting factors in the deployment of these drugs in the future.  
Our metabarcoding data suggest that the microbiomes of H. contortus and T. 
circumcincta are significantly different from their ovine environment most notably 
with respect to E. coli/Shigella spp. E. coli may be a much more natural coloniser of 
nematodes than of animals, and there are several pieces of clinical evidence that 
support this. Firstly, it is known in human subjects that E. coli is not among the most 
abundant species found in the gastrointestinal tract and that its numbers may in fact 
be quite low (49). Moreover, probiotic strains of E. coli, such as E. coli Nissle 1917, 
are frequently unsuccessful colonisers of the human gut even when administered in 
relatively high doses (50), and once colonised often do not persist for long in the gut 
once the dose is stopped (51). Thus, naturally low levels of E. coli in animals may be 
sufficient to ensure its selective compartmentalisation in nematodes. Alternatively, it 
is possible that E. coli is vertically transmitted in nematodes and that migration from 
the host either does not take place or has a lesser impact than vertical transmission.  
This study provides a rationale for the study and use of parasite-specific bacteria in 
drug development practices. The successful feeding of infective nematodes with a 
genetically modified bacterium could be exploited in several ways. An example is a 
bacterial assay formatted to assess the efficacy of anthelminthic drugs. Bacteria have 
recently been engineered to ‘sense’ molecules that cannot be quantified by non-
invasive methods (52,53). These bacteria can detect exposure to a drug, and record 
this exposure using a memory circuit. This could create a platform through which 




performed – both on market-approved compounds and drugs still undergoing clinical 
testing. Alternatively, bacteria could be used as vehicles for drug delivery, which has 
many advantages beyond conventional chemical medicines, not least of which is the 
targeted delivery of therapeutics (52).  
E. coli is an ideal candidate for bacteria-mediated drug delivery. It is readily 
engineered and highly flexible as a drug testing platform and various strains of this 
species have attracted interest for their probiotic properties (54). Its preclinical 
validation in various drug delivery modalities is also a reassuring aspect of this 
bacterium (53,55-59). Thus, the selective colonisation of the nematode microbiome 
by E. coli/Shigella is encouraging and invites further investigation of bacteria as 
orally administrable, target-specific agents.  
In summary, this study highlights the potential value in exploitation of nematode 
microbiota in progression of novel treatments for parasitic diseases affecting both 
animals and humans.  
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Supplementary Figure 1: Overview of study timeline. The points at which host and 










Supplementary Figure 2: Flow diagram outlining the number of samples at each stage of the process, from genomic DNA extraction to the 
final sequencing of bacterial 16S rRNA gene amplicons. Numbers of samples are indicated for nematodes (pre-infection larvae and sheep-
derived larval and adult H. contortus and T. circumcincta) and lambs (abomasal and faecal samples). The total number of samples processed is 
shown in square brackets and the round brackets show (number of replicates, number of animals). In total, 215 genomic DNA extractions were 






Supplementary Figure 3: Distribution of ASVs among the ovine microbiome 
(abomasal lumen contents and faeces) and nematode microbiome (larval and adult 
nematodes). ASVs for ‘Nematode Larvae’ were derived from 15 pooled samples of 
~10,000 larvae each (5 pre-infection larvae and 10 post-infection larvae); ASVs for 
the ‘Adult Nematode’ were derived from 12 pooled samples of 100 nematodes each 
(five H. contortus (four males, 1 mixed sex) and seven T. circumcincta (5 females, 1 
male, 1 mixed sex) samples); ASVs for the ‘Abomasum’ were derived from the 
abomasal washings of four lambs; and ASVs for the ‘Faeces’ were derived from 33 
faecal samples taken from the four lambs across 10 timepoints. ASVs unique to any 
of the four environments are indicated by numbers in non-overlapping sections of 
the diagram. ASVs shared between two or more environments are indicated by 






Supplementary Figure 4: Bioinformatic analyses of negative control samples to probe for potential sample contamination. (A) Sample 
composition boxplot, at phylum-level, of the 6 negative control samples sequenced. Numbers of high-quality error-free reads obtained from each 
sample are shown above each column. (B) Heatplot of 75 unique ASVs identified in the negative control samples, illustrating their absence in the 







Supplementary Figure 5: Hierarchical clustering of ASVs, filtered for 5% 
presence across the ovine microbiome (abomasal lumen contents and faeces) and 
nematode microbiome (larval and adult nematodes). Data for ‘Nematode Larvae’ 
were derived from 15 pooled samples of ~10,000 larvae each (5 pre-infection larvae 
and 10 post-infection larvae); data for the ‘Adult Nematode’ were derived from a 
pooled mixture of 100 nematodes (five H. contortus (4 males, 1 mixed sex) and seven 
T. circumcincta (5 females, 1 male, 1 mixed sex) samples); data for the ‘Abomasum’ 
were derived from the abomasal washings of four lambs; and data for the ‘Faeces’ 
were derived from 33 faecal samples taken from the four lambs across 10 timepoints. 
Hierarchical clustering was carried out using the Ward-linkage procedure. Each 
row represents one ASV, with the relevant phylum indicated by the coloured bar to 







Supplementary Figure 6: Comparison of the microbiomes of male and female 
nematodes. (A) Beta diversity, visualised using Bray-Curtis dissimilarity, is 
represented in two dimensions using a PCoA plot. Samples are coloured according 
to the host lamb of origin, and shaped according to gender. Data were derived from 
five pooled H. contortus (4 male, 1 mixed sex) samples of 100 nematodes each and 
seven pooled T. circumcincta (5 females, 1 male, 1 mixed sex) samples of 100 
nematodes each.  (B) Boxplot comparing average Chao1 Species richness between 









Supplementary Figure 7: Comparison of alpha diversity between the adult 
nematodes H. contortus and T. circumcincta. Data were derived from five pooled 
H. contortus (4 male, 1 mixed sex) samples of 100 nematodes each and seven pooled 
T. circumcincta (5 females, 1 male, 1 mixed sex) samples of 100 nematodes each. 
Alpha diversity measured as Chao1 species richness. Statistical testing was 









Supplementary Figure 8: Differential abundance of ASVs between the adult 
nematodes H. contortus and T. circumcincta. ASVs for H. contortus were derived 
from five pooled samples of 100 nematodes each (4 male, 1 mixed sex) and ASVs for 
T. circumcincta were derived from seven pooled samples of 100 nematodes each (5 
females, 1 male, 1 mixed sex). Differential abundance was calculated based on log 
fold change, as calculated by the Deseq2 algorithm.  
 
 
Supplementary Figure 9: Comparison of beta diversity of the ovine intestinal 






Supplementary Figure 10: Statistically significant ASVs in the ovine faecal 
microbiome when correlated against time. ASVs were derived from 33 faecal 
samples taken from four lambs across 10 timepoints. ASVs present in lamb faecal 
samples were correlated against time using the Spearman correlation method. 






Supplementary Figure 11: Proportion of bacteria in the larval nematode 
microbiome potentially originating from host (ovine) contamination. Analyses 






Supplementary Figure 12: Differential abundance of ASVs between pre- and 
post-infection nematode larvae. Each point on the plot is derived from a pooled 
mixture of ~10,000 nematode larvae. Differential abundance was calculated using 
Deseq2; points are coloured according to phylum, and size is scaled to the base 







Supplementary Figure 13: Hierarchical clustering of ASVs present both in ovine 







Supplementary Figure 14: Hierarchical clustering of ASVs present both in the 






Supplementary Figure 16: Differential abundance of E. coli/Shigella spp. 
between the adult nematode and ovine abomasal lumen microbiomes and 
phylogenetic analysis. (A) ASVs for the ‘Adult Nematode’ were derived from from 
12 pooled samples of 100 nematodes each (five H. contortus (4 male, 1 mixed sex) 
and seven T. circumcincta (5 females, 1 male, 1 mixed sex) samples); ASVs for the 
‘Abomasum’ were derived from the abomasal washings of four lambs. Each row is 
individually scaled from dark-blue to red, with dark-blue indicating that the ASV in 
question is absent, and red indicating the most abundant sample for that ASV. (B) 
Dendogram of ASVs compared with V3-V4 regions of significant strains of E. coli, 


















This research consists of novel approaches and protocols to broaden the scope of 
research material for microbiome research, and aid in reproducibility. This is 
followed by two approaches attempting to progress the translational aspects of this 
research. 
Given the potential impact of environmental contamination on sequencing projects 
such as those seeking to characterise tumour-related microbiota, a robust 
contamination control strategy with accompanying validation such as that shown in 
Chapter 2 is the minimum requirement before proceeding any further with research 
of this kind. This methodology proved to be effective when used on samples 
showing mild to moderate levels of contamination, but was unable to completely 
differentiate low abundance bacterial reads from low abundance contaminant reads 
in the presence of overwhelming levels of contamination as in the FFPE breast 
tumour samples of Chapter 4. It is clear that there is room for improvement for 
retrospective removal of environmental contamination using bioinformatic methods. 
Future work to achieve this could involve the use of an ensemble classification 
method such as RandomForest to accurately identify contaminant reads from within 
datasets with the assistance of biological standards and use them as a training set 
with which to query newly generated data for contamination.  
Unfortunately, the advancement of retrospective contamination removal does not 
address the larger issue of the inefficiency caused by environmental contamination, 
in terms of discarded sequencing reads. The cost of sequencing is constantly be 
sinking, but it remains an expensive proposition for many labs globally. Given the 
extent of contamination observed in some samples across this research thesis, the 
practical effect of this is a doubling of the cost of sequencing at a minimum. The 
results of either an ensemble based classification method, or a biological standard 
such as the protoblock described in Chapter 4 to identify contamination can be used 
to inform biologists of contaminant sequences which could then be targeted by 
amplification blocking oligonucleotides (1), effectively removing them from the 
PCR pool, as discussed earlier.  
Justified criticisms of previous strategies for characterising the microbial 
communities within tumours employed by a number of groups, have provided a 




new survey of the potential breast tumour microbiome was required, taking into 
account the various concerns raised in recent times, particularly the presence of 
contamination. This re-affirmed the suggested presence of a bacterial community in 
both malignant and non-malignant breast samples, possibly due to migration of 
bacteria inhabiting the skin. This is evidenced by the similarity between skin swabs, 
healthy adjacent samples and tumour samples. Additionally, a distinct microbial 
signature within tumour samples was detected using a variety of statistical methods.  
In addition to the strain level analysis of bacterial communities required for 
biomarker discovery discussed earlier, which has the potential to progress the 
effectiveness of bacterially administered therapeutics, future work could focus on 
sequencing a matching host genomic and transcriptomic profile to complement the 
metataxonomic profile acquired here. This would allow the integration of 
information about possible biotransformation of therapeutics by bacteria (2), effect 
of bacterial community on host gene expression (3) and variation in reponse to 
treatment due to genetic profile (4) into one consolidated profile, progressing 
personalised cancer treatment.  
Chapter 4 describes a multifaceted approach to address two significant issues which 
are arresting the progress of microbiome research, particularly into non-GIT based 
ecological niches where stool cannot be used as a proxy; 
• Access to samples, particularly healthy controls is restricted by the 
invasive nature of the sampling process. This makes it difficult to 
obtain a sufficient sample size for statistical significance.  
• Lack of representative biological standards to validate experimental 
accuracy.  
 
This chapter describes the first method for the extraction of DNA from FFPE 
samples that is tailored to the unique characteristics of bacterial DNA, and while the 
method does require further optimisation, the initial results are promising. Many of 
these results are derived using a novel biological standard to complement FFPE 
samples. This “protoblock” was designed with the increasing requirements of 
validation and reproducibility within microbiome research in mind and offers 




when applied to FFPE samples. Two examples of this are the inclusion of host DNA, 
and formalin fixing to mirror the conditions faced by DNA in the samples.  
Future work from a bioinformatic perspective must be to provide a definitive answer 
on the applicability of this method to low biomass samples such as tumour tissue 
samples. Given the log fold decrease in DNA quantity expected after formalin 
fixation, and the low levels of bacteria expected in tumour biopsies (particularly in 
relation to the levels of host DNA), it is entirely possible that no endogenous 
bacterial community remains in levels high enough to be differentiated from 
contamination. Recent studies successfully characterising bacteria in several other 
tumour sites from FFPE samples using the gold standard Qiagen kit dictate that this 
method should also be examined with the FFPE samples used here. The results of 
this could be compared with improvements made to our own method outlined 
previously.  
Despite appearing to be a thematic outlier, the aim in Chapter 5 of characterising and 
exploiting the bacterial community within a foreign body for drug development or 
treatment purposes is as relevant to human tumours as it is to parasitic nematode 
infection, and can be seen as a proof of concept. The result, a bacterial taxonon only 
found in nematodes and absent from the surrounding host, with deliberate 
colonisation validated ex vivo would represent the ideal result in any metagenomics 
survey of a human tumour. That being said, the work is significant in its own right as 
a potential counter measure to rising anthelminthic resistance.  
Without ignoring the effect nematode infection has on livestock globally, future 
work should focus on determining whether the results of this study are replicable in a 
human model. Nematode infections affect up to 50 % of the global population (5), of 
which 450 million are seriously ill as a result. Only 125,000 deaths each year are 
directly attributable to nematode infection, compared to 3 million caused by malaria 
which affects a similar demographic, but this a function of the reporting methods as 
nematode infection related morbidity is not directly fatal. A more accurate metric is 
disease affected life years (DALYs). 39 million DALYs are lost each year from 
nematode infection compared to 35.7 million from malaria (6). The practise of only 
reporting deaths directly attributable to nematode infection, and the fact that almost 




neglected diseases from an awareness, research and funding perspective. As in 
livestock, anthelminthic resistance is developing in human nematode infection (5) 
and new treatment strategies are essential.  
Work thus far has centred on the accurate characterisation of ecological niches, with 
the hope of identifying bacterial biomarkers. If a candidate is found, a possible 
therapeutic intervention is to engineer the candidate bacterium to produce a 
therapeutically useful biomolecule such as a protein at the site of required 
intervention. These proteins are rarely in their native form, rather an aggregation of 
several functional subunits, and as most proteins only have marginal stability, these 
modifications can destroy their function. There are numerous in silico options for the 
prediction of protein function, as has been discussed previously, and the crux of 
Appendix I was the development of a method for their integration to provide a 
unified score that could be associated with the expected performance of a candidate 
protein. This in turn would be expected to significantly streamline the design and 
testing stages of biomolecular design. At present the tool is limited by the relatively 
small number of predictive features used, and the relatively narrow scope of the 
experimental validation. Future work must try and broaden the applicability by 
validating the tool in different experimental conditions, which could be accelerated 
through the construction of a database for community-based reporting of 
experimental results following publication. 
On a more general note, the field of bioinformatics is facing a potential critical 
juncture. The length of the individual reads being sequenced by single cell methods 
such as Oxford Nanopore are constantly increasing, while the total reads yielded by 
the newest Illumina ultra-high-throughput methods are also increasing rapidly. The 
result is data generation exceeding the rate at which the processors needed to analyse 
them are advancing. This comes at a time when bioinformaticians are incorporating 
more computationally intensive machine learning algorithms into the analysis of 
sequencing data, and biological research in general begins to incorporate more 
bioinformatics in the scientific method. This machine learning driven research in 
particular favours scalability, and already breakthroughs have been facilitated by 
large technology corporations who have both the machine learning expertise and 
processing power in abundance. A prime example of this being the unprecedented 




to the best efforts of academic institutions and in a fraction of the time. The 
involvement of companies such as Amazon and Google has precipitated scientific 
breakthroughs that may have taken years otherwise, but steps must be taken to 
preserve not for profit university research in the future.  
Given that one of the aims of this research project is to advance the cause of 
precision medicine, this provides a fitting example. A recently published review in 
Nature states that although people of European descent account for only 16% percent 
of the global population, they represent almost 80% of the sequenced genetic 
information available. It is safe to assume the same holds true for metagenomic 
information (7). This is unsurprising, as it presumably roughly mirrors the funding 
for scientific research. Although this imbalance is beginning to be adjusted by 
projects such as the GenomeAsia 100K project (8), it is difficult to see how more 
private involvement in academic research through institutions such as Google will 
help to address this issue rather than exacerbate it.  
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Background Protein engineering and synthetic biology stand to benefit immensely 
from recent advances in in silico tools for structural and functional analyses of 
proteins. In the context of designing novel proteins, current in silico tools inform the 
user on individual parameters of a query protein, with output scores/metrics unique 
to each parameter. In reality, proteins feature multiple ‘parts’/functions, and 
modification of a protein aimed at altering a given part, typically has collateral 
impact on other protein parts. A system for prediction of the combined effect of 
design parameters on the overall performance of the final protein does not exist.  
Aim Function2Form Bridge (F2F-Bridge), attempts to address this by combining 
the scores of different design parameters pertaining to the protein being analysed into 
a single easily interpreted output describing overall performance.  
Methods The strategy comprises 1. A mathematical strategy combining data 
from a myriad of in silico tools into an OP-score (a singularsingle score informing 
on a user-defined overall performance); 2. The F2F-Plot, a graphical means of 
informing the laboratory biologist holistically on designed construct suitability in the 
context of multiple parameters, highlighting scope for improvement.  
Conclusion F2F predictive output was compared with laboratory data from a 
range of synthetic proteins designed, built and tested for this study. 
Statistical/machine learning approaches for predicting overall performance, for use 
alongside the F2F plot, were also examined. Comparisons between laboratory 
performance and F2F predictions demonstrated close and reliable correlations. 
This user-friendly strategy represents a pivotal enabler in increasing accessibility of 





Proteins are large biomolecules, which perform various fundamental functions of 
life. The structure and function of these biomolecules is defined by a sequence of 
amino acids, which begin to fold into a 3D structure even during the protein’s 
synthesis by a ribosome [1]. Our understanding of this process, and consequent 
ability to modify and engineer proteins, has progressed dramatically in recent times. 
This has gone hand in hand with the development and improvement of 
computational tools designed to predict how proteins will behave. Tools exist 
allowing the user to predict:  
• the three dimensional structure of a protein [2] 
• its physical and chemical properties [3] 
• how it interacts with other proteins [4]  
• which active sites facilitate these interactions [5]  
• with more expert use, tools also exist to modify these proteins if any of these 
parameters do not match what is desired in the rapidly expanding field of de 
novo protein design [6].  
These tools offer a considerable advantage over the traditional structural exploratory 
techniques of NMR and CryoEM in terms of cost and ease of use, and the gap in 
terms of accuracy between the gold standard and in silico approaches is shrinking.  
The design of a protein involves defining the overall desired function, and 
associating this with a 3D structure. This is in turn coded into an amino acid 
sequence. In many cases, this overall function is achieved by fusing different sub-
functional protein components (parts) together. In addition to de novo protein design, 
a simple example is the conjugation of protein therapeutics with delivery factors, 
such as cell penetrating peptides to enhance their efficiency. Once the construct has 
been defined, the typical process of protein modification or design for therapeutic 
use entails designing thousands of variant structures in order to find the small 
minority of these proteins that will be (i) expressed by the bacterial cellular 
machinery and (ii) in the correct conformation to carry out the desired function. 
Following this, optimal candidates are selected and validated in a wet-lab setting 




Proteins, whether natural or designed, have broad applications across many fields of 
science, but medical research in particular has benefitted from our increase in 
understanding and the research and development of protein based therapeutics has 
been a clear beneficiary of this. The scope of protein-based biopharmaceuticals is 
broad, but it is dominated by humanised monoclonal antibodies, which made up 48 
% of the therapeutic proteins market in 2010. A fundamental problem with these 
antibodies has been their size - at 150 KDa on average, they are often too large to 
bind to the desired active sites, or efficiently penetrate into host tissue targets such as 
tumours. With the advances in in silico capacity, groups are now isolating only the 
active site from these antibodies and fusing them with much smaller and more stable 
backbones, or in other cases dispensing with naturally occurring antibodies entirely 
and simply reverse engineering de novo antibodies based on the requirements of the 
active site [7]. 
A key problem with these in silico mediated advances in protein analysis and design, 
is that they remain simulations of how the protein will fold, or bind to an active site 
for example. The overall performance prediction problem is how to weigh the 
positive and negative effects of modifications to a synthetic protein in such a way 
that the effectiveness of the construct in experimental conditions can be predicted. 
Advances in the in silico prediction of overall protein performance have to the 
potential to yield considerable savings both in time and money by reducing the 
amount of wet-lab testing and validation that must go in to the production of a novel 
protein for the first time. Given all the disparate data now available through in silico 
protein analysis, the potential for a big data approach to attempt to predict the 
function of these proteins warrants attention.  
 
In this work, a novel mathematical strategy (F2F-Bridge) aimed at predicting the 
overall performance of a synthetic protein is proposed. Several test sequences were 
designed for a defined overall function. The individual scores for all the different 
design parameters pertaining to each test sequence are condensed into a graphical 
output. The result is a visual and numerical evaluation of the test sequence. The 
graphical output (F2F-Plot) and the numerical evaluation (OP-score) together form a 




performance of the given set of test sequences. This method combines user input 
with in silico data to give insights into the predicted overall performance of a test 
sequence. With view to eventually developing a robust tool for protein performance 
prediction, relationships between in silico and laboratory data for test proteins were 
also examined using two different strategies for feature selection and predictive 








MATERIALS AND METHODS 
Laboratory work was performed by other members of the Tangney lab. 
In silico design of test sequences: 
Luminescence proteins: Each construct was designed to have a luminescent 
domain, a binding domain, a solubility tag and a secretion signal. All parts are linked 
in all possible permutations using different rigid and flexible linker sequences[8] 
(Figure 1). Variable heavy and light chain AA sequences from different antibodies 
were used as the binding domains, from an antibody targeting either cell surface 
associated epithelial mucin 1 (MUC1; mammalian antigen) or Clumping factor A 
(ClfA) of Staphylococcus aureus (bacterial antigen). Test sequences were designed 
to bind to their respective target and present luminescence as a readout (bound 
protein luminescence). Fluorescence proteins (used for further validation) are 
described in Supplementary Text 3. 
 
 
Figure 1: 3D structure of the designed luminescence test sequences examined 








The different in silico features analysed in relation to the overall performance of the 
test protein, and how they are generated is outlined in Table 1, with more detailed 
instructions found in Supplementary Text 1.  
Table 1: Common in silico tools, and the purpose they serve 
Design Parameter Metric and Scale 
range 
Metric description Effect on overall 
performance 
Generated: 
3D structure C-score 2 : -5 Confidence in the 
model and folds 
predicted 
Higher confidence 




Docking ΔG kcal/mol Gibbs free energy 
released by reaction 
Protein-protein 
interactions at the 
active site predicted 
Autodock 
Vina*[10]  
Quality of model RC – score   Proportion of amino 
acids in different 
regions based on 
steric hindrance 
High agreement with 
stereochemistry and 
free energy reflects 
stability of structure 
Saves 
server[11]  
Active site solvent 
accessibility  
0-9 A measure of the 
exposure of A residue 
or group of residues 
Depending upon the 
function, the active 
site could be exposed 
to the solvent or 











-4.5 to +4.5 Each amino acid has a 
hydrophobicity score 
between -4.5 and +4.5 
as per Kyte Doolittle 
scale.  







Size kDa Total weight of the 
protein 
Size forms an 
important factor if the 





Hosted by  
Expasy[13]  
 
Isoelectric point pH 0 to 14 Point at which 
molecule carries no 
The integrity of the 
structure of the 
ProtParam 




net charge protein in a setting is 




Potential active sites 0 to n Number of potential 
active sites 
Predicting the 
potential active sites 
on the designed 





Instability 0 to 100 Half life of protein in 
vitro 
Gives an indication of 
the viability of the 
protein 
ProtParam 




The data described in the data generation stage were taken as input into the 
Function2Form function, written in the R programming language by the author. The 
F2F function takes as input a data frame with all proteins to be screened as rows, and 
the different in silico observations as columns. The first row of the table contains a 
set of user desired input values. Some of these are based on the benchmarks provided 
by in silico programmes such as RC score and Instability, while in other cases the 
user can specify the ideal needs for the protein (e.g. hydrophobic and < 30 kDa). The 
features used in this study are detailed in Table 1, but the F2F-Bridge function is not 
limited to these and can be easily expanded or condensed depending on individual 
user requirements. 
The test sequences are then screened by the function and the output is a data frame of 
the test sequences and their respective scores, along with a radar plot for each test 
sequence, highlighting the differences between each sequence and the input 
parameters as can be seen in Figure 5. Areas where the candidate protein does not 
meet the preset requirements will appear outside the coloured region of the reference 
values. As well as this visual analysis of the suitability of the protein, a score 
indicating overall function is provided. The OP score is the grand average of 
absolute distance between each particular feature of the protein, and the user-
specified/program specified reference range. For cases of high throughput in silico 
screening, an additional function allows the user to extract the n top scoring test 






F2F R function  
Generating the OP score 
(i) Where possible, convert different in silico observations to same scale 
𝑖 = (
(𝑂 −  𝑂𝑚𝑖𝑛)
(𝑂𝑚𝑎𝑥 −  𝑂𝑚𝑖𝑛)
) ∗  (𝑁𝑚𝑎𝑥 −  𝑁𝑚𝑖𝑛) + 𝑁𝑚𝑖𝑛 
Where O is the old range and N is the new range, which in the case of the F2F 
function is always 0-100.  
(ii) F2F function then iteratively scores each test sequence supplied in input table 




Where x is the test sequence to be scored, y is the set of reference values, i refers to 
the ith observation within the in silico data table supplied to the algorithm, and n is 
the total number of observations i.  
Generating the F2F plot 
Figure 3 shows the graphical output of the F2F function. Each sequence tested is 
assigned an OP score as discussed above, and a radar plot is generated. For every in 
silico observation provided in the input data, an axis is created on the radar plot. This 
enables the user to see which specific in silico feature or features are making the test 
sequence unfit for purpose. 
 
Statistical and Machine learning methods 
Two other methods of transforming the in silico data into a prediction of overall 
performance were assessed. The aim was to examine the data for relationships of any 
kind between the predictive features and the laboratory output with the view to either 
design a system of weights for the predictive features to improve the F2F plot, or to 




i) LASSO Feature selection and subsequent generation of predictive models can 
be used in conjunction with the F2F-Bridge programme. LASSO regression puts a 
constraint on the sum of the absolute values of the model parameters, which must be 
less than a fixed upper limit. It does this by applying a regularisation process 
(shrinkage) where it penalizes regression coefficients and shrinks a selection to zero. 
Variables that still have a non-zero coefficient after the shrinking process are 
selected to be part of the final model [14] . 
ii) TREE BASED METHOD The second method was to use a regression tree as per 
the random Forest package in R to generate a variable importance plot, again using 
the in silico parameters as input, and laboratory detected luminescence as the 
indicator of overall performance. An outline of how random forest works in 
generating these regression trees is as follows. A predefined number of bootstrapping 
samples are drawn from the original data. For each of these samples, an “un-pruned” 
regression tree is grown. Traditionally, the best split at each node to differentiate all 
predictors would be used, but in this instance the best split is found amongst a 
random subset of the predictors. Following this, predictions are made by aggregating 
the predictions of the pre-defined number of trees and taking the average value[15]. 
The quality of the model was ensured by finding the optimal number of features to 
randomly sample at each split, and to ensure that enough iterations of the model are 
run to ensure that the out of bag error has stabilised. 
  
Laboratory validation 
The luminescence test synthetic proteins examined are outlined in Figure 3. Two 
biological facets were used to assess the effectiveness of the functional prediction 
strategies – i) binding; ii) secretion. Sub-function parts on the test sequences include: 
(i) Active site: Heavy and light chains of anti-MUC1 antibody (C595) and anti-ClfA 
antibody were fused with EAAAK (rigid) and GGGGS (flexible) linkers to obtain 
Monospecific bivalent diabodies and Monovalent ScFVs (monobodies), (ii) 
Secretion signal: Gaussia luciferase’s native secretion signal, (iii) Solubility 
enhancer: SUMO tag, (iv) Reporter: Truncated version of Gaussia luciferase was 
used as a luminescence reporter. (v) Detection tag: Flag peptide was used as a 




Presence or absence of certain sub-function parts or their design orientation has a 
significant effect on the overall performance of the protein and should be accounted 
carefully in the design phase. In our case, over 50 different amino acid sequences 
were designed against each target. Of these, eight variants per target were 
synthesised for testing in the laboratory. These test sequences vary in (a) (+/-) 
solubility enhancer, (b) (+/-) and positioning of Active site and (c) the type/format of 
Active site. All these test sequences were tested for their overall performance. 
Laboratory data was used to validate and improve the results from the F2F-Bridge. 
An outline of the laboratory workflow can be seen in Figure 2, and a more detailed 
description on synthesis and build of ‘test sequences’ can be found in Supplementary 
Text 3. 
 
Data generation from laboratory experiments with luminescence proteins 
Binding assays: 108 Staphylococcus aureus TCH959 (naturally bearing clfA) or 106 
MCF7 cells (naturally bearing MUC1) were blocked with 5% BSA for 2 h followed 
by incubation with supernatant containing each test construct. Cells were washed 3 
times and resuspended in PBS. Luminescence was measured using Promega 
GloMax® 96 luminometer. In our case, since bound luminescence is the overall 
function, the luminescence readings corresponding to each test sequence are 





Figure 2: Workflow of laboratory validation of test sequences. 
 
 
Statistical analysis  
All statistical testing, unless otherwise stated, was performed in the base R 
environment v3.4.3 [16]. The LASSO regression feature selection method was 
implemented using the Glmnet library v2.0-16 [17], and the Random Forest 
regression tree analysis was performed using the RandomForest library v4.6-14 [18]. 
The radar plot within the F2F-bridge function was implemented with the fmsb 







Overall Biological Performance - Bound luminescence 
16 test amino acids sequences were scored using F2F-plot. The result of F2F-plot 
analysis and associated scores for all test sequences can be seen in Figure 3 and 
Supplementary Figure 1, and a detailed workflow of the strategy can be found in 
Supplementary Text 2, additionally the raw data can be found in Supplementary 
Table 1. It can be seen from the output of the F2F-bridge that the ClfA Monobody 2 
test sequence (represented by the pink shaded region) has an instability index score 
that is far higher than the user required level (blue shaded region), but there is 
minimal difference between the different shaded regions across the other axes, which 
contributes to ClfA Monobody 2 having a low and therefore good score. The test 
sequence predicted to have the poorest overall performance, ClfA Diabody 2, has 
levels of solvent accessibility and docking affinity that are much lower than required, 
as well as an increased instability index. These factors combine to give this test 





Figure 3: F2F-bridge output for ClfA test sequences. Areas where the candidate 
protein (pink) does not meet the preset requirements is highlighted by contrasting 
with the coloured region of the reference values (blue).  The plot is generated using 
a bespoke function written in R, and detailed instructions on its use can be found in 




These sequences were used to generate the corresponding proteins as outlined in the 
Methods section. Biological performance of these proteins was assessed in the 
laboratory using binding assays with luminescence as the readout, corresponding to 
Overall Performance.  
Table 2 shows the results (laboratory – luminescence units; F2F – OP score) of all 
test sequences whose biological performance was predicted with F2F-Bridge. The 
accuracy of F2F prediction was assessed by comparing the F2F-prediction of overall 
biological performance with the laboratory luminescence data.  
Table 2: Agreement between experimental results and F2F plot - Luminescence. 
 
In both antiMuc1(A) and Anti-ClfA(B), the binding affinity of each protein is 
measured by luminescence output. Proteins are ranked by their OP score in both 
tables, and coloured from green (best performing protein), through yellow, to red 
(worst performing protein) for both luminescence and OP score (Lowest number = 
best OP score.) 
Overall, the correlation pattern showed the F2F-Bridge method providing a general 
guide for how the test sequence can be expected to perform. In a database of this 
limited size, there was no statistically significant correlation between the OP-score 
and the ‘bound protein luminescence’ evident. This was repeated with 
‘luminescence’ as the laboratory output, but again there was no relationship present 






Investigation of alternative methods to complement F2F plot 
1) LASSO Regression 
‘Bound luminescence’ as overall performance 
 The output of Lasso analysis of the test sequences for bound protein luminescence 
can be seen in Figure 4. In the case of test sequences against MUC1, the features 
deemed to have the most effect on bound protein luminescence were Docking 
Affinity, Hydrophobicity, Solvent accessibility and isoelectric point. However, when 
these predictive features were input into a linear model, no linear relationship was 
detected. The same was found when analysing the potential relationship between the 
test sequences against ClfA and their eventual bound protein luminescence. In this 
case, Hydrophobicity and Instability were the features selected, and again, no linear 
relationship was found.  
Despite the LASSO method detecting possible relationships between the predictive 
features and the test variable (bound protein luminescence), no predictive linear 
model could be constructed (Table 3). We speculate that there may be too many 
variables present from a laboratory perspective for us to accurately predict bound 
luminescence with a database of this size. 
Table 3: Results of multiple regression analysis of features selected by Lasso 
regression analysis against experimentally determined luminescence.  
Test sequences p-value Adjusted R Squared 
antiClfA 0.507 -0.06 









‘Secreted luminescence’ as overall performance 
 
To counter this, we also examined ‘luminescence’ only resulting from protein 
secretion as a measure of overall biological performance. As we are just measuring 
the degree of luminescence of the test sequences, and not their binding to a target, 
the two groups (antiMUC1 and antiClfA) can also be directly compared, doubling 
our sample size. Figure 4 uses the LASSO method to investigate the relationship 
between in silico observations and luminescence due to secretion of anti–Clfa test 
sequences. In silico observations implicated in dictating the level of secretion of a 
test sequence were identified by LASSO. These were then used to generate a linear 
model to examine the degree to which they explained the luminescence due to 
secretion of the test sequences. This gave a linear model that explained 84.6% of the 
variability in luminescence of all test sequences, with an associated p-value of 0.004. 
This led us to explore the utility of a LASSO dictated linear model as a predictive 
tool. The luminescence levels predicted by the model were correlated with the 
experimentally determined luminescence levels. This, and also correlation 
coefficients of individual test sequence groups against their luminescence, are shown 
in Figure 6, and numerically in Table 4. As would be expected, antiClfA test 
sequences which are the training set, show stronger correlation (Rho 0.93), but that 
of the antiMUC1 test sequences was also significant. 
2) Alternative methods for prediction of test sequence performance; Random 
Forest Regression Tree analysis 
The same methodology was used for a regression tree implemented within random 
Forest. The test sequences against ClfA were used as the training data set, and the 
test sequences against MUC1 test sequences were used as the test set. The regression 
model derived from the random forest algorithm was able to explain 41% of the 
variability in the luminescence of the training set data test sequences (Figure 6). The 
values predicted by random forest for luminescence for the individual proteins were 
then correlated with their experimentally derived levels of luminescence (Table 5). 
This method showed a significant correlation between the luminescence values 




forest regression analysis was carried out with bound protein luminescence as the 
laboratory output, but no significant results were found (data not shown). 
Table 5: Results of various predictive models of secreted luminescence generated 
using RandomForest regression trees, when correlated with the lab-generated 
values.  
      antiClfA antiMuc1 Total 
p value 0.002 0.05 1e-5 








Figure 4: Output of F2F Post Hoc Analysis 
(A) shows the graphical output of LASSO features selection for both (i) antiMuc1 
and (ii) antiClfA test sequences for predicting bound protein luminescence. Each 
coloured line corresponds to a predictive feature used in the F2F-Bridge function. 
The lines plot the path of the variables coefficient against the L1-norm, of the whole 
coefficient vector as lambda varies. Both show that Lasso regression analysis was 
capable of identifying relationships between the examined predictive features, and 
experimentally determined luminescence. 
(B)(i) shows the same LASSO based feature selection for antiClfA test sequences, 
using secreted luminescence as output.  In this instance, Isoelectric point enters the 
model first, and Instability appears to have the most pronounced effect on the test 
variable. The relationship between these and the experimentally derived 




to be significant in the model, which explained 84.61% of the variability in 
luminescence, with an associated p-value of 0.004. This allowed us to build a 
predictive model using antiClfA test sequences as the training set. (ii) Shows a 
correlation plot of luminescence values for test sequences predicted by a LASSO 
directed linear model, vs experimentally derived secreted luminescence values. The 
training set (antiClfA test sequences) is coloured blue, and the test set (antiMUC1) is 
coloured red. 
(C) summarises the Random Forest regression tree analysis. As with (B) the 
successful model was trained on the antiClfA data, and tested on the antiMUC1 
data. (i) shows mean node purity for each predictive feature. The lower this value, 
the more important it is to the model.  The model, trained on the antiClfA test 
sequences was able to explain 41% of the variability in experimentally determined 
secreted luminescence. The model was then used to predict secreted luminescence 
values of the training set (antiClfA) and the test set (antiMUC1), and these predicted 
values were correlated with experimentally derived luminescence values in figure 
(ii). The overall correlation coefficient was 0.87, with an associated p-value of 1e-
05, indicating the value of the predictive model generated. 
We postulate that with an increased amount of data available for training the models, 
this accuracy can only increase. A summary of all the tests performed and their 





Table 6: Summary of statistical tests performed. 












The F2F plot was able to 
provide a guide for the expected 
performance of the test sequence 
when the test sequences were 
ranked by OP score and by 
laboratory output, and the 
accompanying plot was able to 
inform on how to improve the 
test sequence. No statistically 
significant relationship between 
OP score and laboratory output 
could be found.  
LASSO feature 
selection and linear 
model building 
Binding antiClfA and 
antiMUC1 
LASSO regression analysis was 
able to detect discrete patterns in 
the data, showing 
Hydrophobicity and Isoelectric 
point both to have a positive 
relationship with bound 
luminescence in antiClfA. In the 
case of antiMUC1 Docking 
Affinity and Solvent 
accessibility were shown to have 
a positive effect, Isoelectric 
point and Hydrophobicity a 
negative one.  
Using LASSO 
regression analysis 
dictated linear model 
as a predictive tool 
Binding antiClfA and 
antiMUC1 
The models predicted in the 
above analysis were unable to 
exaplain any of the variability in 
the bound luminescence of 
antiMUC1 or ClfA test 
sequences.  
LASSO feature 
selection and linear 
model building 
Luminescence antiClfA LASSO regression analysis was 
able to detect discrete patterns in 
the data, a linear regression with 
solvent accessibility and 
instability was able to explain 
86.4% of the variability in 




dictated linear model 
as a predictive tool 
Luminescence antiClfA and 
antiMUC1 
The model created in the above 
test was used to predict 
luminescence values for both 
antiClfA and antiMUC1. In both 
cases these predictions showed 
strong positive correlations with 




values which were statistically 
significant. 
Random Forest 
regression tree model 
building 
Luminescence antiClfA A regression tree implemented 
with randomForest was able to 
explain ~41% of the variability 
in the luminescence of antiClfA 
test sequences. 
Using Random Forest 
regression tree as a 
predictive tool 
Luminescence antiClfA and 
antiMUC1 
The model created in the above 
test was used to predict 
luminescence values for 
antiClfA and antiMUC1 test 
sequences. In both cases, these 
predictions showed strong 
positive correlations with the 
experimental luminescence 




Further Validation – Fluorescence Proteins 
The F2F plot was further validated on a second dataset of 8 test sequences and 
resulting laboratory data (fluorescence readings from proteins). In this instance there 
was no need for the secondary functionality of feature selection and model building 
based on a subset of the data, as the OP score predicted showed a statistically 
significant inverse correlation with overall performance of the test sequence. These 
results are presented in Figure 5 and Table 7, and the accompanying F2F plots, 
scores and raw data are shown in supplementary Figure 2 and Table 2. In this case, 
fluorescence was the overall function of the 8 test sequences to be predicted. Unlike 
the dataset discussed previously, in this case, the F2F-plot predicted scores showed a 
strong inverse correlation with the overall performance of the proteins, which is the 





Table 7: Agreement between experimental results and F2F plot - Fluorescence. 
Proteins are ranked by their OP score, and coloured from green (best performing 
protein), through yellow, to red (worst performing protein) for both Fluorescence 




Figure 5: Correlation plot of OP-Score vs Overall Biological Performance.  
Overall biological performance was scored for fluorescence. Correlation test 





In this study, we have shown how F2F plot could help to visualize the overall 
performance of a test sequence, particularly if complemented by the statistical 
methods examined. For each sequence, the OP score predicts the expected efficacy, 
and the F2F plot provides a graphical overview of predicted strengths and 
weaknesses. Unlike the pre-existing in silico tools that inform the quality of 
individual design parameter, F2F bridge takes a top down approach on overall 
performance by predicting the collective influence of all the design parameters on 
given test sequence. Such a holistic outlook on the overall performance holds a key 
for informed protein design. F2F bridge could be used either for low throughput 
design (see Table 8), accounting for the ‘pitfalls and merits’, in the design 
corresponding to a particular test sequence, or for high throughput in silico screening 
by comparing and ranking a set of test sequences. 










Scale of use Outcome 
High Throughput A database of test sequences or extant proteins of known 
sequence can be queried with the F2F-bridge scoring each 
test sequence and identifying those most suitable. 
Low Throughput On a protein by protein basis the F2F-bridge provides a 
graphical overview of the relationship between the features 
of the test sequence and the optimal values specified by the 





By informing the end user (laboratory  biologist) with performance predictions, F2F 
plot and OP score together aim to ultimately bridge the gap between easily 
generated, seemingly abstract in silico values, and experimental results. 
When combined with downstream testing, we have shown that patterns exist in the 
easily generated in silico data that can be used to generate predictive models. 
F2F Bridge An unweighted and unsupervised combination of features deemed 
likely to have an effect on biological performance showed promising results. The 
F2F-Bridge is able to give an early indication of the expected performance of a test 
sequence. Given the ease of implementation, in comparison with laboratory 
experiments, any information provided about candidate test sequences prior to 
synthesis is extremely valuable. As well as the OP-score provided, the 
accompanying radar plot can also highlight any design aspects of the test sequence 
that diverge from what is required as per the user input parameters. We expect a 
considerable improvement in performance of both the F2F-Bridge and associated 
models, with an expanded dataset, in the meantime further work to refine or build on 
the method was carried out.   
 
Feature selection driven linear models with LASSO  
LASSO regression was used to search for patterns in the data that could help predict 
the level of luminescence due to a test sequence binding to its target. Features that 
have an effect on bound luminescence were identified. When viewing the plots of 
normalised Lambda1 vs coefficients, what is important is the point at which the 
predictive feature enters the model, and the effect it has on the dependent variable. In 
this case, it was impossible to incorporate them into a statistically significant linear 
model to predict any of the variability in bound protein luminescence. We speculate 
that, with a database of this small size, there were too many different processes 
involved from a laboratory perspective for the strategy to accurately predict the final 
outcome (steps in cell expression of a given test sequence, protein binding to target, 
luminescence production). For this reason, and the opportunity to increase the 
sample size, we also analysed the secreted luminescence data. This was much more 




LASSO regression-based feature selection was used again, to look for patterns 
between in silico observations of the antiClfA test sequences and their 
experimentally determined secreted luminescence [14] . This was more effective. We 
have shown that a linear model can be predicted using LASSO feature selection that 
can predict values for luminescence that correlate strongly with experimentally 
determined values. This functioned retrospectively to find patterns between in silico 
features of antiClfA test sequences and their eventual levels of secreted 
luminescence, it can also function prospectively. Once the linear relationship 
between a subset of the in silico features and luminescence has been established for 
antiClfA, this was used to successfully predict luminescence values in a test set of 
antiMUC1 proteins which correlated with the experimental values. The antiMUC1 
data originated from a different experiment, and a different class of proteins to the 
antiClfA test sequence training set, so the fact that the linear model still has 
predictive power is extremely encouraging.   
Random Forest regression trees  
The random forest regression tree model, given the same in silico features as the 
LASSO regression, was able to explain ~41.01% of the variability in secreted 
luminescence within the antiClfA test sequence dataset. The predicted secreted 
luminescence values generated by the regression tree model significantly correlated 
with the experimentally derived secreted luminescence values. On a group by group 
basis, it is extremely encouraging that, as with the LASSO based method previously, 
a random forest regression model trained on the antiClfA test sequences was then 
able to predict luminescence for the test set (antiMUC1 test sequences) that 
correlated significantly with the values derived experimentally [15]. Future work, 
with an expanded database would involve assessing whether these associations 
identified with the two above methods become stronger as the database size 
increases, and also, if this method of predicting overall biological performance holds 
true for other tasks, opening up the possibility of the design of an accurate prognostic 
tool for test sequence performance.  
Relevance to the laboratory scientist  
It is important to frame these results in the context of the difference in cost between 
in silico- and laboratory-based screening. In silico screening requires a fraction of 




of this data can lead to considerable operational savings. Laboratory  
experimentation is often a prolonged process in biological research. In most cases, 
the data from laboratory assays has to be processed/filtered to observe the intended 
correlations between the experimental aims. 
We have shown that in silico predicted protein attributes can play a significant role 
in optimising the design and production of protein constructs. With a larger sample 
size, we expect the aforementioned methods to become more accurate, and therefore 
call for the establishment of a community wide database for sharing both in silico 
and experimental data so that this can be incorporated into a much larger training 
data set applicable to a variety of biological functions. Inspiration came, in part, from 
the SourceTracker algorithm used in metagenomic studies to track possible sources 
of contamination in HTS studies. This involved establishing a database of known 
contaminants, used by the algorithm to refine the search for contaminant bacteria[21] 
. We hope that the establishment of a database of potential test sequences used in 
other research laboratories, combined with their in silico parameters and in the case 
of those that are synthesised, their biological output, would similarly improve the 
accuracy of the predictions of the F2F-Bridge. To expedite the process of database 
formation we plan to launch a server in the coming months which will take as input 
an amino acid sequence, and perform all of the necessary calculations, and will also 
accept one or more measures of overall biological function, in the hope that fellow 
researchers will submit their published data. Both linear models (selected with lasso 
regression) and tree based methods (random forest regression trees) can further assist 
in the prediction of “overall biological performance”. With larger datasets, we hope 
to develop one or more of the following strategies:  
• A method of applying weights to the features in the F2F-Bridge based on the 
outputs of the two models previously mentioned 
• Develop a distinct predictive tool based purely on one or both of these 
methods 
• Design a protocol suited to large scale projects whereby an initial subset of 
the test sequences are generated and screen experimentally and in silico, by 
the F2F-Bridge itself, or with a combination of the three methods outlines in 
this paper. The resulting information could then be fed back into the design 





The design-build-test-learn approach of synthetic biology stands to benefit 
immensely from this method. laboratory assays to test multiple test sequences 
demand a huge amount of resources, time and human effort. In such a situation, 
Function2Form becomes an indispensable strategy for a biologist to visualise and 
improve a given test sequence or to triage potential best performers by scoring and 
ranking the test sequences. Integrating F2F-Bridge into the ‘learn’ step aids user 
empowerment by providing a laboratory biologist with a holistic readout on the 
overall performance of the protein. With a community-based data reporting system 
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Supplementary Text 1: 
Calculation of in silico parameters 
Many in silico features, including those of Molecular Weight, Theoretical pI, and Instability 
Index used in this study, are calculated using the ProtParam facility, hosted by expasy. This 
web-server takes as input only the amino acid sequence and does not require any further user 
engagement. As these are all calculated based on the amino acid sequence they can all 
alternatively be calculated with simple scripts in R or Python, as has been done with Grand 
Average of Hydropathicity (see R script in Github repository). The protein tertiary structure 
prediction was generated by the I-TASSER suite (v5.1), this tool also provides a file 
detailing the per residue solvent accessibility. This can be subset in R to find the 
accessibility of the active site. If I-TASSER is not used, online tools for solvent accessibility 
of particular residues exist, such as the GETAREA tool, hosted by the Sealy Center for 
Structural Biology. The Ramachandran plot is generated on the Saves Server, using the 
Verify3D utility. 
The protein-protein interaction or “Docking” was modelled using a heuristic implementation 
of the Autodock Vina algorithm, Qvina2, within the MGLTools/Autodock Tools (v1.5.6) 
interface. The number of potential active sites within a test sequence was calculated using 
















Supplementary Text 2 
General description of F2F bridge workflow. 
 
1) Collection of data 
The protein scientist must identify the features considered important for the analysis, 
from the literature or from experience. The predictive features to be included in the 
analysis must be converted to the same scale. 
 
2) Preparation of data 
The data must be stored in a table in the following format: 
-Columns must be the predictive features selected for the experiment 
-Rows 4 to end must be the unique names of the test sequences to be analysed 
-Rows 1 and 2 must be the minimum and maximum values (Should be scaled 1:100 
unless impossible) 
-Row 3 should contain the user supplied values either taken from the literature or 
suited to the experimental conditions 
 
3) Running the programme and creating the data 
The F2F function takes as input a table prepared in the manner described in step 2 
and produces both a plot for each sequence and a data frame containing all sequences 
and their associated F2F-plot score. The script can be called from the linux command 
line, or executed within R. For high throughput analysis, the option of generating a 








4) Database free mode 
As a database of protein test sequences, their OP-scores, and their overall biological 
performance is ideally required to apply a system of weights to the predictive 
features used in the plot, an alternative is provided until such a database can be 
established. A function for feature selection with LASSO is provided, and can be 
used to detect relationships between the input in silico data and the overall 
performance on a subset of the experimental data, and the resulting model can then 
be applied to the remaining data. The user is not restricted to the LASSO function 
provided, a variety of tools for feature selection and subsequent model building exist, 
such as RandomForest which was also implemented in the main manuscript.  
 






Supplementary Text 3: 
 
Fluorescence proteins 
Eight synthetic proteins based on the mCerulean Fluorescent Protein, or parts 








Split mCerulean with 
















Split mCerulean without 



























Split mCerulean with 





Protein-related Laboratory Methods  
DNA construct design and build:  DNA sequences were obtained by reverse 
translating the amino acid sequences using EMBOSS Backtranseq 
(https://www.ebi.ac.uk/Tools/st/emboss_backtranseq/). The DNA sequences were 
codon optimized using IDT codon optimisation tool 
(https://eu.idtdna.com/codonopt). Each DNA construct was designed with a FLAG-
tag and homology arms which were verified for upstream experiments using 
SnapGene’s Gibson Assembly simulator (SnapGene.com). 
 
Gene Block synthesis: Gene blocks for the test constructs were sourced from IDT 
(Integrated DNA Technologies, Inc) and amplified using corresponding PCR 
primers. The amplicons were verified using gel electrophoresis (1.5 % agarose) and 
ImageLab 5.2.1, (Bio Rad Inc) was used for band visualisation. 
 
Primer Design: Primers were designed using Benchling (Benchling.com) to 




Primer3Plus to test the primer suitability in terms of appropriate Tm as well as the 
presence of G-C clamps. NEBuilder assembly tool (www.nebuilder.neb.com) was 
used to design assembly primers for the purpose of facilitating construct insertion 
into the plasmid during Gibson Assembly. The finalised primers were obtained from 
IDT. 
 
Competent E. coli: E.coli cells were made competent following the protocol 
described in Cohen et al. 1972. All cells were stored at -80 ˚C and thawed at room 
temperature. OG176 (Oxford genetics, mammalian expression vector) was used for 
amplification and expression of the test sequences with luminescence as the overall 
function and RSFDuet-1 (Novagen, bacterial expression vector) was used for 
amplification and expression of the test sequences with fluorescence as the overall 
function. Both the expression plasmids included Kanamycin resistance gene (KnR). 
For plasmid amplification, the  plasmids were transformed into E. coli BL21 by 
mixing 100 ng plasmid DNA into 30 μL of competent cells. The cells were 
incubated on ice for 20 min and heat shocked by placing at 42˚C for 45 sec. The cells 
were then placed on ice for a further two min. The cells are then suspended into 500 
μL of LB, 100 μL transformed cells were cultured on LB agar supplemented with 50 
μg/mL kanamycin and incubated O/N at 37 ˚C. Select colonies were then grown in 
20 mL liquid LB with 30 ng/mL kanamycin O/N. 
 
Plasmid Extraction: After suspension in liquid LB supplemented with 30 ng/mL 
kanamycin O/N, transformed cells were pelleted by centrifugation at 4000 rpm (2500 
x g) for 10 min. Following the instructions of the Monarch Plasmid miniprep kit 
(New England Biolabs) plasmid DNA was extracted, eluted in 15 μL EB and DNA 
concentration was quantified with a Nanodrop. The eluted samples were stored at -
20 ˚C until further processing. 
 
Restriction Digestion:  The plasmids were digested by appropriate restriction 
enzymes (NcoI, AflII, NdeI, and AvrII) with the addition of CutSmart reaction buffer 




was then incubated at 37 ˚C for 1 h, after which time the digestion was confirmed by 
gel electrophoresis on a 1.5 % agarose gel at 80 V for 90 min. Plasmid DNA was 
purified using a PCR purification kit (Qiagen) and eluted in 15 μL EB. 
 
Gibson Assembly: The assembly master mix was made up in accordance to the 
protocols and reagents described by DG Gibson et al 2009. The gene blocks were 
combined with the plasmid in a DNA concentration ratio of 3:1 in which 72 ng/μL 
plasmid DNA was incubated in a Gibson Assembly master mix with 225 ng/μL of 
construct DNA. The mixture was incubated for 1h at 50 ºC followed by transformed 
into E. coli BL21 cells. 
 
Colony PCR: Colony PCR was used to determine the success of the Gibson 
Assembly and evaluate the transformation of the construct into bacterial cells. In this 
case, select colonies were added to a PCR master mix containing; 25 μL Q5 
polymerase (NEB), 2.5 μL of forward and reverse primers and 20 μL milliQ. Sanger 
sequencing was then carried out by GATC’s light-run service and was verified by 
aligning with a reference sequence. 
Mammalian cell transfection (Luminescence proteins): CHO-K1 (ATCC® 
CCL-61™) cells were used for luminescence protein production. Turbofect 
transfection reagent (Cat No: R0532) was used for in vitro transfection. Transfection 
was carried out using manufacturer’s protocol and supernatant containing protein 
collected after 48 h. 
 
Binding assays: 108 Staphylococcus aureus TCH959 (naturally bearing clfA) or 106 
MCF7 cells (naturally bearing MUC1) were blocked with 5% BSA for 2 h followed 
by incubation with supernatant containing each test construct. Cells were washed 3 
times and resuspended in PBS. Luminescence was measured using Promega 





Fluorescence protein production and bacteria harvesting: Samples were grown 
overnight in liquid LB with 30 ug/mL kanamycin. 100 ml fresh LB was inoculated 
with 5 ml of overnight culture. Bacteria were induced with 1 mM Isopropyl ß-D-
thiogalactoside at 0.5-0.6. OD. Bacteria were harvested when they reached an OD 
0.8. Bacteria were washed and pelleted by centrifugation at 2,500 x g for 10 min. 
BugBuster lysing buffer supplemented with cOmplete protease inhibitor (Roche) and 
Lysonase reagent used for bacterial cell lysis according to the manufacturer’s 
protocols. Protein production was confirmed by running an SDS page. 
 
Fluorescence assays: Fluorescence was measured using an Omega Plate Reader 
(BMG LabTech) and IVIS Lumina II imaging system (Perkin Elmer). Samples were 
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